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Abstract 
The principal serum antibody in birds, IgY, represents a conserved form 
of the last common ancestor of two important mammalian antibody isotypes, 
IgG and IgE. As IgG and IgE perform very different functions in the mammalian 
immune system, the structure and function of chicken IgY was studied to better 
understand the evolutionary changes that brought about this divergence. 
Paradoxically, IgY appears to combine some of the structural and 
functional features of IgG and IgE in one molecule. IgY is functionally equivalent 
to IgG, mediating important immunological effector functions, including 
opsonisation, phagocytosis, complement activation and neonatal protection 
following transportation into the egg yolk. 
Structurally, however, IgY shares features with IgE, the isotype 
responsible for the immediate hypersensitivity reaction which, as systemic 
anaphylaxis, is potentially fatal. Certain structural characteristics of lgE-Fc, 
particularly those shared by IgY but not IgG, are known to contribute directly to 
its anaphylactic properties by influencing the kinetics of binding to its Fc 
receptor, FccRI, i. e. slow dissociation rate and long half-life of receptor-bound 
IgE in tissue. 
A series of recombinant IgY-Fc fragments were designed and expressed, 
containing various mutations to explore the effects of glycosylation and inter- 
heavy chain disulfide bond linkage on the properties of IgY-Fc. Cells expressing 
Fc receptors were identified and used in cell-binding assays to characterise the 
interaction with IgY-Fc. Several features of IgY-Fc were found to be conserved 
-5- 
in IgG-Fc or IgE-Fc, and their structural and functional consequences were 
investigated, providing insights into the evolution of IgG and IgE. 
Finally, two receptor sequences, chFcR/L and FcRy, were cloned from 
chicken leukocytes and found to be homologous to important immunoregulatory 
receptor families in mammals. Unusual features of chFcR/L were identified, 
adding to the rapidly expanding body of research into the phylogeny of the 
adaptive immune system. 
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Chapter 1 Introduction and aims 
Chapter 1 
Introduction: IgY and the evolution of mammalian immunology 
1.1 Overview: studying vertebrate evolution by comparison of extant 
species 
Evolutionary biologists must piece together clues from the present in 
order to study the past. The rate of evolutionary change in a population of 
organisms is driven by selection pressure, which is unique to a particular 
ecological niche. Species that survive to pass on their genetic information 
through successive generations will remain well conserved in the absence of 
further impetus to adapt to their environment. One of the most famous 
examples of this are the coelacanths, a lobe-finned fish thought to be one of the 
closest extant relatives of all land vertebrates (Johanson et al., 2006). Their 
modern-day counterparts, Latimeria (Smith, 1939), bear a striking resemblance 
to relatives preseved in 65-400 million year old fossils (Figure 1.1 i). Although 
the amount of time that has passed for the coelacanth lineage and for the 
lineage of modern mammals since their divergence has been the same, their 
rates of change have clearly been significantly different. In some instances, 
comparative biology can therefore allow deductions to be made about common 
ancestors which are now extinct. At the molecular level, this concept applies to 
sequence divergence of homologous genes. With some notable exceptions, 
biomolecules in fossilised remains older than the cenozoic have not survived to 
the present. Therefore, the only way to study divergence over a range of 
-17- 
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evolutionary timescales is to compare present-day examples from different 
taxonomic classes (Hillier et al., 2004). 
Figure 1.1 i 
A living fossil: coelacanths are an extreme example of how evolution and 
selection pressure are inexorably linked 
One of the greatest zoological `discoveries' of the 20`h century, a modern-day 
coelacanth, Latimeria (top), two species of which have now been described 
(Pouyaud et al., 1999; Smith, 1939). Numerous coelacanths with astonishingly 
similar morphology have been unearthed as fossils (bottom), the oldest of which 
dates back -400 million years (Johanson et al., 2006). 
Birds (ayes) are one of the closest classes to mammals; the last common 
ancestor was thought to have lived -310 million years ago (Hedges, 2002; 
Reisz and Muller, 2004), which places birds at a useful 'intermediate' 
phylogenetic distance from mammals in the vertebrate timescale (Furlong, 
2005). The avian fossil record is patchy, but includes Archaeopteryx, a -150 
-18- 
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million year old relative of all extant bird species, including chickens (Figure 1.1 
ii). Archaeopteryx (and other primitive birds) combine features of both dinosaurs 
and birds, which supports a theropod origin for all modern day birds (Mayr et al., 
2005). 
Figure 1.1 ii 
Archaeopteryx supports a dinosaur origin for all modern birds 
The first Archaeopteryx fossil (left), discovered in 150 million year old limestone 
in Solnhofen, Germany, appears to share features with both dinosaurs and 
modern-day birds, such as the chicken (right). 
Molecular evidence in agreement with this classification is beginning to 
be elucidated (Vargas and Fallon, 2005), although debate as to when speciation 
of most bird lineages occurred (the `neoaves radiation') continues (Brown et al., 
2007; Ericson et al., 2006; Ericson et al., 2007). Amazingly, Tyrannosaurus 
collagen was recently isolated from a uniquely well preserved cretaceous fossil 
by Schweitzer et al. and, consistent with the relationship between dinosaurs and 
birds, the protein sequence was found to share highest identity with a chicken 
homologue (Asara et al., 2007; Schweitzer et al., 2007). The fossil also 
-19- 
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appeared to contain red blood cells, which were nucleated as they are in birds 
(Schweitzer et al., 2005). 
The overall aim of the work presented in this thesis is to exploit the phylogenetic 
relationship between chickens (Gallus gallus) and humans to gain a better 
appreciation of the evolutionary history of some important antibody isotypes, 
with particular emphasis on IgE, the mammalian isotype typically responsible for 
priming of immediate hypersensitvity in severe allergics. 
1.2 Antibodies and their isotypes 
The ability to mount specific anti-pathogenic responses is the hallmark of 
the adaptive immune response. In jawed vertebrates, lymphocytes that 
recognise a particular antigen, following generation of receptor diversity through 
a variety of techniques (Cooper and Alder, 2006), can become activated to 
secrete antibodies (immunoglobulins). This strategy allows gene 
rearrangements (and/or mutations) necessary to generate antigen receptor 
diversity to occur in a particular set of immune cells. The resulting ability to 
recognise specific antigen is thus disseminated to a variety of cell types that 
express Fc receptors (FcR), thereby linking humoral and cellular immunity. 
Through precisely regulated expression of antibodies and their Fc receptors, the 
immune system is capable of tailoring where and how it responds to a particular 
threat (Ravetch and Kinet, 1991). 
Antibodies are glycoproteins and most share a similar heterotetrameric 
structure of two heavy and two light chains composed of globular domains 
containing the immunoglobulin (Ig) fold (Amzel and PoIjak, 1979), one of the 
most abundant motifs in the animal kingdom due to its evolutionary mobility 
-20- 
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(Doolittle and Bork, 1993). The heavy and light chains are joined by disulfide 
and non-covalent bonds in such a way that three separate regions are formed 
(Figure 1.2): two identical Fab arms, which contain the variable regions that 
form the antigen binding site, and an invariant Fc region, which contains binding 
sites for cellular activatory and inhibitory receptors, soluble regulatory receptors 
and the complement system (Sondermann and Oosthuizen, 2002; Woof and 
Burton, 2004). 
In mammals, there are 5 major antibody isotypes (IgM, IgD, IgG, IgE, 
IgA), distinguished by structural and functional differences in their Fc regions; 
classically, the molecular weight of their heavy chains (Janeway, 2001), and the 
particular Fc receptors by which they are recognised (Ravetch and Kinet, 1991). 
In humans there are four subclasses of IgG, which vary in the length of a 
flexible hinge connecting their Fab and Fc regions, although it is IgG1 that 
occurs at the highest levels in serum, '9mg/ml. 
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Fab 
Figure 1.2 
Typical antibody (immunoglobulin) architecture 
Schematic showing the basic structural organisation of an antibody molecule. 
Two heavy (H) and two light (L) chains, composed of either variable (VH or VL) 
or constant (CH or CL) immunoglobulin domains, are held together by disulfide 
bonds (shown in red). In IgG, IgD and IgA a hinge is in place of CH2. Fab and 
Fc regions are indicated. 
In birds, reptiles and amphibians, the predominant serum 
immunoglobulin is an isotype distinct from IgG, called IgY (Amemiya et al., 
1989; Chartrand et al., 1971; Fellah et al., 1993; Leslie and Clem, 1969; Leslie 
and Clem, 1972; Magor et al., 1992). IgY has the typical heterotetrameric 
structure of other antibody isotypes (i. e. the overall architecture of Figure 1.2), 
but is distinct from mammalian IgG, which contains a hinge linker region instead 
of one of the Ig domains (that labelled CH2 in Figure 1.2) in each of its heavy 
(upsilon, v) chains. This, and other structural features, suggest that IgY is more 
similar to mammalian IgE than IgG (Parvari et al., 1988). 
-22- 
Chapter 1 Introduction and aims 
1.2.1 Evolution of the immunoglobulin heavy chain genes 
The Ig heavy chains have evolved through a series of duplication events 
originating from the archetypal mu (µ) gene (which encodes the heavy chain of 
IgM), and subsequent diversification (Figure 1.2.1) has allowed different 
isotypes to specialise or to acquire new functions. The generation of paralogues 
in this way is thought to be one of the major mechanisms by which molecular 
evolution operates (Maynard Smith, 1998). In mammals, the gamma (y) and 
epsilon (c) genes (which encode the IgG and IgE heavy chains respectively) 
appear to have evolved from the duplication and diversification of an upsilon 
(u)-like common ancestor (Warr et al., 1995; Flajnik, 2002). Consequently, the 
adaptive immune systems of modern day mammals now use IgG and IgE in 
place of IgY, whereas the ancestral isotype has been conserved in the 
amphibian, reptile and bird lineages. 
Egg-laying mammals (monotremes), the most 'primitive' extant mammal 
order, possess IgG and IgE that have the same structural organisation as their 
placental and marsupial homologues (Atwell and Marchalonis, 1977; 
Vernersson et, al., 2004; Vernersson et al., 2002). The most recent phylogenetic 
analysis suggests that monotremes diverged from other mammals -166 million 
years ago (Bininda-Emonds et al., 2007), so the duplication of v and the 
divergence to y and e must have occurred in a relatively narrow window (by 
evolutionary standards) of 166-310 million years ago. 
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Figure 1.2.1 
Phylogeny of the immunoglobulin heavy chains 
Phylogram showing the appearance of immunoglobulin heavy chain genes (and 
therefore Ig isotypes) throughout the jawed vertebrates. IgM (µ) occurs in all 
gnathostomata analysed to date and is thought to be ancestral to all other 
isotypes, which have been derived through gene duplication events (Flajnik, 
2002). Several isotypes have arisen in a lineage-restricted fashion or have been 
lost in the common ancestors of other lineages: teleost IgZ (ý) (Danilova et al., 
2005), IgH (H) (Savan et al., 2005), IgT (i) (Hansen et al., 2005) and amphibian 
IgF ((p) (Zhao et al., 2006) and IgX (x, ) (Hsu et al., 1985). IgY (u) appears to be 
well conserved in amphibians (Amemiya et al., 1989), reptiles (Chartrand et al., 
1971; Fellah and Charlemagne, 1988) and birds (Magor et al., 1992; Parvari et 
al., 1988) but appears to have been duplicated in the mammal lineage to 
produce two new isotypes, IgG (y) and IgE (c) (Mussmann et al., 1996; Warr et 
al., 1995). 
-24- 
Chapter 1 Introduction and aims 
1.3 The nature of avian IgY and its mammalian homologues, IgG and IgE 
The best studied IgY is that of birds, particularly the chicken (Gallus sp), 
which has provided an invaluable model organism for a wide range of research 
fields including developmental biology, neurobiology, genetics, virology and, of 
course, immunology. IgY provides a general role in defence against invading 
pathogens in the adult animal (Ambrosius and Hadge, 1987), just as IgG does 
in mammals, through neutralisation of viruses (Kermani-Arab et al., 1976), 
opsonisation of bacteria in order to stimulate phagocytosis (Kogut et al., 2001; 
Qureshi et al., 2000; Qureshi et al., 1990) and activation of complement 
(Koppenheffer et al., 1999). In an analogous system to transcytosis of IgG 
across the mammalian placenta, IgY can be selectively transported into the egg 
yolk, in order to provide protection for the developing embryo and the hatched 
chick (Linden and Roth, 1978; Malkinson, 1965; Tressler and Roth, 1987; West 
et al., 2004). 
IgY has been shown to be capable of mediating passive cutaneous 
anaphylaxis (Bellavia at al., 1992; Chand at al., 1976; Faith and Clem, 1973) 
through sensitisation of granulocytes (Wilson and Heller, 1976) and has been 
shown to be involved in mast cell activation in the chicken gut in response to 
protozoan infections (Rose et al., 1980). In mammals, these properties are 
normally associated with IgE, the isotype that sensitises mast cells and 
basophils in classic type I hypersensitivity (Gould et al., 2003), although murine 
studies have suggested that IgG may also be capable of inducing anaphylactic 
responses, albeit in very high concentrations (Finkelman et al., 2005; Woolhiser 
et al., 2001). 
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IgY was originally referred to as chicken IgG, or y-globulin (Dreesman 
and Benedict, 1965a), but was renamed due to its structural differences with 
mammalian IgG and its occurrence in yolk (Leslie and Clem, 1969). cDNA 
encoding the chicken upsilon heavy chain has been cloned, which allows 
tertiary structure predictions to be made (Parvari et al., 1988). The gamma 
heavy chain of mammalian IgG contains three constant domains (Cy1 to 3) with 
a flexible hinge region between Cyl and Cy2, whereas both IgE and chicken 
IgY contain four constant domains (each encoded by a separate exon as in 
other isotypes) and no hinge (Figure 1.3 i). The hinge region has been 
suggested to increase segmental flexibility in order to allow the Fab 'arms' to 
engage antigen more effectively (Nezlin et al., 1973; Oi et al., 1984), so may 
represent an adaptation of IgG to immunological demands to bind a more 
diverse range of multivalent antigens. The presence of IgF, a hinge-containing 
isotype related to IgY in an amphibian, Xenopus tropicalis (Zhao et al., 2006), 
suggests that this modification of IgY has evolved at least twice, which probably 
reflects its immunological usefulness. 
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IgY 
IgE IgG 
Figure 1.3 i 
Structural similarities between chicken IgY and its mammalian 
homologues, IgG and IgE 
Schematic showing predicted structure of chicken IgY compared with human 
IgE and IgG1. IgG contains only three heavy chain constant domains, and thus 
Cy2 and Cy3 are homologous to Cu3 and Cu4 of IgY, respectively. The pattern 
of putative disulfide bonds and N-linked glycosylation in the Fc region in IgY is 
more similar to that of IgE than IgG. 
Interestingly, although chicken produces only 'full length' IgY either in a 
secreted or membrane bound form (in its role as aB cell receptor), some 
species of amphibian (Marchalonis and Edelman, 1966), reptile (Chartrand et 
al., 1971) and bird, particularly waterfowl (Lundqvist et al., 2006), produce 'full 
length' IgY and/or a truncated version, IgY EFc, whose heavy chain lacks the 
last two C-terminal domains, Cu3 and Cu4 (Magor et al., 1992); the AFc forms 
consequently have limited effector functions (Grey, 1967a; Grey, 1967b). This 
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has been shown in the duck to be the result of alternative mRNA splicing 
(Magor et al., 1994). Quite why some species do this is poorly studied, but it 
has been suggested to be involved in dampening down acute phase reactions 
(Humphrey et al., 2004), presumably in order to avoid IgE-like anaphylactic 
consequences (Parham, 1995). However, this does not explain how chickens 
are able to function with only the 'full length' form. 
Many of the cysteine residues found in the upsilon heavy chain are 
conserved in both mammalian heavy chain classes, which implies similarities in 
disulfide bond configuration, although several of these are conserved between 
IgY and IgE, but not IgG. Typically, immunoglobulin domains contain a single 
'intradomain' disulfide bond. Although this is true of most mammalian IgG Cyl 
domains, except that of rabbit (O'Donnell et al., 1970), the equivalent domain in 
IgE, CE1, contains two (Dorrington and Bennich, 1978). The Ig domains of the 
upsilon heavy chain contain the necessary cysteines at the appropriate 
positions for single intra-domain disulfides, although the homologous domain to 
CE1, Cut, also contains an additional pair. In IgE, this trait and the position of 
interchain disulfides between the two heavy chains in Cc2 (Wan et al., 2002) 
and between the heavy and light chains, appears to be inherited from its IgY- 
like precursor. In human IgG1, both the inter-heavy-light chain bond and the 
inter-heavy chain bonds are in different positions (Milstein and Pink, 1970). The 
upsilon heavy chain additionally contains another cysteine not found in the 
epsilon heavy chain (Figure 1.3 ii), which might allow the formation of a third 
interchain disulphide bond. 
Further structural similarities between IgY and IgE concern the pattern 
and type of N-linked glycosylation. Although IgE is more heavily glycosylated in 
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the Fab region than IgY, their Fc regions share well-conserved glycosylation 
sites. The glycosylation site in chicken Cu2 (N308) is equivalent to the site in 
CE2 (see Figure 1.3 ii), but no homologous site exists in IgG. Although N407 of 
IgY is a site well-conserved in both IgE (N394) and IgG (N297), it is linked to 
high mannose in both IgE and IgY, whereas in IgG complex-type carbohydrate 
is attached (Suzuki and Lee, 2004). 
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Figure 1.3 ii 
Alignment of the heavy chain constant regions of human IgE and chicken 
IgY 
Amino acid sequence alignment of constant regions of human epsilon heavy 
chain and chicken upsilon heavy chain. Immunoglobulin domains are 
differentiated by colour. Cysteine residues are highlighted as follows: Pink = 
forms inter-heavy-light chain disulphide bond. Blue = forms inter-heavy chain 
disulphide bond. Uncoloured = involved in intradomain disulphide bond. The 
additional cysteine in the upsilon chain (C347) that does not occur in the epsilon 
chain is shown highlighted in red. N-linked glycosylation sites are shown in 
grey. 
The CE2 glycosylation site in the human epsilon heavy chain (N265) is -34 
amino acids closer to the C-terminus in all other mammalian epsilon heavy 
chains sequenced to date (Vernersson et al., 2004), a position which aligns with 
chicken N308 (Suzuki and Lee, 2004). The N407 core glycosylation site in the 
chicken upsilon heavy chain is well-conserved in both the epsilon heavy chain 
of IgE (N394) and the gamma heavy chain of IgG (N297, not shown). 
Sequences were aligned using ClustalW (Thompson et al., 1994). Accession 
numbers for sequences used: human epsilon heavy chain: L00022 (Flanagan 
and Rabbitts, 1982); chicken upsilon heavy chain: X07174 (Parvari et al., 1988). 
See appendix 1 for an explanation of upsilon heavy chain amino acid 
numbering. 
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The sequence identity between Cu, Cc and Cy domains (up to -35%) is 
consistent with the level seen between many bird/mammal homologues (Hillier 
et al., 2004), particularly those of the immune system, one of the most rapidly 
evolving biological systems due to the selective pressure of the host/pathogen 
arms race (Hughes, 1997; Murphy, 1993). Comparison of u, c and y heavy 
chain sequences does not unequivocally prove the basal relationship of IgY to 
IgG and IgE, even when individual domains are aligned, which Parvari et al 
ascribe to the divergence time between birds and mammals (Parvari et al., 
1988). However, recent phylogenetic analyses using heavy chain sequences of 
most isotypes cloned from a wide range of taxonomic classes support the 
proposed relationship (Vernersson et al., 2004; Warr et aL, 1995). 
Levels of homology between u, c and y vary along the length of the 
heavy chain (see appendix 1) (Parvari et al., 1988). CH1 is the most poorly 
conserved between u/c and u/y, and both Cu2 and Cu3 show similar amino acid 
identity with all three Cy domains. Overall, domain equivalence seems to be 
most consistent between u and c. DNA segments and even whole exons (which 
encode a complete Ig domain) appear to have been reshuffled between the 
heavy chains of IgG subclasses in some mammals, either by gene conversion 
or unequal crossing-over (Hayashida et al., 1984). Although this is thought not 
to have occurred between the human IgG subclasses, similar processes may 
have occurred early on in the mammal lineage, before the further duplication of 
the early y gene to produce multiple subclasses. 
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1.4 The structure of IgE and its role in immediate hypersensitivity 
IgE-mediated responses are thought to have developed in order to 
provide powerful anti-parasitic immunity (Capron et al., 2004; Zaccone et al., 
2006), although they have been extensively studied due to their inappropriate 
role in allergy or type I hypersensitivity (Gould et al., 2003). 
Mast cells and basophils become primed when antigen-specific IgE binds 
to high affinity receptors on the cell surface. In this state, exposure to that 
antigen (the 'allergen') causes cross-linking of IgE, resulting in an activation 
signal to release inflammatory mediators that cause the sudden onset of allergic 
symptoms. Depending on many factors, such as genetic predisposition, allergen 
dose and mode of entry to the body, these symptoms can range from minor 
local effects to systemic anaphylaxis, which may be life-threatening (Gould et 
al., 2003). Although many factors contribute to priming of the allergic response, 
IgE sensitisation of mast cells and basophils is a crucial part of the pathway and 
is primarily due to the uniquely high affinity of the interaction between IgE and 
its 'high-affinity receptor', FccRI (Gould et al., 1991). 
IgE has an affinity (KA) for FccRI of -1010 M'1, which is approximately two 
orders of magnitude greater than the highest affinity IgG receptor interaction 
(Ravetch and Kinet, 1991) and five orders of magnitude greater than the affinity 
of IgG for FcyRIII, the receptor that is the closest relative of FcERI (Maenaka et 
al., 2001). This exceptionally high receptor affinity is predominantly caused by a 
slow rate of dissociation, leading to a half life of -16 hours (McDonnell et al., 
2001), which is increased in tissue to -2 weeks due to rebinding and slow 
antibody clearance (Geha et al., 1985; Gould et al., 2003). The half-life of 
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equivalent IgG: FcyR complexes, by contrast, is in the minute timescale despite 
structurally similar interactions (Garman et al., 2000; Sondermann et al., 2000). 
Although IgE binds with high affinity through sites in CE3 (Garman et al., 
2000), biophysical studies involving IgE-Fc fragments and soluble FcERIa 
receptor domains have shown that the Cc2 domain is responsible for an 
increased stability of the IgE: FcERI complex (McDonnell et al., 2001). 
Interactions between a soluble CE2 domain and both a soluble FccRla construct 
and a CE3-4 fragment have been demonstrated using NMR and analytical 
ultracentrifuge experiments, respectively (McDonnell et al., 2001). The crystal 
structure of the complete lgE-Fc region (Cc2-4) shows that it has an 
asymmetrical, acutely bent structure (Figure 1.4), with the Cc2 domains doubled 
back over in contact with one of the CE3 domains (Wan et al., 2002). These 
data, together with differences observed in the crystal structures of unbound 
CE3-4 (Wurzburg et al., 2000) and CE3-4 in complex with receptor (Garman et 
al., 2000) has led to the postulation of a conformational change upon FccRl 
binding, which may explain the importance of CE2 in determining the observed 
slow rate of dissociation that leads to effector cell priming in vivo (Wan et al., 
2002; Wurzburg and Jardetzky, 2002). 
Accessibility of residues in the receptor binding site appear to be 
somewhat restricted in the unbound CE3-4, with the CE3 domains adopting a 
'closed' conformation. In the bound structure, the orientation of the Cc3 domains 
has changed so that they are markedly further apart, or'open'. In the complete 
(unbound) IgE-Fc structure, one of the CE3 domains is in the `open' state, but 
the other is 'closed'. A movement of at least one Cc3 domain therefore seems 
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necessary to allow full access to the receptor binding site, accompanied by a 
major rearrangement of the CF-2 domains, in order to expose the second Cc3 

















The structure of IgE-Fc is asymmetric and acutely bent 
The crystal structure of full length IgE-Fc CE2-4 solved by Wan et al. (2002) 
shows that whilst the CE3-4 portion of the Fc has a symmetrical `horseshoe' 
structure similar to that of IgG-Fc (Deisenhofer, 1981), the CE2 domain pair is 
bent back over one of the CE3 domains, not raised above them in the same 
plane, as predicted by previous models (Padlan and Davies, 1986). The crystal 
structures are shown in the ribbon diagram (centre), with schematics showing 
how domains are coloured (left) and oriented (right). 
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The lack of a domain homologous to CE2 in IgG subclasses would 
preclude such a mechanism in this isotype, and may explain, or at least 
contribute to, the lower affinity of IgG-Fc receptor interactions. However, the 
apparent combination of IgG-like function and IgE-like structure in a conserved 
form of their evolutionary precursor, IgY, seems paradoxical. Further study of 
the structure and function of avian IgY and its Fc receptors in comparison with 
the mammalian homologues has the potential to reveal which phylogenetic 
changes have led to the dichotomy of IgE and IgG function. 
The proposed conformational change in IgE upon receptor binding may 
be one of the most significant differences between IgE and IgG; it will be 
informative to investigate whether a similar mechanism occurs upon IgY binding 
to receptor. IgM, the primordial antibody isotype from which all others are 
thought to be derived (Flajnik, 2002), can form large pentameric (high-avidity) 
complexes that undergo a conformational change when antigen is bound, from 
a planar structure to a 'table'- or 'staple'-like structure (Feinstein and Munn, 
1969), revealing complement binding sites (Hughes-Jones et al., 1984). 
Interestingly, the conformational change in IgM occurs through a pivoting of Cµ2 
(Perkins et al., 1991), the domain homologous to Cu2 in IgY and CE2 in IgE. As 
the mu heavy chain of IgM was duplicated to produce the upsilon heavy chain 
of IgY, from which IgE was derived in mammals (Warr et al., 1995), flexibility 
may have been conserved from Cµ2 to CE2, via Cu2. 
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1.5 Antibody Fc receptors and their homologues 
Fc receptors have been studied extensively in mouse and human, 
although orthologues have been identified in many other mammals. Very little is 
known about Fc receptors in other vertebrate classes, but the existence of 
analogues can be inferred in species whose humoral immunity has similar 
aspects to that of mammals. Fc receptors provide the means by which 
antibodies are 'sensed' by the immune system in order to regulate their levels, 
export them across mucosal epithelia and, of course, trigger anti-pathogenic 
effector responses. Antibody-dependent responses include opsonisation- 
induced phagocytosis, antibody-mediated cellular cytotoxicity (ADCC), release 
of inflammatory mediators and classical complement-mediated killing. The 
nature of the antibody-induced response depends on a complex interplay of the 
various antibody isotypes with several types of Fc receptor that differ in 
structure, distribution, signalling potential, and affinity and specificity of the 
antibody interaction (Cohen-Solal et al., 2004; Nimmerjahn and Ravetch, 2006; 
Ravetch and Kinet, 1991). 
With a few exceptions, such as the low affinity receptor for IgE (FccRII or 
CD23), which is a C-type lectin (Gould et al., 1991) and the neonatal Fc 
receptor (FcRn), which is an MHC Class I related protein (Ghetie and Ward, 
2000), the mammalian Fc receptors (FcR) for IgE and IgG are members of a 
closely related protein family which, like their ligands, are also members of the 
immunoglobulin superfamily. The 'a-(alpha) chains' of the receptors for the IgG 
subtypes, FcyRI (CD64), FcyRII (CD32), FcyRlll (CD16), and the high affinity 
receptor for IgE, FccRl are composed of two or three immunoglobulin-like 
domains, a transmembrane domain and a cytoplasmic tail (Table 1.5). The a- 
-36- 
Chapter 1 Introduction and aims 
chains reside in the plasma membrane such that the immunoglobulin-like 
domains, which contain the Fc binding site, are extracellular. Except for FcyRll 
and its isoforms, the FcR a-chains invariably lack signalling motifs in their 
cytoplasmic tails and must associate with adaptor molecules (typically FcsRly) 
in order to have signalling potential (Ravetch and Kinet, 1991). Classically, 
cross linking of receptors upon binding to aggregated antibody (typically caused 
by multivalent antigen) causes phosphorylation of these motifs, recruiting SH2- 
containing signalling molecules, which, in sufficient numbers, initiates a 
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Table 1.5 (previous page) 
Structural and functional heterogeneity of Fc receptors for human IgG and 
IgE 
Characteristics and expression patterns of human FcyRs and FccRs. FcyRs 
have different affinities for the four subclasses of IgG, the values shown are for 
the subclass with highest affinity. The affinity of the FcyRII & III isoforms is low 
enough that monomeric IgG dissociates too rapidly to be detectable in cell 
binding assays. These receptors recognise IgG that is already cross-linked, 
either in immune complexes (networks of antibodies bound to antigen) or on the 
surface of larger particles or opsonised bacteria, which have a higher avidity. 
The balance between the proportion of cross-linked receptors that have 
activatory motifs (or are associated with activatory subunits) and those that 
either lack signalling potential or have inhibitory motifs is crucial to the 
regulation of the induced effector response. Data shown are from Ravetch and 
Kinet (1991), Cohen-Solal et al. (2004), Gould et al. (2003), Janeway (2001), 
McCloskey et al. (2007) and S. N. Karagiannis (personal communication). 
*FccRI has been shown to be expressed on airway smooth muscle cells and is 
thought to be involved in triggering airway constriction, particularly in asthmatics 
(Gounni et al., 2005). CR = complement receptors. I= inducible. 
Although a receptor that mediates transcytosis of secreted IgA in 
mucosal immunity has been characterised in the chicken (Wieland et al., 2004), 
so far the only IgY-Fc receptor to be cloned is the yolk sac receptor, which 
allows antibody to be transported into the chicken egg yolk in order to provide 
neonatal protection (Linden and Roth. 1978; Tressler and Roth, 1987; Morrison 
et al., 2001; West et al., 2004). Importantly, the yolk sac receptor has been 
shown to be unrelated to its functional equivalent in mammals, the MHC-related 
FcRn, which transfers IgG from mother to foetus (Ghetie and Ward, 2000). At 
the time of this investigation, no leukocyte Fc receptor analogous to receptors 
for IgG or IgE have been isolated. Previous studies have shown indirect 
evidence for the existence of such receptors, particularly those mediating 
phagocytosis of opsonised bacteria (Kogut et al., 2001; Qureshi et al., 1990 & 
2000) and hypersensitivity (Faith and Clem, 1973). 
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1.5.1 Fc receptors that do not bind Fc? 
The Fc receptor family is one of many Ig-like immunoreceptor families 
which all share a common ancestry. Through global genome and EST studies, it 
is becoming increasingly apparent that Ig-containing receptors have undergone 
considerable duplication and divergence throughout the jawed vertebrates. 
Many families have been differentially favoured and expanded in a lineage- 
restricted manner, so that a great deal of heterogeneity exists between the 
number of homologues of each family. 
A large array of human and mouse FcR family members was recently 
discovered on the basis of sequence similarity. Initially, these genes were given 
a host of different designations depending on how they were discovered (Davis 
et al., 2001; Hatzivassiliou et al., 2001; Mechetina et al., 2002), but for clarity 
they are now termed "Fc receptor-like" (FCRL or Fcrl) (Maltais of al., 2006). 
Despite conservation of many of the key residues involved in the binding sites 
of FcyRl-III and FccRI, the FCRLs appear to lack the ability to bind Fc (Davis of 
al., 2002). As yet, no ligands have been found for any FCRL, but several 
features are consistent with an immunoregulatory role; FCRL appear to be 
preferentially expressed on B cells (Davis of al., 2001; Hatzivassiliou of al., 
2001; Miller et al., 2002) and contain signalling motifs in their cytoplasmic 
regions that have been shown to be functional in an activating FCRL (Leu et al., 
2005) and an inhibitory FCRL (Ehrhardt et al., 2003). This is further supported 
by links between an FCRL promoter polymorphism and autoimmune disease 
(Ikari et al., 2006; Umemura et al., 2006), which occurs when immune 
regulation is dysfunctional. 
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Closely related sequences to the FcR and FCRL proteins have been 
noted in several other species but with a wide variation in frequency. In frog, 
there are more than 70 homologues, termed XFL (Guselnikov, 2004), whereas 
in fish there may be very few (Stafford et al., 2006). Davis et al. suggest that the 
presence of FcRH genes throughout the jawed vertebrates is an indication of a 
crucial function that has been conserved (Davis et al., 2005), however it may be 
the case that convergent evolution has selected different receptor families to 
perform similar tasks in different species. At the commencement of this 
investigation, no Fc receptor family members (either FcR-like or FCRL-like 
proteins) had been reported in the chicken. 
1.6 Aims of the investigation 
Although chickens were the model for many early experiments in 
immunology, very little is known about the structure and function of one of their 
key immunological players, the principal serum antibody, IgY. As recent studies 
have suggested that this isotype represents a conserved form of the last 
common ancestor of IgG and IgE, two of the most important mammalian 
isotypes, IgY is worthy of further investigation. The overall aim of the work 
reported in this thesis was to initiate a structural and functional investigation into 
IgY and its Fc receptors. Specific questions to be addressed were: 
1) What structural and functional features of IgG and IgE in mammals are 
conserved from IgY? 
There are several similarities and differences in the minimal structural 
requirements in IgG and IgE for Fc receptor recognition. Several factors were 
selected for investigation in IgY: presence of the Fab region, presence of Cu2, 
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and position of glycosylation and inter-heavy chain disulfide bonds in the Fc 
region. 
2) Which immune cell types in the chicken possess IgY-Fc receptors and 
what are their structural and functional characteristics? 
At the outset of this investigation, no IgY receptors analogous to FcyRI-III 
or FccRI-II were reported. In order to begin a study of IgY-Fc receptor binding, 
cells bearing receptor and/or soluble receptor were required. 
3) Following identification of an IgY-Fc receptor, which parts of the IgY 
structure influence the kinetics of receptor binding? 
Given the unusual structure of IgE (CE2 domains and bent IgE-Fc) and 
its influence on receptor binding kinetics, the similarity in secondary structure 
between IgY and IgE poses an interesting question; is the 3D structure of IgY 
similar to that of IgE and if so, how is IgY able to function as an IgG-like 
antibody? The IgE: FccRI interaction is a potential target of allergy therapeutics. 
A means of reducing the binding affinity or increasing the dissociation rate of 
IgE from effector cells (i. e. conferring IgG-like kinetics) may be an effective way 
to prevent long-term sensitisation. Studying how the structure and function of 
IgE has evolved since the last common ancestor with IgG in order to enhance 
its anaphylactic properties, may provide some clues as to which structural 
elements may be the best targets for inhibitory small molecules. 
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Chapter 2 
Materials and Methods 
2.1 Materials and stock solutions 
The following listing details stock solutions and other materials used in 
this investigation. All other chemicals are listed with their suppliers in 
subsequent protocols. Solutions were made up in Milli-Q water unless specified 
otherwise. 
AC elution buffer: 0.2M glycine + 0.1% sodium azide. pH 2.5.0.45µm filtered, 
degassed, and stored at 4°C. 
AC equilibration I wash buffer: 10mM Tris-HCI + 0.1M sodium chloride + 
0.1% sodium azide. pH 8.6.0.45µm filtered, degassed, and stored at 4°C. 
AC neutralisation buffer: 2M Tris-HCI + 0.1% sodium azide. pH 8.6.0.451im 
filtered, degassed, and stored at 4°C. 
Acrylamide: 30% (w/v) Acrylamide / Bisacrylamide (Severn Biotech, 20-2100- 
05). 
Activation buffer (for papain): 100mM Tris-HCI, pH 7.2 + 2mM EDTA + 10mM 
Cysteine-HCI (Perbio/Pierce, 44889) 
Ammonium persulfate (APS): 10 % (w/v) solution stored at 4°C (Sigma, 
A3678). 
Antibodies, see section 2.1.1. 
Antibiotics 
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Ampicillin (1000X): 100mg/ml (Sigma, AG518). 
Kanamycin (1000X): 50mg/ml (Sigma, K4000). 
Geneticin (G418): 50mg/ml (Gibco, 10131-027). 
Hygromycin B: 50mg/ml (Invitrogen, 10687-010). 
Blood, chicken: peripheral blood from 4-8 week old broilers, Leonard Ames 
Ltd., Ampthill, Bedfordshire, UK. 
cDNA clones: IMAGE clones obtained from Geneservice: 
human FccRIa in pDNR-LIB (IMAGE 4294467). 
human FcRy in pBS SK- (IMAGE 6129089). 
cDNA library, chicken splenocyte: A kind gift from J. Young, BBSRC Institute 
for Animal Health, Compton, UK. 
Cells, see section 2.1.2. 
ChloroformllAA: 24: 1 chloroform to isoamyl alcohol, stored at 4°C in the dark. 
Competent E. coli: 
XL-1 Blue: Stratagene, 200249. 
XL-10 Gold: Stratagene, 200314. 
TOP 10: Invitrogen, C4040-03. 
Coomassie blue stain: Milli-Q water, methanol and acetic acid, 5: 5: 1 + 0.05% 
(w/v) Coomassie brilliant blue R250 (Electran, 44418). 
Coomassie destain: 5% methanol + 7.5 % acetic acid. 
DEAE sepharose: HiTrap DEAE FF, 5ml prepacked column (GE Healthcare, 
17-5154-01). 
DLS buffer: 20mM Tris-HCI, pH 7.5 + 25mM sodium chloride. 
DNA breaking buffer (vacuum blotting): 0.25M hydrochloric acid. 
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DNA denaturing buffer (vaccum blotting): 1.5M sodium chloride + 0.5M 
sodium hydroxide. 
DNA gel loading buffer (x6): Promega, G1881. 
DNA molecular weight markers 
1 kb ladder: Promega, G6941. 
100bp ladder: Promega, G8291. 
I/ EcoRl / Hindill: Prepared in house (P. Marsh). 300µg/ml in 10mM 
Tris-HCI, pH 8.0 + 20mM sodium chloride + 10mM EDTA, 5% (v/v) 
glycerol + 0.025% (w/v) Bromophenol Blue. 
DNA neutralisation buffer (vacuum blotting): 1.5M sodium chloride + 0.5M 
Tris-HCI, pH 7.0. 
DNA transfer buffer (vacuum blotting): 1.5 M sodium chloride + 100mM 
sodium hydrogen phosphate + 10mM EDTA. pH 7.4. 
DTT: 1M Dithiothreitol (Sigma, D9779), prepared fresh before use. 
EDTA: 0.5M disodium ethylenediamine tetraacetic acid, pH B. O. Sodium 
hydroxide was added until EDTA was dissolved, then pH adjusted to pH8.0 with 
concentrated hydrochloric acid. 
ELISA Coating buffer: 15 mM Sodium carbonate + 35 mM Sodium hydrogen 
carbonate. pH 9.6. 
ELISA phosphate-citrate buffer: 0.05 M phosphate-citrate buffer + 0.03% 
sodium perborate (Sigma, P4922). 
Ethidium bromide: 10mg/ml (Sigma, E1510). 
Formaldehyde (37%): Sigma, F1635. 
Freeze medium (N2 storage of cells): 10% DMSO (Sigma, D2650) + 90% 
FBS. 
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GIA (100X): 600mg Glutamate (Sigma, G-5638) + 600mg Asparagine (Sigma, 
A-4159) in 100ml Milli-Q water. 0.2µm filtered and stored at -20°C 
HPLC running buffer: 0.5M Tris-HCI + 0.25M sodium chloride + 0.05% (w/v) 
sodium azide. pH 7.2. Degassed and 0.2µm filtered. 
IE bind / wash buffer: 20mM Tris-HCI + 25mM sodium chloride. pH 7.5. 
IE elution buffer: 20mM Tris-HCI + 2M sodium chloride. pH 7.5. 
Luria-Bertani (LB) agar: 32g/L in Milli-Q water, autoclaved at 121°C for 15 
minutes (Invitrogen, 22700-025). 
Luria-Bertani (LB) broth: 20g/L in Milli-Q water, autoclaved at 121°C for 15 
minutes (Invitrogen, 1278-052). 
Lysis buffer (for cell membrane protein solubilisation): 0.5% NP-40 (BDH, 
56009) or Triton X-100 (Sigma, T8787) + 10mM Tris, pH 7.5 + 25mM potassium 
chloride + 120mM sodium chloride + 1X Complete protease inhibitors (Roche, 
1873580). 
Media (cell culture), see section 2.1.2. 
Nucleosides (50X): 35mg Adenosine (Sigma, A-4036) + 35mg Guanosine 
(Sigma, G-6264) + 35mg Cytidine (Sigma, C4654) + 35mg Uridine (Sigma, U- 
3003) + 12mg Thymidine (Sigma, T-1895) in 100ml Milli-Q water. 0.2µm filtered 
and stored at -20°C. 
Nitrocellulose blotting membrane: Protran BA83 0.2µm (Schleicher and 
Schuell, 10401396). 
Oligonucleotides / Primers, see section 2.1.4. 
Papain digestion buffer: 0.1 M sodium phosphate buffer, pH 7.0 (see below) + 
3mM EDTA +1 0mM L-cysteine (Sigma, W326305). 
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PBS (Phosphate buffered saline, 10X): 1.37M Sodium chloride + 27mM 
Potassium chloride + 80mM Disodium hydrogen phosphate + 15mM Potassium 
dihydrogen phosphate. pH 7.4.0.05% sodium azide added to 1X PBS when 
used as a protein storage buffer. 
PBS (for cell methods, IX): D-PBS, Invitrogen, 14190-094. 
PBS-Marvel: 1X PBS + 2% (w/v) Marvel powdered milk (Premier international 
foods). 
PBS-Tween: 1X PBS + 0.05% (v/v) Tween-20 (Sigma, P5927) 
PBS-Tween-Marvel: 1X PBS + 0.05% (v/v) Tween-20 (Sigma, P5927) + 2% 
(w/v) Marvel powdered milk (Premier international foods). 
PBS-BSA: 1X PBS + 1% (w/v) bovine serum albumin (Sigma, A7030) + 0.05% 
sodium azide. 
Phenol: Chloroform: isoamyl alchohol (25: 24: 1): Sigma, P-2069. 
Ponceau Red stain: 1.25g (0.25% w/v) Ponceau S+ 200ml methanol + 75ml 
acetic acid + 225ml Milli-Q water. 
Plasmids, see section 2.1.3: 
Protein molecular weight standards: 
For SDS-PAGE: SeeBlue Plus 2 (Invitrogen, LC5925). 
For size exclusion chromatography: Gel filtration molecular weight 
marker kit (Sigma, MW-GF-1 000). 
PVDF membrane: Sequi-Blot PVDF (Biorad, 162-0186). 
SDS stock for PAGE gels: 10% (w/v) sodium dodecyl (Lauryl) sulphate 
(Sigma, L3771). 
SDS-PAGE loading buffer (4X): 8% SIDS + 40% Glycerol + 20% ß- 
mercaptoethanol + 0.008% bromophenol blue + 0.25M Tris-HCI. pH 6.8. 
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SDS-PAGE running buffer (10X): 0.25M Tris + 1.92M Glycine + 1% SDS. PH 
8.3. 
Semi-dry transfer anode buffer: 0.4M Hexanoic acid (c-amino-n-caproic acid) 
+ 0.025M Tris + 20% (v/v) methanol. PH 9.4. 
Semi-dry transfer cathode buffer: 0.3M Tris + 20% (v/v) methanol. PH 10.4. 
SOC medium: Invitrogen, 15544-034. 
Sodium phosphate buffer (pH 7.0): 19.5ml 0.2M monobasic sodium 
phosphate + 30.5ml 0.2M dibasic sodium phosphate. pH 7.0. 
Southern hybridisation buffer: ULTRAhyb (Ambion, 8670). 
Standard saline citrate (SSC, 20X): 3M sodium chloride + 0.3M sodium citrate. 
pH 7.0. 
Streptavidin-RPE: Dako cytomation, R0438. 
Stock isotonic Percoll: 90% Percoll, 1,130 g/mI (Amersham, 17-0891-01) + 
10% 1.5M sodium chloride. 
Superdex 200: Pharmacia/GE Heathcare, 17-5175-01. 
TBE (10X): 0.89M Tris + 0.89M Boric acid + 0.02M EDTA. pH 8.3. 
TBS (10X): 1M Tris-HCI + 1.5M Sodium chloride. pH 7.5.0.05% sodium azide 
added to 1X TBS when used as a protein storage buffer. 
TE: 10mM Tris-HCI, pH7.6 + 1.0mM EDTA, pH 8.0. 
TEMED: N, N, N', N'-tetramethylethylenediamine (Sigma, T-9281). 
Trypan blue solution (0.4%): Sigma, T8154. 
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2.1.1 Antibodies, fragments and conjugates 
Polyclonal / Catalogue Other Species Monoclonal Reactivity Conjugate Supplier number info 
Goat P IgY-Fc - ICL GGFC-30A 
Rabbit P IgY HRP Promega G135A 
Rabbit P IgY FITC Promega G269A 
Donkey P IgY - Chemicon AP194 





Mouse M IgY - Sigma C7295 
clone 
CG-106t 
Rabbit P Goat Igs FITC Abcam ab6737-1 
Mouse M FLAG tag - Sigma F1804 
Mouse M V5 tag - Sigma V-8012 
clone 
V5-10 
Goat P Mouse Igs FITC Dako F0479 F(ab')2 
Rabbit P Hu Gsn FITC Dako F0315 F(ab')2 
Mouse M human FcsRla - 
clone 
15-1$ 
Table 2.1.1 1 
Primary and secondary antibodies used in immunoassays 
* Immunogen was papain-derived IgY-Fc. 
t Antibody was found to react with Cu2-4 but not Cu3-4 (data not shown), 
therefore epitope is likely to be in Cu2. 
$ Antibody prepared in house (S. Karagiannis), cells originally a gift from J. -P. 
Kinet (Wang et al., 1992). 
Species Fragment Supplier Catalogue Other info 
number 
N265Q/N371Q 
Human IgE-Fc Made in house (Young et al., (C£2-4) 
1995) 
Human I G1 Sigma 1-5154 
Human I Gl-Fc Bethyl Laboratories P80-104 
Rabbit IG Sigma 1-15006 
Chicken IgY Jackson 003-000- (Serum) Immunoresearch 003 
Chicken IgY (Yolk) Prepared in house from egg yolk 
Chicken IgY-(Fab)2 Rockland 003-0104 Sold as F(ab)2, but found to 
be 
single Fab (data not shown) 
Table 2.1.1 ii 
Antibodies and antibody fragments used as test material 
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2.1.2 Cell lines & media 
MQ-NCSU: chicken monocyte-like cells, a kind gift from M. A. Qureshi (Qureshi 
et al., 1990), North Carolina State University, Raleigh, USA. 
38.5% Lebovitz L-15 medium (Invitrogen 11415-056) 
38.5% McCoy's 5a medium (Invitrogen, 22330-070) 
5% tryptose phosphate broth (Invitrogen, 18050-039) 
8% ultra-low IgG foetal bovine serum (Invitrogen, 16250-078)* 
2mM L-glutamine (Invitrogen, 25030-024) 
11 pg/ml sodium pyruvate (Invitrogen, 11360-039) 
10pM 2-mercaptoethanol (Invitrogen, 31350-010) 
1% penicillin/streptomycin (Invitrogen, 15140-122) 
1% amphotericin B desoxycholate ('Fungizone', Invitrogen, 15290- 
026) 
* Original MQ-NCSU culture media ('LM-Hahn') contains 10% chick serum 
(Sigma, 5405) in addition to 8% FBS (Invitrogen, 10270-106); the medium was 
modified so that IgY would be absent. 
CHO-KI: Chinese hamster ovary cell line (Kao and Puck, 1968; Puck et al., 
1958). ECACC No. 85051005. 
D-MEM (Sigma, D6046) 
10% FBS (Invitrogen, 10270-106) 
1% penicillin/streptomycin/glutamine (Invitrogen, 10378-016). 
NS-0: Mouse myeloma cell line that is phenotypically glutamine synthetase 
(GS) negative, so can be stably transfected with GS vectors (Bebbington et al., 
1992; Galfre and Milstein, 1981; Young et al., 1995). ECACC No. 85110503. 
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Non-selective NS-0 media: 
IMDM w/o L-glutamine (Sigma, 13390) 
2mM Glutamine (Invitrogen, 25030-024) 
10% FBS (Invitrogen, 10270-106) 
1% penicillin/streptomycin (Invitrogen, 15140-122) 
Selective NS-0 media (Glutamine free): 
IMDM w/o L-glutamine (Sigma, 13390) 
10% Dialysed FBS (Invitrogen, 26400-044) 
1X Nucleosides (see section 1.1) 
1X G/A (see section 1.1) 
1X Non-essential amino acids (Invitrogen, 11140-035) 
1% penicillin/streptomycin (Invitrogen, 15140-122). 
HEK 293: Human embryonic kidney cell line (Graham et aL, 1977). ATCC No. 
CRL-1573. Same growth medium as CHO-K1 above. 
U937: Human monocyte-like cell line (Sundstrom and Nilsson, 1976). Cells 
were a kind gift from J. -P. Kinet, Harvard University, Cambridge, USA. 
RPMI 1640 (Invitrogen, 31870-025) 
10% FBS (Invitrogen, 10270-106) 
1% penicillin/streptomycin/glutamine (Invitrogen, 10378-016). 
RBL-SX38: Rat basophilic leukaemia cell line transfected with human FcERI 
subunits a, ß, and y (Wiegand et al., 1996). Cells were a kind gift from J. -P. 
Kinet, Harvard University, Cambridge, USA. 
MEM (Invitrogen, 31095-029) 
10% FBS (Invitrogen, 10270-106) 
1% penicillin/streptomycin/glutamine (Invitrogen, 10378-016). 
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2.1.3 Plasmid vectors 
pRY24: Mammalian expression vector based on pMRRO18 / pEE6hCMV 
(Stephens and Cockett, 1989), modified to encode human IgE-Fc CE2-4 (Young 
et al., 1995). Contains a gene encoding glutamine synthetase. Selected in E. coli 
using ampicillin resistance. 
pSP64T: Cloning vector (Genbank accession no. X65327), previously 
commercially available (Promega). Vector was a kind gift from P. Marsh, King's 
College London. Selected in E. coli using ampicillin resistance. 
pCDNA3: Mammalian expression vector containing neomycin/G418 
resistance gene (Invitrogen, V79020). Selected in E. coli using ampicillin 
resistance. 
pCDNA3.1/Hygro: Mammalian expression vector containing hygromycin 
resistance gene (Invitrogen, V87020). Selected in E. coli using ampicillin 
resistance. 
pCR4-TOPO: TOPO vector used to clone PCR products with T/A ends for DNA 
sequencing (Invitrogen, 45-0071). Selected in E. coli using kanamycin 
resistance. 
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2.1.4 Oligonucleotides 
All oligonucleotides were synthesised by MWG Biotech. 
Oligonucleotide Notes 
5'- TAAATCCCGGTAAATGAGTTTAAACCTGCCTCCCTCCCTCCCAGG - 3' Mutagenesis primers to introduce 
5' - CTGGGAGGGAGGGAGGCAGGTTTAAACTCATTTACCGGGATTTAC - 3' Pmel restriction site 
Into pRY24 
Forward primer used to amplify Cu2-4 
5' - TGCTCAAAAAGGAGGATATCGTCGCCCGAGTAGGGCCCCCACTG - 3' from cDNA library with Ec0RV 
restriction site 
Forward primer used to amplify Cu3-4 
5' - GTGGAGGATCACGTC ATAT TGCCCGGACGGCGCTCAG - 3' from cDNA library with coRV 
restriction site 
Reverse primer used to amplify Cu2-4 
5' - CGAGGGTTTCGCACCCGTTTAAACTTATTTACCAGCCTGTTTCTG - 3' and Cu3-4 from cDNA library with Pmel restriction site 
5' - AGCCTGAGCAGCCGCGTCCAGGTCAGCGGCACCGATTGG - 3' Mutagenesis primers to introduce 5' - CCAATCGGTGCCGCTGACCTGGACGCGGCTGCTCAGGC - 3' N308Q mutation into IgY-Fc 
5' - GTCCTCCAAGAACACTTCCAGGGCACCTACAGCGCCAGC - 3' Mutagenesis primers to Introduce 5' - GCTGGCGCTGTAGGTGCCCTGGAAGTGTTCTTGGAGGAC - 3' N407Q mutation into IgY-Fc 
5' - GCCAGATGTGATATCTGCCCGGACGGCGCTCAG - 3' Mutagenesis primers to Introduce 5' - CTGAGCGCCGTCCGGGCAGATATCACATCTGGC - 3' C340S mutation into IgY-Fc 
5' - GACGGCGCTCAGAGCTGCAGCCCCATCCAGCTG - 3' Mutagenesis primers to introduce 5' - CAGCTGGATGGGGCTGCAGCTCTGAGCGCCGTC - 3' C347S mutation into IgY-Fc 
5'- ATGTGATATCTGCCCGGACGGCGCTCAGAGCTGCAGCCCCATCC - 3' ' C340S and 
Mutagenesis 
C347S 
primers to introduce 
340S mutations into 5 - GGATGGGGCTGCAGCTCTGAGCGCCGTCCGGGCAGATATCACAT - 3' IgY-Fc 
5' - TGGCAAACTCCTGGAGCACACAGAAAC - 3' 
chFcR/L ECI forward 
'gene specifc primer for RACE PCR 
5' - GGCATTCTGGATCCTGTACGTGTTGGTT - 3' 
chFcR/L ECI reverse 
'gene specifc pecifc primer' for RACE PCR 
5' - GCAGTTTGGCTGCGGTGCGGTTCTAC - 3' 
chFcR/L EC2 forward 
'gene specifc primer' for RACE PCR 
5' - GTTTGGTGATGTCGGCTCCATCCCTG - 3' 
chFcR/L EC2 reverse 
'gene specifc primer for RACE PCR 
5' - TCCTCTGAGTACCAGGTGCCAGCAGTGG - 3' 
chFcR/L EC3 forward 
'gene specifc pecifc primer' for RACE PCR 
5' - CAGGAGTAGAACCCCGTGTCCATCAGCC - 3' 
chFcR/L EC3 reverse 
'gene specifc primer' for RACE PCR 
5' - TCGACCCAACAGAGTGACAACGGGC - 3' 
chFcR/L EC4 forward 
'gene specifc primer' for RACE PCR 
5'- ACCTTCAGGCTCCGGGCTGGGCT - 3' 
chFcR/L EC4 reverse 
'gene specific primer' for RACE PCR 
5' - CTAGACAGGTGGTTCGGGATG - 3' 
chFcR/L forward primer to obtain'full- 
length! CDS 
5' - TGGGTTTACGGCGCTCCT - 3' chFcR/L 
reverse primer to obtain 'full- 
len th' CDS 
5'- ACTGGCAGAGCCGGAGCTGTGCTACG - 3' chFcRg 
forward primer to obtain'full- 
length! CDS 
5' - TGGTGGTGGGGGGGTCCGAACTCAGG - 3' 
chFcRg reverse primer to obtain'full- 
' lenth CDS 
5'- GATGGCGGTG ATA GGTAAGCCTATCCTAACCCTCTCCTC... 
Forward primer used to amplify 
chFcR/L CDS with EcoRV restriction 
... GGTCTCGATTCTACGGAGATGGCCCTGCTGACC - 3' ML% and V5 tag 
Reverse primer used to amplify 
5' - GTGGGTTTACGTTTAAACTCAAACATCCCCT - 3' chFcR/L CDS with Pmei restriction 
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Oligonucleotide Notes 
5' - CGCTCTGCTGGATATCGACTATAAGGACGATGATGAC... Forward primer used to amplify chFcRg 
CDS 
... AAGGAGCCGGAGCTGTGC - 3' 
with EcoRV restriction site and FLAG tag 
5' - GGTGGTGGGGGGGTTTAAACTCAGGCTTTGTGC 3' 
Reverse primer used to amplify chFcRg CDS 
with Pmel restriction site 
5- GGGCTGCAGGTCGATCG -3' 
Forward sequencing primer complimentary to 
B72.3 VLk leader 
5- CGGAGGTGCAGGTCCTC -3' 
Forward sequencing primer complimentary to 
Cu2 
5- GGACGGCGCTCAGAGC -3' 
Forward sequencing primer complimentary to 
CO 
5- CGTATTCCTGTAGACGCTC -3' 
Reverse sequencing primer complimentary to 
CO 
5- TTATTTACCAGCCTGTTTC -3' 
Reverse sequencing primer complimentary to 
Cu4 
5- CTCTGAGCAGGCACAG -3' 
Reverse sequencing primer complimentary to 
hulgE UTR 
5- ATGTATCATACACATACGAT -3' Forward sequencing primer for pSP64T 
5- CAAAGTTGAGCGTTTATTCTGAG -3' Reverse sequencing primer for pSP64T 
Table 2.1.4 (above and previous page) 
Oligonucleotide primers used for cDNA amplification, plasmid 
mutagenesis, nucleotide sequencing and bacterial colony screening 
2.2 Nucleic acid methods 
Agarose gel electrophoresis (analytical) 
Plasmids, RNA, PCR products and DNA digests were analysed using 
gels composed of 1-2% agarose (Sigma, A9539) in TBE with 0.5g/ml ethidium 
bromide. Boiled agarose solution was poured and set in a gel tray with a gel 
comb, before being placed into a gel tank and submerged in TBE with 0.5g/ml 
ethidium bromide. Samples were diluted in DNA gel loading buffer and loaded 
adjacent to appropriate DNA molecular weight markers. Gels were run at 100V 
until sufficient separation of loading dye was seen. DNA/RNA was visualised by 
UV transillumination (320nm) using a Gene Genius bio-imaging system 
(Syngene). 
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Agarose gel electrophoresis (preparative) 
Restriction digestion products were separated using agarose gel 
electrophoresis as described above, except that gels were made with SeaKem 
GTG agarose (Cambrex, 50071). Bands representing the desired fragments 
were visualised by UV transillumination, excised using a sterile razor blade and 
electro-eluted into 200µI TBE in a dialysis bag (Medicell, DTV12000.02.000). 
5'-dephosphorylation of linearised plasmids 
5' phosphate groups were removed from linearised plasmid vector DNA 
in order to reduce self-ligation in ligation reactions. Shrimp alkaline phosphatase 
(Promega, M8201), 1 Unit/µg DNA, was mixed with each sample in 
dephosphorylation buffer (10X stock supplied with enzyme: 0.5M Tris-HCI, pH 
9.0 + 100mM Magnesium chloride) in a total reaction volume of 30µI. Samples 
were heated at 37°C for 15 minutes, then at 65°C for a further 15 minutes, in 
order to heat inactivate the enzyme. Enzyme and buffer were removed using 
phenol: chloroform extraction and ethanol precipitation. 
Estimation of nucleic acid concentration 
DNA and RNA concentration were calculated from the absorbance of 
solutions at 260nm (see 'Estimation of protein concentration' for explanation), 
measured using a Cary 50 spectrophotometer (Varian): 
Concentration of DNA (Ng/ml) =A 260 x (dilution factor) x 50 pg DNA/ml/A260 unit 
Concentration of RNA (Ng/ml) =A 260 x (dilution factor) x 40 pg RNA/ml/A260 
unit. 
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Ethanol precipitation of DNA 
Samples were mixed with 1 /10th volume 3M sodium acetate, pH 5.2, then 
2 volumes of ice-cold 100% ethanol and cooled at -20°C for 1 hour in order to 
precipitate DNA. Samples were centrifuged at 13,000 rpm at 4°C for 30 minutes 
and the supernatant discarded. Pellets of DNA were washed with 70% ethanol 
and spun for a further 10 minutes. Supernatant was removed and pellets dried 
using a vacuum centrifuge. Dried pellets were resuspended to the desired 
concentration in either autoclaved water or TE. 
Propagation and storage of transformed bacterial colonies 
Individual bacterial colonies resulting from selection on LB-agar with 
antibiotic were picked using a sterile pipette tip and transferred to sterile LB- 
broth containing the same antibiotic. Cultures were grown at 37°C for -16 hours 
with shaking (220rpm). A culture volume appropriate to the required quantity of 
plasmid DNA to be extracted was prepared (see 'Purification of plasmid DNA 
from bacteria'). For cultures exceeding 100ml, a 5ml starter culture was grown 
for -8 hours at 37 °C with shaking and used to inoculate the main culture 
(1: 250). For storage, a 1.5ml aliquot of 16 hour culture was removed and 
vortexed with 0.5ml sterile 60% glycerol. Glycerol stocks were snap frozen in 
liquid nitrogen and stored at -70°C. 
Ligation of DNA fragments 
Gel purified DNA inserts prepared by restriction digestion were ligated 
into dephosphorylated, linearised plasmids using T4 DNA ligase (Promega, 
M1801). Generally, a 3: 1 molar ratio of insert: vector was used with 100ng 
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vector and 1 unit of enzyme in ligase buffer (10X stock supplied with enzyme: 
300mM Tris-HCI, pH 7.8 + 100mM Magnesium chloride + 100mM DTT + 10mM 
ATP), with a final reaction volume of 10µI. For sticky-end ligation (5' or 3' 
overhangs), the reaction was performed at room temperature for 3 hours. For 
blunt end ligation, the reaction was performed at 15°C overnight. 
Polymerase chain reaction (PCR) methods 
PCR using the primers specified in section 2.1.4 was used for several 
applications: 
(1) Bacterial colony screening. The presence of plasmid was assayed 
following transformation with ligation reaction products and selection on 
LB-agar with appropriate antibiotic. A sterile pipette tip was used to pick 
each colony and resuspend it in 201iI sterile water. 10µI was removed, 
boiled for 5 minutes and spun at 13,000 rpm in a microfuge. 1µl 
supernatant was used in a PCR reaction. For this application, fidelity of 
replication was not important, so a pre-mixed Taq polymerase cocktail 
was used, PCR Master Mix (Promega, M7502). 
(2) Rapid amplification of cDNA ends (RACE-PCR). A SMART RACE kit (BD 
Biosciences/Clontech, 634914) was used to amplify previously unknown 
5' and 3' ends of chFcR/L cDNA fragments, following the manufacturer's 
protocol. Briefly, cDNA was reverse transcribed from MQ-NCSU-derived 
RNA, with known sequences incorporated at the 5' and 3' ends. Primers 
complimentary to these known sequences, together with 'gene specific' 
primers (see section 2.1.4) were used to amplify cDNA fragments, which 
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were then isolated using agarose gel electrophoresis, T/A cloned and 
sequenced. 
(3) Amplification of 'complete' cDNA. IgY-Fc cDNA was amplified from a 
chicken splenocyte cDNA library and both chFcR/L cDNA and chFcRy 
cDNA were amplified from reverse transcribed RNA purified from MQ- 
NCSU cells or primary chicken basophils. For preparation of a Southern 
hybridisation probe, forward and reverse sequencing primers specific for 
exon III (encoding domain EC3 of chFcR/L) were used. 
(4) Mutagenesis of plasmid vectors. Site-directed mutagenesis was 
I 
performed using a Quikchange II XL kit (Stratagene, 200521-5), as per 
the manufacturer's instructions, using primers specified in section 2.1.4. 
Briefly, PCR using Pfu proofreading polymerase was carried out in which 
mutagenic primers were annealed to the plasmid to be altered and 
extended in order to synthesise new strands incorporating the desired 
mutation. After 18 cycles, the original unmodified parental strands were 
digested using a dam-methylation-sensitive restriction enzyme. Mutated 
plasmids were transformed into XL-10 gold competent E. coli, in order to 
repair nicks and replicate the plasmid. Sufficient plasmid DNA was 
extracted to allow the nucleotide sequence to be determined to confirm 
the presence of the mutation. 
In most instances, a typical PCR reaction was prepared on ice as follows, using 
a high-fidelity proofreading polymerase: 
5µI 10X PCR buffer for Pfu (Supplied with Pfu: 200mM Tris-HCI, 
pH 8.8 + 100mM potassium chloride + 100mM ammonium sulfate 
+ 20mM magnesium sulfate + 1% Triton X-100 + 1mg/ml BSA) 
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1µI 50X dNTP mix, 10mM each dNTP (Promega, 1511) 
1 µM Forward primer (see section 2.1.4) 
1 µM Reverse primer (see section 2.1.4) 
0.5µg Template plasmid, or 2.5µg cDNA library 
1.25 Units Pfu polymerase (Promega, M774A) 
Final volume 50µI with sterile water. 
Most reactions were run with the following profile in a GeneAmp 9700 PCR 
system (Applied Biosystems): 
95°C 2 minutes (Initial Denaturation) 
95 °C 1 minute (Denaturation) 
-25 cycles X°C 30 seconds (Annealing) 
74 °C 2 minutes per kb of amplicon (Extension) 
74 °C 5 minutes (Final extension) 
4 °C indefinite (Soak/End) 
The annealing temperature (marked X) was determined by the primer pair used, 
and usually had to be optimised. The melting temperature of each primer was 
calculated using MWG Biotech's primer design tool and roughly 5°C above the 
highest melting temperature was used as the annealing temperature. 
Purification of plasmid DNA from bacteria 
Plasmid DNA was extracted from bacterial clones grown overnight in 
selective LB-broth using a Qiagen purification kit, according to the 
manufacturer's protocol. The quantity of culture volume and the kit used 
depended on the required amount of DNA. For cloning methods and 
sequencing, up to -20µg was prepared using a 'QlAprep Spin miniprep' kit 
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(Qiagen, 27104). For applications where larger quantities were required (e. g. 
transfection by electroporation), a 'Hispeed Plasmid midiprep' kit (Qiagen, 
12643) or a 'QlAfilter Plasmid maxiprep' kit (Qiagen, 12262) was used. For 
sensitive applications, or if a high concentration of DNA was required, plasmid 
DNA was further purified using phenol: chloroform extraction and/or ethanol 
precipitation. 
Purification of RNA from cells 
Total cell RNA was prepared from MQ-NCSU cells and a crude 
preparation of chicken peripheral blood basophils using a 'Midas pure RNA' kit 
(Biogene, BG-SPR/50). The manufacturer's protocol was followed, with the 
addition of an genomic DNA digestion step, using RNase-free DNase I (Qiagen, 
79254). For each column, 30 Kunitz units of DNase I were diluted in the 
supplied digestion buffer to a final volume of 75µI and incubated with RNA on 
the column membrane for 15 minutes at room temperature. Purified RNA was 
eluted in DEPC-treated water, snap frozen in liquid nitrogen and stored at - 
70°C. 
Reverse transcription of RNA 
For RACE-PCR (see 'PCR methods'), cDNA was synthesised using 
reagents and protocols included in the SMART RACE cDNA amplification kit 
(BD Biosciences/Clontech, 634914). For other applications, a first strand RT 
reaction was prepared as follows: 1X first-strand buffer (supplied with 
Superscript II enzyme) + 5mM DTT (Invitrogen, Y00147) + 0.4mM dNTPs 
(Invitrogen, 18427-013) + 0.2ng oligo dT primer (Promega, C1101) + 0.05ng 
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random primers (Promega, C1181) +8 units RNaseOUT RNase inhibitor 
(Invitrogen, 10777-019) + 1µg RNA, to a final volume of 40µI with nuclease-free 
water (Promega, P1193). Prior to the addition of 400 units Superscript II reverse 
transcriptase (Invitrogen, 18064-022), the reaction mixture was heated at 70°C 
for 2 minutes to denature the RNA, then immediately placed on ice. The 
reaction was carried out by incubation at 37°C for 10 minutes, 42°C for 45 
minutes, and 50°C for 10 minutes. 160µI of nuclease-free water was added to 
the reaction and the enzyme was inactivated by heating at 100°C for 2 minutes. 
cDNA was stored at -20°C. 
Restriction digestion 
Plasmid DNA or PCR products were digested using one or more of the 
following restriction enzymes: EcoRl (Promega, R6011), EcoRV (Promega, 
R6351), Hindill (Promega, R6041), Pmel (New England Biolabs, R0560S), Sall 
(Promega, R6051) or Xhol (Promega, R6161). Generally, reactions were set up 
as follows; where a double digest was required, the appropriate reaction buffer 
was chosen from the Promega '4-core' buffer set (Promega, R9921). 2µI 10X 
restriction buffer (supplied with enzyme or from '4-core' set) + 2µg acetylated 
BSA (supplied with enzyme)+ 1µg DNA +5 units restriction enzyme, to a final 
volume of 20µI using autoclaved Milli-Q water. For a preparative restriction 
digestion, the reaction was scaled up 5-10-fold and the digestion products 
separated using agarose gel electrophoresis. 
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Phenol: chloroform extraction 
Phenol: chloroform extraction was used to separate protein contaminants 
of DNA solutions. An equal volume of phenol: chloroform: isoamyl alcohol, 
25: 24: 1 (Sigma, P-2069), was added to the sample and emulsified using a 
vortex mixer. The organic and aqueous phases were separated by 
centrifugation at 13,000 rpm in a microfuge for 1 minute at room temperature. 
The aqueous phase was removed and extraction repeated until no protein was 
visible at the interface of the two phases. To remove phenol, an equal volume of 
chloroform: isoamyl alcohol, 24: 1, was added to sample, mixed, spun and the 
aqueous phase removed as above. Ethanol precipitation was performed to 
recover the purified DNA. 
Radiolabelling of single-stranded cDNA 
A single stranded radiolabelled cDNA probe was prepared for Southern 
hybridisation using DNA labelling beads (GE Heathcare / Amersham, 27-9240- 
01) with [a 32P]-dCTP (GE Heathcare / Amersham, AA0075). A double-stranded 
cDNA fragment comprising part of exon III of chFcR/L was amplified by PCR, 
then purified using phenol: chloroform extraction and ethanol precipitation. DNA 
at -100ng/µl in TE was denatured to produce a single-stranded species by 
heating at 100°C for 2 minutes, then immediately cooling on ice for 2 minutes. 
The reaction was prepared by adding 50ng DNA to 5OtCi [a_32 P]-dCTP and a 
labelling bead. Milli-Q water was added to a final volume of 50µI, and the 
mixture incubated at 37°C for >15 minutes. The labelled probe was used 
immediately. 
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Sequence determination 
Nucleotide sequencing was performed by MWG Biotech, or by P. Marsh 
and R. Chen, King's College London, using the fluorescent DNA dideoxy chain 
termination method (Sanger et al., 1977). Sequences were analysed and 
aligned using ChromasPro software v1.3 (Technelysium). 
Southern hybridisation (Southern blot) 
PCR reactions to amplify 'full length' chFcR/L cDNA from MQ-NCSU or 
chicken peripheral blood basophils (contaminated with erythrocytes) were 
suspected to contain numerous products resulting from non-specific priming. To 
establish which products contained chFcR/L exons, a Southern hybridisation 
was performed using a radiolabelled probe complimentary to exon III of 
chFcR/L (see 'Radiolabelling a single-stranded cDNA probe'). PCR reactions 
were separated using agarose gel electrophoresis and transferred to 
nitrocellulose membrane (see 'Vacuum transfer of DNA'). The membrane was 
placed in a hybridisation bottle with -10ml Southern prehybridisation / 
hybridisation buffer (Ambion, 8670) for 30 minutes at 42°C in a hybridisation 
oven. The buffer was removed and replaced with a fresh buffer and 10 µl 
(-10ng) of newly labelled 32P-ssDNA probe and incubated at 42°C overnight. 
The membrane was repeatedly washed at 42°C as follows: once with 5X SSC + 
0.1% SDS for 5 minutes, twice with 1X SSC + 0.1% SDS for 5 minutes each, 
once with 0.2X SSC + 0.1% SIDS for 15 minutes, and once with 0.1X SSC + 
0.1% SDS for 15 minutes. The membrane was covered with a sheet of Saran 
wrap and used to expose a piece of Fuji RX X-ray film (GRI, JTS010) for 1 hour 
in an X-ray cassette with intensifying screens. The film was developed using an 
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X-OMAT developer (Kodak). The membrane was used to expose another piece 
of film for a further -16 hours to ensure no further bands were visible. 
T/A cloning of PCR products 
In order to obtain high-quality sequences of RACE-PCR products, 
fragments were separated using agarose gel electrophoresis and cloned using 
a TOPO T/A cloning kit (Invitrogen, 45-0071), following the manufacturer's 
protocol. The RACE PCR products were amplified using the Advantage II 
polymerase mix (BD Biosciences, 639207), so contained 3'-adenine overhangs, 
which could be reacted with linearised pCR4-TOPO vector, containing 3'- 
thymidine overhangs. Reacted vectors were used to transform TOP10 
competent E. coli, and positive clones (assayed by PCR) were propagated. 
Plasmids containing the various RACE PCR products were extracted and 
sequenced. 
Transformation and selection of competent cells 
Competent E. coli were used to clone and amplify plasmid DNA encoding 
antibiotic resistance genes. E. coli were stored at -70°C, then thawed on ice 
immediately before transformation. -10ng pre-chilled DNA was added to 50µI 
E. coli (_108 cells), mixed gently by flicking the tube, and incubated for 30 
minutes on ice. The cells were then heat shocked at 42°C for 30-90 seconds 
(depending on the strain of E. coli used) and placed on ice for a further 2 
minutes. 0.9m1 SOC medium (pre-warmed to 37°C) was added and bacteria 
incubated for 1 hour at 37°C with shaking (220 rpm). Bacteria were plated onto 
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selective LB-agar (5,50 and 500µI per petri dish), containing either ampicillin 
(100pg/ml) or kanamycin (50pg/mi), and grown overnight at 37°C. 
Vacuum transfer of DNA 
In preparation for Southern blotting, DNA in a 1% agarose gel was 
vacuum transfered onto nitrocellulose blotting membrane. The gel was soaked 
in DNA breaking buffer, DNA denaturing buffer and DNA neutralisation buffer 
for 30 minutes each, rinsing with Milli-Q water between buffers. A piece of 
blotting membrane was cut to the size of the gel and placed together with 
plastic sealing sheets, into an LKB 2016 VacuGene vacuum blotting system 
(Pharmacia). The gel and membrane were covered with DNA transfer buffer 
and blotted for -90 minutes. Transferred DNA was crosslinked onto the blotting 
membrane using a Stratalinker 1800 UV crosslinker (Stratagene) for 60 
seconds. 
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2.3 Protein methods 
Acetone precipitation of protein 
Acetone precipitation was used to prepare samples for SDS-PAGE 
analysis when proteins were of insufficient concentration (>0.1 mg/ml) or in a 
buffer unsuitable for electrophoresis (e. g. high salt). Four volumes of cold 
acetone (-20°C) was added to the sample, mixed by inversion and incubated at 
-20°C for 1 hour. The sample was centrifuged at 14,000xg at 4°C and the 
supernatant discarded. The protein pellet was dried in a vacuum centrifuge and 
resuspended in the desired buffer (e. g. 1X SDS-PAGE loading buffer). 
Affinity chromatography 
Affinity chromatography was used to purify recombinant IgY-Fc from 
culture supernatant of stably transfected NS-0 cells and to extract IgY from 
solubilised membrane preparations, following incubation of MQ-NCSU cells in 
chicken serum IgY. In both instances, the affinity matrix consisted of goat 
polyclonal anti-IgY coupled to agarose beads (Gallus Immunotech, DAIgY-AGA- 
5). 5ml slurry was packed into a glass 10mm diameter Econo-column (Bio-rad, 
737-1011) with an appropriate flow adaptor (Bio-rad, 738-0015). The column 
was run at 4°C using a peristaltic pump at a flow rate of 0.75ml/min. Before 
each run, the column was regenerated with 25ml AC elution buffer, then 
equilibrated with 50ml AC equilibration/wash buffer. For preparative runs, 
sample (supernatant or solubilised protein preparation) was filtered through a 
0.45µm cellulose acetate membrane (Sartorius, 11106-47------N) then re- 
circulated through the column until saturation of the affinity matrix. The column 
was washed with 100ml AC equilibrationtwash buffer and bound material eluted 
-66- 
Chapter 2 Materials and methods 
using 10ml AC elution buffer. The sample was immediately neutralised using 
AC neutralisation buffer (-'20µl per ml). An automated microfluidics system 
(constructed in-house by A. J. Beavil) was used to perform multiple 
load/wash/elute cycles. For analytical runs, a similar protocol was used, except 
100µI fractions of eluate were collected, acetone precipitated, resuspended in 
1X loading buffer and analysed using SDS-PAGE. 
Biotinylation of antibodies and antibody fragments 
IgY and IgY-Fc mutants were biotinylated to allow detection of MQ- 
NCSU cell binding using streptavidin conjugated to RPE (Dako cytomation, 
R0438). Proteins were dialysed against OA M sodium hydrogen carbonate, pH 
9.0, using slide-a-lyser units (Pierce, 69570) and adjusted to -1 mg/ml. NHS- 
biotin (Sigma, H1759) was prepared as a 1mg/ml stock in DMSO (Sigma, 
D2650) and incubated with protein at a ratio of 3: 1 (biotin to protein), for four 
hours at room temperature. 
Concentration of proteins 
IgY-Fc mutants were concentrated and buffer exchanged from affinity 
chromatography eluates using stirred cells and centrifugal filter units at 4°C, 
following the manufacturer's protocols. For large volumes (>100ml), an Amicon 
stirred cell with a 10,000 MWCO ultrafiltration membrane was used (Millipore, 
PLGC07610). For smaller volumes, Centricon Plus-7010,000 MWCO (Millipore, 
UFC701008) or Amicon Ultra-15 5,000 MWCO (Millipore, UFC900524) filter 
units were used. Filters were thoroughly washed with TBS before use. 
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Crystallisation of IgY-Fc 
Hanging drop vapour diffusion kits 'Classics' (Nextal, NSO-96-CLs) and 
'PEGs' (Nextal, NSO-96-PGs), were used to screen for (papain-derived) IgY-Fc 
crystallisation conditions, following the manufacturer's protocol. Each well of the 
hanging drop plates contained a reservoir of crystallising buffer (typically, buffer, 
salt and precipitant). In each well, l µl of IgY-Fc (-5mg/ml) was mixed with an 
equal volume of crystallisation buffer and sealed airtight with the drop 
suspended above the reservoir. This method causes the buffer in the droplet to 
slowly equilibrate with the reservoir. Under favourable conditions, this can lead 
to supersaturation and crystallisation of the protein. Plates were examined 
every day for one month, then once per week. Crystals were assayed for 
protein by adding 0.05% methylene blue, incubating for 5 minutes and 
examining for dye uptake using light microscopy. Optimisation of positive hits 
was performed by varying the crystallisation conditions (pH and/or 
concentration of salt and precipitant) in replicate screens (see chapter 3, table 
3.5 ii). Common cryoprotectants were screened by examining crystal stability 
upon their addition. 
Crystallisation conditions for recombinant IgY-Fc were screened using a 
sitting drop method. The mechanism for this method was similar to that 
described above (vapour diffusion), except that 100nl drops of IgY-Fc (-5 
mg/ml) were dispensed onto sitting drop plates using a Cartesian Microsys 
robot (Genomic Solutions) and mixed with an equal volume of a large variety of 
screening solutions prepared by the Oxford Protein Production Facility. Plates 
were stored in a temperature controlled vault (TAP HomeBase) and monitored 
using an automated Veeco imager. 
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Deglycosylation under native conditions 
Native serum IgY, IgY-Fc Cu2-4 [wt] and human IgGI were 
deglycosylated using PNGase F (New England Biolabs, P0704S). 20µg of 
protein was incubated with 1000 units (2µI) PNGase F in 20µl 1X G7 buffer 
(supplied with enzyme: 50mM sodium phosphate buffer, pH 7.5) for 72 hours at 
37°C. Control reactions were also prepared as above, but without enzyme. 
Samples were assayed for complete removal of carbohydrate by SDS-PAGE. 
Dynamic light scattering 
Dynamic light scattering (DLS), also known as photon correlation 
spectroscopy, was used to compare thermal stability of several antibodies and 
antibody fragments. 0.1 mg/ml protein solutions in DLS buffer were heated in 
5°C increments from 20°C (allowing 3 minutes for equilibration at each 
temperature) using a DynaPro 99 instrument (Protein Solutions). An 
approximate melting temperature (Tm) was determined by thermally-induced 
aggregation. Although a DLS instrument does not measure melting or unfolding 
of proteins directly, the formation of aggregates can be inferred from rapid 
changes in the light scattering properties of the solution. DLS essentially 
measures how a beam of monochromatic light is differentially scattered over 
time. This can be used to calculate the rate at which particles in solution are 
moving (i. e. Brownian motion), assuming they can be modelled as spheres of 
equivalent and homogeneous shape and density. In this case, these particles 
are proteins. The mean hydrodynamic radius (Stoke's radius) of a protein 
solution increases as the proteins unfold and aggregate, which affects their 
motion in solution, as defined by the Stokes-Einstein equation: 
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D= kBT (eqn 2.3 i) 
37Md 
where D is the particle diffusion constant, d is their diameter, T is the 
temperature (in Kelvin), n is the viscosity of the medium and kB is Boltzmann's 
constant. 
Enzyme linked immunosorbent assay (ELISA) 
An anti-IgY 'sandwich' ELISA was used to estimate the concentration of 
recombinant IgY-Fc in transfected cell culture supernatant. All wash steps were 
carried out using PBS-Tween with a SkanWasher 300B automated ELISA 
washer (Skatron Instruments). 96-well Maxisorp plates (Nunc, 442404) were 
coated with 100µI donkey anti-IgY (Chemicon, AP194) capture antibody (at 
140ng/ml in ELISA coating buffer) overnight at 4°C. Plates were washed twice, 
then uncoated sites were blocked with 200µI PBS-Tween-Marvel for 1 hour at 
room temperature. Plates were washed twice again, then 100µI of each sample 
(serially diluted in fresh culture medium) and control (fresh medium alone) were 
added in triplicate. On every plate, three-fold serial dilutions of purified papain- 
derived IgY-Fc (starting at 800ng/ml in culture medium) were also added in 
triplicate, in order to generate a standard calibration curve. Plates were 
incubated overnight at 4°C, then washed 4 times. Rabbit anti-IgY-HRP 
(Promega, G135A) was added to every well (100µI per well, 0.5µg/ml in PBS- 
Tween-Marvel), and incubated for 4 hours at room temperature. Plates were 
washed 4 times and developed by adding 50µI 0.4mg/mi OPD (Sigma, P-6912- 
100TAB) in ELISA phosphate-citrate buffer for 10-20 minutes in the dark. HRP 
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catalyses a colourimetric reaction between OPD and hydrogen peroxide 
(generated by hydrolysis of sodium perborate), so can be used to measure the 
concentration of anti-IgY, and thus IgY-Fc, present in each well. The reaction 
was stopped by adding 50µI 3M HCI to each well. The absorbance at 492nm 
(A492) of each well was determined using a Multiscan EX plate reader (Thermo) 
and the standard curve was plotted using Ascent software v2.6 (Thermo). The 
concentration of each sample was estimated from the linear part of the curve, 
using a sample dilution that lay within the appropriate sensitivity range. 
Ellman assay 
A modified Ellman assay (Ellman, 1958; Riddles et al., 1979) was used 
to quantify free sulfhydryls in IgY and IgY-Fc, in order to establish whether all 
cysteine residues in the upsilon heavy chain are involved in disulfide bonds. 
Ellman's reagent, DTNB (Sigma, D8130), reacts with free thiol groups, so that 
an equimolar quantity of 2-nitro-5-thiobenzoate (TNB) is bound. Upon reduction, 
the coloured anion (TNB2") is released and can be detected photometrically, 
allowing the molar ratio of protein: free sulfhydryls to be determined. Bovine 
serum albumin (which contains one free sulfhydryl) was used as a positive 
control. Human IgG1 and IgGl-Fc (which contain no free sulfhydryls) were used 
as negative controls. DTNB was freshly prepared at 4mg/ml (in 100mM 
phosphate buffer, pH 7.2, + 0.1 mM EDTA) and 6µI was added to 200µI of 
sample protein at '1 mg/ml in PBS + 6M guanidine-HCI. Each sample was 
incubated for 15 minutes at room temperature, then dialysed into PBS (with 
0.1% sodium azide) using slide-a-lyser units (Pierce, 69570). The absorbance 
of each sample at 280nm and 412nm was measured using a Cary 50 
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spectrophotometer (Varian), before and after the addition of 0.05% ß- 
mercaptoethanol. The concentration of protein was determined using A280 
absorption coefficients calculated by ProtParam software (see below). The 
concentration of TNB2" was determined using an A412 absorbance coefficient of 
14,150 M''cm-1 (Riddles et aL, 1979). 
Estimation of protein concentration 
The concentration of protein in a solution was determined using UV 
spectrophotometry. The absorbance of a sample in a1 cm path length quartz 
cuvette (Hellmann) was measured across a spectrum of UV wavelengths (240 
to 340 nm) using a Cary 50 spectrophotometer (Varian). The absorbance of the 
buffer used in the sample was also measured across the same spectrum and 
subtracted from the sample absorbance. The Beer-Lambert law defines the 
correlation between the absorbance, A, and concentration, c: 
A= csl (eqn 2.3 ii) 
where I is the path length (cm) and c is the absorbance coefficient (M'1cm'1). 
The absorbance coefficients for IgY and the IgY-Fc mutants (table 2.3 iii) were 
calculated using ProtParam software (Walker, 2005). 
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Molar Molecular Extinction Weight (kDa) A280 (1mg/m1) Coefficient 
Whole Y 209125 161.94 1.29 
24wt 90965 73.66 1.24 
}; N308Q 90965 73.77 1.23 
20 N308Q N407Q 90965 73.8 1.23 
34wt 62630 50.95 1.23 
LL M C340S 62505 50.91 1.23 
. OU 
C347S 62505 50.91 1.23 
C340S C347S 62380 50.88 1.23 
Table 2.3 iii 
Calculated molecular weight and UV absorbance characteristics of IgY 
and IgY-Fc 
Ion exchange chromatography 
A DEAE sepharose ion exchange column (GE Healthcare, 17-5154-01) 
and an FPLC chromatography system (Pharmacia) was used to separate IgY- 
Fc fragments from other yolk IgY papain digestion products. Proteins were 
bound to the column and differentially eluted on the basis of their charge in 
different ionic strengths of buffer. The flow rate was set to 0.5ml/min and the 
column equilibrated using 50ml IE bind / wash buffer. -10mg of IgY papain 
digest (dialysed into IE bind / wash buffer) was loaded onto the column, washed 
with 25ml IE bind / wash buffer, and eluted using a salt gradient (i. e. a steady 
increase from 0 to 100% IE elution buffer). Fractions were collected across A280 
peaks. 
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N-terminal protein sequencing 
N-terminal amino acid sequencing was performed by J. N. Keen, 
University of Leeds, using Edman degradation and reverse-phase HPLC. 
Papain digestion 
Enzymatic cleavage of IgY purified from chicken egg yolk was used to 
prepare IgY-Fc fragments. Papain (Sigma P3125) was pre-activated by 
incubation in papain digestion buffer (pH 5.0) for 15 minutes at 37°C on a 
rotator. Papain was added to IgY (-lmg/ml) in papain digestion buffer (pH 7.0), 
using an enzyme: substrate ratio of 1: 25 (w/w), and incubated for 16 hours at 
37°C on a rotator. The reaction was stopped by adding iodoacetamide (Sigma 1- 
1149) to a final concentration of 30mM. IgY-Fc was isolated using a 
combination of ion exchange and size exclusion chromatography. 
Purification of IgY from chicken egg yolk 
Chicken egg yolk IgY was isolated using an Eggstract Kit (Promega, 
G1531), following the manufacturer's protocol. Repeated lipid and protein 
precipitation steps were used to separate IgY, which was finally resuspended at 
-2-3mg/ml in PBS with 0.05% (w/v) sodium azide. IgY was sterile filtered using 
a 0.2pm membrane (Sartorius, 16534----------K) and stored at 4°C. 
Radioiodination of antibodies and antibody fragments 
Affinity purified IgY and IgY-Fc were radiolabelled with 1251 for use in MQ- 
NCSU cell binding assays using the chloramine-T method (McConahey and 
Dixon, 1980). 1 mg/ml chloramine-T (Sigma, 857319) was freshly prepared in 
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100mM sodium phosphate buffer, pH7.0.5pl chloramine-T solution was added 
to a mixture of 7.4MBq 1251 and 200µg IgY or IgY-Fc (-1 mg/ml in PBS) every 
150 seconds for 10 minutes. The reaction was stopped by the addition of 20µI 
1 mg/ml sodium metabisulfate (Sigma, 255556) in 100mM sodium phosphate 
buffer, pH7.0. Desalting spin columns (Pierce, 89849) were used to remove 
unincorporated 1251 and exchange the radiolabelled IgY or IgY-Fc into PBS, 
following the manufacturer's protocol. The specific activity of each radioligand 
was determined by estimation of the protein concentration (by UV 
spectrophotometry) and radioactivity (counts/min), using a Wizard 1480 gamma 
counter (Perkin-Elmer). 
Reduction and alkylation of antibodies and antibody fragments 
The susceptibility of inter-heavy chain disulfide bonds to reduction was 
investigated using dithiothreitol (DTT). Before analysis using SDS-PAGE, 
samples (at 0.5mg/ml in PBS) were incubated with a two-fold serial dilution of 
fresh DTT (9 concentrations from 10mM to 0.04mM) for 1 hour at room 
temperature. 200mM iodoacetamide (Sigma, 1-1149) was added to alkylate 
reduced cysteines and to prevent further reduction upon protein denaturation in 
SDS-PAGE loading buffer. 
SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE), based on the method of Laemmli (Laemmli, 1970), was used to assess 
the purity of protein solutions, to estimate the molecular weight of proteins, and 
to prepare samples for N-terminal sequencing. SDS is an anionic detergent, 
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which causes proteins to adopt a net negative charge, allowing them to migrate 
toward the anode in an electric field. By forcing them to move through a 
polyacrylamide gel, proteins can be separated on the basis of their size or 
relative molecular weight. 
Gels were prepared using an appropriate percentage acrylamide, in 
order to ensure adequate size separation of sample proteins (table 2.3 iv). 





Acrylamide acrylamide Tris pH Tris pH SDS APS TEMED 
stock (ml) 8.8 (ml) 6.8 (ml) ml 
-(UI ) 
10 8.33 4.7 - 0.25 160 40 
12 10 4.7 - 0.25 160 40 
15 12.5 4.7 - 0.25 160 40 
Stacking 1 - 25 1 0 1 64 15 gel . . 
Table 2.3 iv 
Composition of polyacrylamide gels 
Gels were prepared using stock solutions shown to a final volume of 25ml using 
Milli-Q water (except the stacking gel, which was made to 10ml). TEMED was 
added last, immediately before pouring. 
Gels were poured and set using Atta PAGE apparatus and placed in an 
Atta gel tank with 1X SDS-PAGE running buffer in the upper and lower 
reservoirs. Protein samples were diluted into SDS-PAGE loading buffer (20-30µI 
final volume), with or without 2% ß-mercaptoethanol (for a reduced or non- 
reduced gel, respectively). Samples were heated at 100°C for 5 minutes, 
centrifuged for 1 minute in a microfuge and loaded onto the gel adjacent to 
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appropriate molecular weight markers. The gel was run at 150V for -1-2 hours, 
until loading dye had reached the bottom of the gel plate. Gels were removed 
and stained with either Coomassie blue (total protein) for 1 hour, followed by 
destain overnight, or with a Periodic acid-Schiff (PAS) stain, using a Gelcode kit 
(Pierce, 24562), following the manufacturer's instructions. 
Size exclusion / gel filtration chromatography 
Size exclusion or gel filtration chromatography was used to estimate the 
molecular weight of IgY and IgY-Fc mutants under non-denaturing conditions 
and to purify material for crystallisation. A Superdex 200 column (GE 
Heathcare, 17-5175-01) connected to a Gilson HPLC system was equilibrated 
and run using HPLC running buffer at a flow rate of 0.75ml/min. The column 
was calibrated using a series of protein standards of known molecular weight 
(Sigma, MW-GF-1000). Protein samples, either 60µI at -0.1mg/mI (for analytical 
runs) or 500µI at -1 mg/ml (for preparative runs), were injected onto the column, 
and the UV absorbance (A280) of the eluate monitored over 40 minutes. 
Large proteins and aggregated material elute in a smaller volume (i. e. 
sooner) than smaller proteins, which are retarded by their entry into pores in the 
gel matrix. 
Semi-dry transfer of proteins 
Proteins were transferred from SDS-PAGE gels onto either (a) PVDF 
membrane (pre-activated by washing in methanol and equilibrated in semi-dry 
transfer anode buffer), for N-terminal sequencing or (b) nitrocellulose 
membrane, for Western blotting, using a Novablot II semi-dry electroblotter 
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(Pharmacia). In both instances, the membrane and four pieces of filter paper 
(Whatman No. 1) were cut to the size of the gel. A stack was assembled 
comprising two pieces of filter paper (soaked in semi-dry transfer anode buffer), 
membrane, gel, and two more pieces of filter paper (soaked in semi-dry transfer 
cathode buffer). Protein transfer occurs in the direction cathode to anode, so the 
stack was positioned membrane toward the anode, gel toward the cathode. Any 
air bubbles between the gel and membrane were removed and the blotter run at 
0.8-1 mA/cm2 for 30-45 minutes. 
Western Blot 
Western blotting was used to detect IgY and IgY-Fc fragments 
transferred onto a nitrocellulose membrane from an SDS-PAGE gel. An 
appropriate quantity of sample was loaded so that the quantity of detected 
protein(s) would fall within the sensitivity of the technique (5-100ng, depending 
on sample purity and efficiency of transfer). Following adsorption onto the 
blotting membrane, unbound sites were blocked by incubating for 60 minutes in 
PBS-Marvel at room temperature, with gentle shaking. The blocking solution 
was then discarded and the membrane was incubated in 0.5µg/ml rabbit anti- 
IgY (Promega, G135A) in PBS-Tween-Marvel for a further 60 minutes. The 
membrane was washed three times by incubating in PBS-Tween for 10 minutes 
each, then rinsed with PBS. The presence of anti-IgY-HRP was revealed using 
an HRP-catalysed chemoluminescence reaction (Luminol / H202, Pierce, 
434080). The membrane was used to expose a piece of Fuji RX X-ray film 
(GRI, JTS010) for 20 seconds. The film was developed using an X-OMAT 
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developer (Kodak). The membrane was used to expose another piece of film for 
a further -16 hours to ensure no further bands were visible. 
2.4 Cell methods 
Buffy coat layer separation 
Chicken peripheral blood was collected into acid citrate dextrose (ACD) 
anticoagulant solution (Sigma, C3821), using -0.25ml ACD per ml of blood. The 
Buffy coat (leukocytes) was separated by centrifugation at 200xg (without the 
brake) and removed using a Pasteur pipette. Cells were resuspended in PBS 
and kept on ice. 
Cell binding assays 
Radioiodinated IgY and IgY-Fc fragments were used to determine the 
number of IgY-Fc receptors on MQ-NCSU chicken monocytes and their binding 
kinetics. Binding was assumed to follow a simple one-step reaction: 
k+1 
k _1 
where [R] is the concentration of Fc receptor, [L] is the concentration of ligand 
(IgY or IgY-Fc), [RL] is the concentration of receptor: ligand complex, k+1 is the 
association rate constant (or on-rate) and k. 1 is the dissociation rate constant (or 
off-rate). In cell binding assays, measurement of bound ligand allows [RL] to be 
determined. 
The mean number of total receptor sites per MQ-NCSU cell was 
determined by saturating with radiolabelled IgY or IgY-Fc Cu2-4 [wt] of known 
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specific activity (see section 2.3, 'Radioiodination of antibodies and antibody 
fragments'). MQ-NCSU cells growing in IgY-free medium were washed and 
incubated in PBS-BSA (with 0.05% sodium azide) for 10 minutes at 4°C. 1x106 
cells were incubated with 10,20 and 75nM 1251 labelled IgY or IgY-Fc Cu2-4 [wt] 
in 100µI PBS-BSA (with 0.05% sodium azide) for 2 hours at 4°C, then layered 
onto a 200µI cushion of phthalate oil in a microtube and spun for 1 minute in a 
microfuge to separate cells (and therefore bound radioligand) from supernatant 
containing free ligand. The bottom of the tube was cut off so that the 
radioactivity of the cell pellet could be measured using a Wizard 1480 gamma 
counter (Perkin-Elmer). No more radioligand was bound when cells were 
incubated with 75nM than with 20nM, so receptors were assumed to be 
saturated. 
Dissociation experiments were performed using the method of Kulczycki 
and Metzger (Kulczycki and Metzger, 1974), but with all steps carried out at 
room temperature. MQ-NCSU cells growing in IgY-free medium were washed 
and incubated in PBS-BSA (with 0.05% sodium azide) for 10 minutes and 
incubated at 1x10' cells/ml with lOnM 1251-lablled IgY or IgY-Fc for 1 hour on a 
rotator. The cells were spun for 2 minutes in a microfuge, resuspended at the 
same cell concentration in PBS-BSA (with 0.05% sodium azide) containing 
excess (350nM) unlabelled IgY and placed back on the rotator. At 1,2,3,4,5, 
10,20,40 and 60 minute time points, 100µI (1x106 cells) were removed, 
immediately spun through phthalate oil and the cell pellet kept for gamma 
counting, as described above. Non-specific binding was determined by pre- 
incubating cells in excess (350nM) IgY for 60 minutes before addition of 1OnM 
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radiolabelled ligand for a further 60 minutes. Non-specific counts were 
subtracted from the counts obtained from the unblocked cells. 
The rate of change of a receptor: Iigand complex is determined by the 
rate of its formation minus the rate at which dissociation occurs: 
d[RL] 
= k+1 [R][L] -k -1 
[RL] (eqn 2.4 ii) 
dt 
As radioligand dissociation was measured in the absence of re-association (due 
to the presence of excess unlabelled ligand), the k+1[R][L] component in 
equation 2.4 ii is zero. In these experiments, the change in receptor: ligand 
concentration is entirely determined by the rate of dissociation: 
d[RL] 
= -k., [RL] (eqn 2.4 iii) dt 
A non-linear regression analysis was made by fitting an equation that 
expands on equation 2.4 iii (Goodrich and Kugel, 2007), in order to allow for 
populations of radioligand that dissociate very quickly or very slowly (e. g. 
caused by non-specific interactions or aggregated radioligand): 
[RL]t = ([RL].,.. - [RL],,,, )(e-k. 1t) + (RL].,,. (eqn 2.4 iv) 
where [RL]max is the true starting point of the decay curve and [RL]min is where it 
levels out (i. e. no further radioligand dissociates). SigmaPlot v6.0 (SPSS) was 
used to fit this equation to the data, using [RL]max, [RL]min and k, as variables. 
The results obtained using equation 2.4 iv were checked against dissociation 
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rate constants determined from linear regression of a plot of ln[RL] versus time 
(Rosenthal, 1967); equation 2.4 iii can be derived to show that the gradient of 
this plot is equal to k1. However, this type of analysis can frequently produce 
errors, so was only used for rough comparison with values obtained using non- 
linear regression, which is a more appropriate means of analysis in this type of 
study (Bylund and Toews, 1993). 
Association experiments were performed following the method of Young 
et al. (Young et al., 1995). A similar protocol to that used for dissociation 
experiments was used, except that cells were removed at 1,2,3,4,5,10,20, 
40 and 60 minutes after the addition of lOnM radiolabelled IgY or IgY-Fc. Non- 
specific binding was determined by pre-blocking with excess unlabelled ligand, 
and used to determine specific binding, as described above. The data were 
analysed by fitting an equation derived by Young et al. (1995): 
[RL] _ I_k+1[L][R] _ k., [L][R] e-(k+I(L)+k. 1)t (eqn 2.4 v) k., [L] + k., [k, IILI + k., 
Equation 2.4 v assumes that ligand is present in excess, so that the 
concentration, [L], is effectively constant. The equation was fitted to the data 
using SigmaPlot v6.0 (SPSS), using k+1 and k., as variables. The total receptor 
concentration [R] was calculated from the estimated total number of receptors 
per cell and the number of cells per unit volume. The concentration of 
receptor: ligand complex, [RL], was calculated from the bound counts per cell 
per unit volume, divided by the specific activity of the radioligand. 
Cell culture 
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See section 2.1.2 for cell lines and media used. All cell lines were 
maintained using Nunc tissue culture plastics or (for use in fluorescence 
microscopy) grown on glass chamber slides (Fisher, TKT-210-150R), at 37°C in 
an air jacketed incubator (Nuaire) supplemented with 5% carbon dioxide. Cells 
were split 1: 5 upon confluency. CHO-K1 and RBL-SX38 cells were detached by 
exchanging the culture media for trypsin (Sigma, T4174) in PBS for 5-10 
minutes, then washing cells in fresh media. Cell stocks were stored at 1x107 
cells per ml of freeze medium in cryovials, which were incubated for 24 hours at 
-80°C, then transferred to liquid nitrogen. 
Density gradient separation of chicken blood basophils 
Percoll (Amersham, 17-0891-01) was prepared at a density of 1.0808/mI 
in order to separate chicken peripheral blood basophils by mixing 20ml stock 
isotonic Percoll with 13.1 ml 1.5M sodium chloride. Buffy coat layer cells in PBS 
were layered onto the Percoll gradient and centrifuged at 400xg for 20 minutes 
(without the brake). Basophils were collected below the Percoll layer, other 
leukocytes remained above. 
Estimation of cell number and viability 
Cell counts were estimated using a haemocytometer. An aliquot of cells 
were diluted in PBS and Trypan blue solution (to final concentration of 0.2%), 
then 10µI were loaded into a haemocytometer. When the coverslip is placed on 
the haemocytometer with Newton's rings visible, the primary square contains 
1 x10-4 cm3 of cell suspension. The cell concentration of the original sample can 
then be calculated as follows: 
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Cells per ml = (N° of cells in primary square) x 104 x (dilution factor) 
Live cells exclude Trypan blue dye, whereas dead cells take it up readily, which 
allows viability to be estimated. 
Flow cytometry (FACS) 
Flow cytometry or fluorescence activated cell sorting (FAGS) was used to 
detect immunostained cells following their incubation with specific antibodies 
and/or antibody conjugates. In all experiments, cells were washed (by 
centrifugation at 1000xg for 5 minutes) and incubated for 10 minutes in PBS- 
BSA before immunostaining. Cells were washed twice with PBS-BSA both 
before and after all antibody incubation steps. 
A FACSAria preparative instrument (BD Biosciences) was used to 
separate a highly fluorescing population of chicken buffy coat layer cells, 
following incubation for 1 hour at 4°C with anti-IgY-FITC (10µg/ml in PBS-BSA). 
For all other experiments a FACSCalibur analytical instrument (BD 
Biosciences) was used. For extracellular staining, PBS-BSA was used as a 
blocking, washing and incubation buffer. Cells were fixed and analysed in PBS 
+ 4% formaldehyde (Sigma, F1635) only after all immunostaining steps, which 
were carried out for 1 hour each at 4°C. For intracellular staining, cells were 
fixed first, then washed and pre-incubated with PBS-BSA + 0.1% saponin 
(Sigma S4521) for 30 minutes at room temperature. All subsequent 
immunostaining steps were also carried out in PBS-BSA + 0.1% saponin for 30 
minutes at room temperature. 
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In all experiments, the concentration of antibody used was titrated in 
order to optimise the signal-to-noise ratio. In general, -20µg/ml (polyclonal) or 
-5µg/ml (monoclonal) was used for primary antibodies, and -10µg/ml was used 
for secondary antibodies conjugated to fluorophores. 
Fluorescence microscopy 
The cell surface expression of N-terminal V5-tagged chFcR/L was 
detected using transiently transfected CHO-K1 cells grown on chamber slides. 
Growth medium was removed and cells were incubated in PBS-BSA for 15 
minutes, followed by FACS fix for 10 minutes. Before and after all 
immunostaining steps, cells were washed by incubating in PBS-BSA for 15 
minutes, three times. Cells were immunostained using 10µg/ml mouse 
monoclonal anti-V5 antibodies (Sigma, V8012) followed by 50µg/ml anti-mouse- 
FITC antibodies (Dako, F0479) for 30 minutes each at room temperature in 
PBS-BSA. Slides were mounted with fluorescence mounting medium (Dako, 
S3023) and analysed using an Axioskop 20 (Zeiss) fitted with filter set 09 
(Zeiss, 488009-0000-000) and an Axiocam CCD. 
Giemsa staining 
Chicken leukocyte types were identified using Giemsa stain . Cells were 
smeared or spun onto glass slides using a cytospin centrifuge (Shandon), air- 
dried and fixed with methanol. Slides were stained with Giemsa solution 
(Raymond A Lamb) for 20 minutes, then dipped in 1% acetic acid followed by 
distilled water. Slides were air-dried, mounted and examined by light 
microscopy. 
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Solubilisation of cell membrane proteins 
Using a similar method to those reported for solubilisation of the high 
affinity receptor for IgE (Conrad et al., 1976; Kinet et al., 1985), MQ-NCSU cell 
membrane proteins were solubilised in non-ionic detergent (Nonidet P-40 or 
Triton X-100). Cells were resuspended at 2x 107 cells/ml in cold lysis buffer and 
homogenised using a 21G needle. Cells were sonicated using five bursts of 1 
second each, incubated on ice for 30 minutes (vortexing every 5 minutes), then 
centrifuged at 20,000xg for 20 minutes at 4°C. 
Specific production rate 
The IgY-Fc production rate of transiently transfected CHO-K1 cells or 
stably transfected NS-0 cells was determined using an anti-IgY ELISA. Cells 
were plated at 5x105 cells/ml in fresh non-selective medium in a 24-well tissue 
culture plate and incubated for 24 hours. Supernatants were harvested by 
centrifugation and the concentration of IgY-Fc measured by ELISA (see section 
2.3). Specific production rate was expressed in µg protein/1x106 cells/24 hours. 
Stable transfection of HEK 293 cells 
HEK 293 cells at -70% confluency growing on 6-well plates were 
transfected with purified plasmid DNA using Trans-IT-293 reagent (Mirus, 
2700), following the manufacturer's protocol. After 48 hours, cells were re- 
plated onto 100mm tissue culture dishes in growth medium supplemented with 
an appropriate antibiotic, depending on the transfected vector. The 
concentration of antibiotic used (either 0.9mg/ml G418 or 0.3mg/ml hygromycin 
B) was the minimal concentration necessary to kill 100% of untransfected cells 
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within 10 days, as determined by a killing curve experiment. Cells were 
incubated for 10-20 days until colonies of stable transfectants were visible. 
Individual colonies were isolated using cloning cylinders (Sigma, C7983-50E), 
propagated in selective media and assayed using immunofluorescent staining 
for intracellular and extracellular expression. 
Stable transfection of NS-0 cells 
IgY-Fc vectors were linearised by restriction digestion with Sall, purified 
by phenol: chloroform extraction and used to transfect NS-0 cells by 
electroporation. Briefly, 40µg DNA (resuspended in 50µI sterile Milli-Q water) 
was mixed with 1x10' cells (washed once with ice cold PBS, then kept on ice) in 
an ice cold electroporation cuvette, then pulsed twice (at 1500V, 3µF) and 
immediately returned to ice for 5 minutes. Cells were added to 30mis warm non- 
selective NS-0 medium and 10mis removed to create three serial dilutions. All 
dilutions were plated onto 96-well plates (50µI per well) and incubated for 24 
hours. In order to select stable transfectants expressing Blutamine synthetase 
(encoded by the transfected vector), 1501iI selective media was added per well 
and cells were incubated for 20-30 days, until colonies were visible. Individual 
colonies were propagated and repeatedly screened for IgY-Fc expression using 
an anti-IgY ELISA. 
Transient transfection of CHO-K1 cells 
Transient transfection of CHO-K1 cells was performed on cells at -70% 
confluency, growing in either 24-well plates or on chamber slides. Purified 
plasmid DNA was used with Trans-IT-CHO reagent (Mirus, 2170), following the 
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manufacturer's protocol. Cells transfected with chFcRy and/or chFcR/L vectors 
were analysed using immunostaining and fluorescence microscopy after 48 
hours. Cells transfected with IgY-Fc vectors were counted and resuspended to 
5x105 cells/ml in fresh growth medium after 48 hours in order to perform a 
specific production rate assay. 
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Chapter 3 
Purification of Yolk IgY, enzymatic digestion and growth of lgY-Fc crystals 
3.1 Overview 
Comparisons between the structure and function of chicken IgY and 
mammalian IgG and IgE, which are thought to have originated from an IgY-like 
ancestor (Warr et al., 1995), may allow us to gain insights into the evolution of 
these important isotypes. Much of what we know about the structure of IgY to 
date is predicted from the upsilon (v) heavy chain cDNA sequence (Parvari et 
al., 1988), as a crystal structure has not yet been solved. The apparent 
similarities between IgY and IgE are of particular interest due to the unique 
structure of IgE, and the role this plays in exacerbating the hypersensitive 
response (Gould et al., 2003). 
The structures of the incomplete (Cc3-4) and complete (Cc2-4) Fc region 
of IgE have been solved (Wan et al., 2002; Wurzburg et al., 2000), as have 
several IgG structures (Harris of al., 1998; Huber at al., 1976), so it will be 
possible to make detailed comparisons between these and an IgY-Fc structure. 
Traditionally, mammalian IgG can be digested with papain (Porter, 1959), a 
cysteine protease, to separate the parts of the molecule that bind antigen 
(Fabs) from the part that bind receptors in order to initiate effector function (Fc). 
As the Ig domains that make up the Fc region are invariant for any given 
isotype, these fragments are crystallisable, and have been used in many X-ray 
diffraction studies. Papain digestion of IgE, however, appears to completely 
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degrade the Fc region (Haba and Nisonoff, 1991), so recombinant material for 
the crystal structure analysis had to be prepared by transfection of either insect 
or mammalian cells with expression vectors encoding domains CO-4 or CE2-4 
respectively (Garman et al., 2000; Wan et al., 2002; Wurzburg et aL, 2000; 
Young et al., 1995). 
Chicken IgY can also be cleaved into Fab and Fc using papain (Dreesman 
and Benedict, 1965a; Kubo and Benedict, 1969), although at the time of these 
experiments, the composition of the Fc was unknown. 
Chicken egg yolk IgY was purified and digested with papain in order to 
explore whether IgY is cleaved in an IgG-like or IgE-like manner, with the aim of 
purifying IgY Fc for preparation of crystals. 
3.2 Purification of yolk IgY 
IgY is transferred into the chicken egg yolk in order to confer protection 
on the developing embryo, reaching a quantity of 60-100mg in the laid egg. For 
preparation of a yolk IgY stock, a single large egg provided sufficient quantity of 
antibody to accommodate losses upon purification and concentration. Initial 
precipitation of IgY from yolk yielded a heterogeneous mixture with some 
impurities, which were removed by HPLC size exclusion chromatography 
(Figure 3.2). 
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Purification of chicken egg yolk IgY by size exclusion chromatography 
(A) Gel filtration profile indicating pooled fractions of chicken egg yolk IgY from 
Superdex 200 column. 
(B) Non-reducing 10% SDS-PAGE (1 & 2) and anti-IgY western blot (3 & 4) 
showing IgY recovered from crude yolk precipitate (1 & 3) and post-HPLC 
purified material (2 & 4). 
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3.3 Papain cleavage of yolk IgY 
HPLC purified yolk IgY was digested by pre-activated papain and 
analysed by SDS-PAGE (data included in Figure 3.4 iii). IgY was cleaved into 
two major products, both around 45-55kDa, consistent with fragments made up 
of four immunoglobulin domains of -12.5kDa each. The Fab fragments contain 
variable regions that are heterogeneously glycosylated, so they appear as a 
smear on the gel, whereas the Fc fragment is resolved well. The size of the 
papain cleaved Fc is more suggestive of an incomplete Cu3-4 Fc than a 
complete Cu2-4 Fc. 
3.4 Purification and characterisation of IgY-Fc 
The products of papain digestion of yolk IgY were separated using ion 
exchange chromatography (Figure 3.4 i), followed by size exclusion 
chromatography (Figure 3.4 ii). 100pmol of the purified IgY-Fc (-5pg) were 
subjected to non-reducing SDS-PAGE and transferred to PVDF for N-terminal 
sequencing, which was performed and analysed by Dr. J. N. Keen (University of 
Leeds). The major sequence was found to begin SCSPIQL, with a small 
proportion of others differing by a few additional N-terminal residues. This 
sequence matches residues 346 to 352, which are found close to the N- 
terminus of Cu3 predicted by Parvari et al. (1988), suggesting that the Fc 
fragment lacks the Cu2 domains. The apparent molecular weight (Figure 3.4 ii) 
on non-reducing and reducing SDS-PAGE gels (-55kDa and -30kDa 
respectively) is consistent with a disulphide linked Cu3-4 Fc fragment (Figure 
3.4 iv). 
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Figure 3.4 i 
Separation of papain digested IgY fragments by ion exchange 
chromatography 
(A) Elution profile of papain digested IgY fragments from a DEAE FF column 
showing collected fractions subsequently analysed (B) by non-reducing SDS- 
PAGE. P= papain digestion products before separation. 
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Figure 3.4 ii 
Further purification of papain digested IgY-Fc by size exclusion 
chromatography 
Gel filtration profile of papain digested IgY-Fc fragment previously separated 
from Fabs using ion exchange resin (fractions 45-49). The collected peak used 
for analysis of the Fc is shown. 
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Figure 3.4 iii 
Analysis of IgY papain digestion and purified Fc 
Reducing (7,8 & 9, bottom) and non-reducing (1,2 & 3, top left) 12% SDS-PAGE 
gels and western blot (4,5 & 6, top right) showing stages of IgY-Fc preparation. 
Purified IgY (1,4 & 7) was digested with papain (2,5 & 8) and Fc separated 
using two chromatography techniques (3,6 & 9). Bands consistent with Fab and 
Fc are marked. The other marked band (*) is a minor component of the 
separated Fc preparation and probably represents monomeric Fc as the 
preparation reduces into a single band (9). This phenomenon has been 
observed in preparations of IgE-Fc (CO-4) and is likely an artefact of SDS- 
PAGE. 
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Figure 3.4 iv 
Schematic of fragments produced by papain digestion of mammalian IgG 
and avian IgY 
IgG is cleaved by papain in a specific manner to produce Fab and Fc 
fragments. The Fc fragments retain the interchain disulphide bonds that allow 
the Cy2 and Cy3 domains to remain dimeric. Papain cleavage of IgY also 
produces an Fc containing the orthologous Cu3 and Cv4 domains, despite the 
presence of an additional Cu2 domain in the complete antibody, which appears 
to be completely degraded. The IgY-Fc remains dimeric after separation from 
the rest of the antibody, as does the IgG-Fc. Cysteine residues at the N- 
terminus of the IgY-Fc (position 347 in each chain) are apparently able to form 
an interchain disulphide bond. 
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Figure 3.4 v 
Comparison of relative mobility of homologous avian and mammalian 
antibodies and their Fc fragments 
Non-reducing 9% SDS-PAGE gel showing mammalian IgE (lane 1), 
recombinant IgE-Fc Cc2-4 (lane 2), mammalian IgG (lane 3), papain produced 
IgG-Fc Cy2-3 (lane 4), avian IgY (lane 5) and papain produced IgY-Fc Cu3-4 
(lane 6). 
In the IgE-Fc, cysteine residues C241 and C328 in Cc2 are involved in 
interchain disulphide bonds (Wan et al., 2002). The orthologous residues, C252 
and C340 occur in Cv2 and are therefore missing from the incomplete IgY-Fc. 
However, the IgY heavy chain contains a cysteine at position 347, which has no 
equivalent in either the IgE or the IgG heavy chains. These results suggest that 
this residue is capable of forming an interchain disulphide bond (Figure 3.4 iv), 
which allows the Cu3-4 fragment to remain dimeric when denatured in SDS 
(Figure 3.4 iii). 
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3.5 Crystallisation of IgY-Fc 
The purified IgY-Fc (Cu3-4) was used to screen for crystallisation 
conditions using the hanging drop vapour diffusion method as described in 
chapter 2. Screens were examined after one week and crystals of various 
morphologies were observed under several conditions (Figure 3.5 i and Table 
3.5 ii). An example of each crystal was stained with methylene blue to confirm 
that they were composed of protein. 
Crystallisation conditions from hits on the initial screen were varied in 
order to optimise crystal growth. Crystals grew to the same size and 
morphology as noted in the initial screen under a range of pH, precipitant, buffer 
and/or additive concentrations, so several examples of each were wet mounted 
and tested for X-ray diffraction in-house. Others were cryo-cooled and tested at 
the Synchrotron Radiation Source (SRS), Daresbury, UK. 
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Figure 3.5 i 
Crystals of IgY-Fc Cu3-4 
/ 
Examples of each crystal morphology observed. Images B and C are of crystals 
of the same morphology taken from a different angle. Image D shows crystals 
stained with methylene blue. The longest dimensions observed for each 
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Table 3.5 ii (previous page) 
Crystallisation and cryo-protectant conditions for IgY-Fc 
The crystal type refers to the morphology detailed in figure 3.5 I. For those 
crystals that were cryo-cooled, protectants found to be suitable are shown. 
Acknowledgement to Dr. A. Davies & Dr. S. Fabiane for assistance in cryo- 
protectant screening 
3.6 X-ray diffraction of IgY-Fc crystals 
The wet-mounted crystals tested in-house diffracted to -11 A resolution 
and the cryo-cooled crystals tested at SRS (Daresbury, UK) to -8 A resolution 
and the diffraction patterns confirm that they were indeed protein. Diffraction 
images from one of the cryo-cooled crystals are shown in figures 3.6 i and 3.6 ii. 
Unfortunately, these resolutions were insufficient to provide useful structural 
data. 
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Figure 3.6 i 
X-ray diffraction image of an IgY-Fc crystal to -8A resolution 
Image was collected at beamline 10.1, Synchrotron Radiation Source (SRS), 
Daresbury, UK. Crystal to detector distance = 240mm, Exposure time = 60s, 0M 
= 1°. Data collection was performed by Dr. A. Davies and Dr. M. Holdom. 
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Figure 3.6 ii 
X-ray diffraction image of crystals of IgY-Fc 
Image was collected at beamline 10.1, Synchrotron Radiation Source (SRS), 
Daresbury, UK. Distance = 240mm, Exposure time = 120s, tD = 10. This image 
is from the same crystal as figure 3.6 i, but rotated through 90 °. Data collection 
was performed by Dr. A. Davies and Dr. M. Holdom. 
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3.7 Discussion 
IgY was purified from chicken egg yolk and digested by papain in an 
attempt to prepare IgY-Fc in a similar manner to the preparation of Fc from 
mammalian IgG, although it was appreciated that for IgE, the Fc appears to be 
completely degraded by the enzyme. It was found that IgY is cleaved by papain 
in a manner similar to both of these isotypes. An Fc fragment was produced, but 
the Cu2 domains were absent. As a complete Cu2-4 IgY-Fc could not therefore 
be produced by papain digestion, the structure and function of the Cu2 domain 
could not be studied using fragments prepared using this technique. However, 
no part of the IgY three-dimensional structure has been solved to date, so 
crystals of the Cv3-4 Fc were prepared. Unfortunately, it was found that they 
were not of sufficient quality to yield useful structural information. This might be 
explained by heterogeneity of the Fc N-terminus, resulting from incomplete 
digestion of Cu2, as evidenced by the presence of multiple sequences that 
differed in length by a few residues. These 'ragged ends' could be a contributing 
factor to poor packing in the crystal lattice, which would result in disorder within 
the crystal and consequently X-ray diffraction with poor resolution. 
The Cu3-4 Fc fragment appeared to run as a dimer on non-reducing 
SDS-PAGE, but could be readily reduced to a monomeric form, which suggests 
that the fragment is disulphide linked. The major N-terminal sequence of the 
dimeric band showed that of the three cysteines in the heavy chain sequence 
that could be involved in interchain bonds, the only one present was C347, the 
"extra" cysteine that has no equivalent in IgE (Figure 3.7 i). 
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P333 
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T 
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Figure 3.7 i 
Alignment of human epsilon and chicken upsilon Ig heavy chain cDNA 
sequences at the CH2 / CH3 domain boundary 
An alignment of the complete heavy chain constant region from IgE and IgY 
was made using ClustalW. The upsilon chain contains a cysteine residue 
(C347) that is not predicted to be involved in an interdomain disulphide bond. 
The epsilon chain lacks an equivalent cysteine, so IgY may have one more 
interchain disulphide bond than mammalian IgE. 
The finding that this residue is capable of forming an interchain 
disulphide bond in the Cu3-4 Fc could have important implications for the 
structure of IgY and its receptor interactions. An alignment of the upsilon and 
epsilon heavy chains suggests that C347 in IgY is replaced by P333 or G335 in 
IgE. The clustalW alignment software opens a two residue gap just before this 
region, so precisely which residue is a more likely substitute in IgE is unclear. 
Both of these residues are implicated in binding of IgE to its high affinity 
receptor, FccRI (Garman et al., 2000). In the "open" conformation of receptor- 
bound CF3-4 (Garman et al., 2000), and the "closed" conformation of unbound 
CE2-4 (Wan et al., 2002), the change in interchain atomic distances between 
the alpha carbons (Ca) of P333 and G335 are both approximately 7A; from 
10.1A to 17.1A for P333 and from 10.04A to 17.4A for G335 (Figure 3.7 ii). Ca - 
Ca distances between disulphide-bonded cysteines have been noted in crystal 
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structures to range between 4.4A and 9.3A (Krovetz et al., 1997), which would 
suggest that these bonds do not permit flexibility of more than 5A. If an 
interchain disulphide were to exist in this part of IgE, constraints would be 
imposed upon the conformational change that is thought to occur upon receptor 
binding (Wan et aL, 2002). This could mean that despite numerous structural 
similarities, IgY may not behave in the same way as IgE upon receptor binding, 
which may affect the affinity and kinetics of the interaction. 
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Unbound (Cc2-4, Wan et al., 2002) 
B 
15 
Bound to receptor (Cc3-4 / FccRla complex, Garman et al., 2000) 
C 
Interchain Ca-Ca distance 
(Angstroms) 
Proline 333 Glycine 335 
In CF2-4 structure (unbound) 10.1 10.04 
In CE3-4 structure (bound to receptor) 17.1 17.4 
Change upon receptor binding 7.02 7.3 
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Figure 3.7 ii (previous page) 
Interchain alpha carbon atomic distance measurements of residues in 
human IgE orthologous to C347 of avian IgY 
Stereo images of residues 330 to 337 from crystal structures of (unbound) 
complete Fc CF-2-4 (A) and Cc3-4 in complex with the extracellular portion of the 
high affinity receptor for IgE, FctRI (B). Interchain atomic distance 
measurements of alpha carbons in proline 333 (green) and glycine 335 (orange) 
were made using Rasmol. The change in these distances are summarised in 
the table (C). 
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Chapter 4 
Design and construction of IgY-Fc mammalian expression vectors 
4.1 Overview 
In the previous chapter, it was shown that papain digestion could not be used 
to separate a fragment from IgY that contains all of the domains that make up 
the Fc; Cu2, Cu3 and Cu4. This has since been confirmed by another group 
(Suzuki and Lee, 2004). To date, crystals of IgY-Fc prepared in this manner 
have not been reported to yield X-ray diffraction data of sufficient resolution for 
analysis (Kubo and Benedict, 1969). Poor quality crystals could be explained by 
the N-terminal heterogeneity observed in the papain cleaved IgY-Fc. 
In order to obtain an IgY-Fc fragment that contains Cu2 domains, which is 
essential for comparative studies with IgE-Fc (Cc2-4), a recombinant form must 
be produced. Through recombinant DNA technology, large quantities of protein 
can be produced and mutations can be made that allow heterogeneity to be 
minimised, both of which are essential if highly ordered crystals are to be 
grown. 
Vectors encoding IgE-Fc fragments (Cc2-4, CE3-4 and various mutants) 
have been constructed by members of our group and used to express secreted 
material from mammalian cells for crystallography and biophysical 
investigations (Henry et al., 1997; Hunt et al., 2005; McDonnell et al., 2001; Shi 
et al., 1997; Wan et al., 2002; Young et al., 1995). Production rates from stable 
transfectants of up to 33pg/106 cells/24hrs were achieved, such that upwards of 
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100 milligrams could be synthesised per litre of culture (R. J. Young, 1994, PhD 
Thesis). To produce sufficient quantities of recombinant lgY-Fc for similar 
studies, an lgE-Fc expression vector, pRY24, was adapted to express IgY-Fc, 
with as few changes as possible. 
The design of the Cc2-4 and Cc3-4 lgE-Fc fragments produced in the 
above studies were used as guides for design of lgY-Fc fragments. 
4.2 Selection of mutations 
4.2.1 N-linked glycosylation 
Carbohydrate moieties on human IgE and IgG play important roles in 
both structure and function. In IgG, the Fc has a horseshoe-like structure, with a 
core of complex-type oligosaccharides, linked to asparagine residues at position 
297 in each Cy2 domain. Glycosylation has been shown to be crucial for 
maintenance of normal IgG-Fc conformation and the ability to bind Fc receptors 
and complement (Kobata, 1990; Krapp et al., 2003; Mimura et al., 2000; Mimura 
et al., 2001; Radaev and Sun, 2001; Tao and Morrison, 1989; Wright and 
Morrison, 1997; Woof, 1985, PhD Thesis). 
The human IgE-Fc also contains complex-type glycosylation at N265 and 
N371. However, a third asparagine at position 394 is the orthologue of IgG's 
N297 and is linked to high-mannose oligosaccharide (Baenziger et al., 1974a; 
Baenziger et al., 1974b; Dorrington and Bennich, 1978; Wan et aL, 2002). 
Unlike IgG-Fc fragments, IgE-Fc fragments lacking carbohydrate are still able to 
bind the high affinity receptor for IgE, albeit with four-fold lower affinity (Basu et 
al., 1993; Bjorklund et al., 1999; Geha et al., 1985; Helm et al., 1988; Hunt et 
al., 2005; Vercelli et al., 1989). 
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The sequence of chicken IgY-Fc shows two potential N-glycosylation 
sites at N308 and N407, which are linked to complex and high-mannose type 
oligosaccharides, respectively (Suzuki and Lee, 2004). The location and type of 
glycosylation in IgY-Fc are more similar to those in IgE-Fc than IgG-Fc. N308 in 
chicken Cu2 is orthologous to N265 in human CE2 by virtue of it being the only 
glycosylation site in this domain, although its position is more similar to the Ce2 
glycosylation sites of mouse, rat and opossum IgE. N407 in chicken Cv3 
appears to be orthologous to N394 in human C83, as the positions of the 
asparagines involved are well conserved between chicken, duck, human, rat 
and mouse Cu3 and Cc3. In addition, the Cu3- and CE3-linked oligosaccharides 
in birds and mammals are all of the high-mannose type (Suzuki and Lee, 2004). 
The bent structure of CE2-4 suggests that steric hindrance might prevent access 
to these sites by a-glucosidase II, an enzyme that is responsible for processing 
of N-linked carbohydrates (Wan et a/., 2002). In contrast, the structure of IgG-Fc 
imposes no such restriction (Zheng et al., 1992), so glycosylation at N297 in 
Cy2 becomes processed to complex type. The presence of high-mannose 
linked to Cu3 might suggest that N407 is inaccessible in a similar manner to 
N394 in Cc3, which could imply a 3D structure that is more similar to IgE than 
IgG. 
In order to investigate the effect of glycosylation on the structure and 
function of IgY-Fc, recombinant Cu2-4 fragments were produced (i) with both 
sites intact ('wild type' or wt), (ii) asparagine 308 mutated to glutamine (N308Q) 
and (iii) asparagines 308 AND 407 mutated to glutamine (N308Q N407Q) 
(Figure 4.2.1). 
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wt N308Q N308Q 
N407Q 
Figure 4.2.1 
Schematic representation of recombinant IgY-Fc (Cu2-4) fragments 
Three `complete' IgY-Fc (Cu2-4) fragments were designed to be expressed in 
mammalian cells with varying glycosylation states: An unmodified form (wt) and 
two mutants that have one (N308Q) or both (N308Q N407Q) N-linked 
glycosylation sites removed. Sites were removed by mutation of the specified 
aspargine codon to encode glutamine instead. Putative interchain disulphide 
bonds are shown in red and oligosaccharides are shown in blue. 
4.2.2 Interchain disulphide bridges 
Recent studies by Hunt et al. (2005), using a series of Cc3-4 fragments, 
suggest that a non-native interchain disulphide bond in the IgE-Fc at the 
CE2/CE3 boundary is required to enable both Cc3 domains to bind to a single 
high affinity receptor for IgE, Fc6RI, thereby increasing the affinity of binding 
and reducing the rate of dissociation from the receptor. The maintenance of 
proximity of the CE3 domains in the CE3-4 fragment prevents artefactual 1: 2 
receptor interaction stoichiometry (Hunt et al., 2005). 
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The sequence of the upsilon heavy chain and the results of the previous 
chapter suggest that the IgY-Fc may possess three interchain disulphide bonds, 
two of which are at an orthologous position to the CE=c3 boundary in IgE-Fc. 
In order to investigate the effect of disulphide linkage on the structure 
and function of IgY-Fc, a series of recombinant Cu3-4 fragments were 
produced, allowing direct comparisons to be made with the CE3-4 mutants 
designed and synthesised in earlier investigations. The Cu3-4 mutants were 
designed to have (a) both cysteines present ("wild type" or wt), (b) cysteine 340 
mutated to serine (C340S), (c) cysteine 347 mutated to serine (C347S) and (d) 
cysteines 340 AND 347 mutated to serines (C340S C347S) (Figure 4.2.2). Cv2- 
4 fragments with disulphide bond mutations have not been produced in this 
investigation. Biophysical investigations using Cc3-4 have shown that this 
fragment retains receptor binding affinity that is comparable to Cc2-4 and whole 
IgE (Hunt et al., 2005; Keown et al., 1997; McDonnell et al., 2001). These data 
suggest that the orthologous Cu3-4 will also bind, allowing the role of Cys 347 
to be investigated. 
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wt 
C340S C347S C340S 
C347S 
Figure 4.2.2 
Schematic representation of recombinant IgY-Fc (Cu3-4) mutants 
Four IgY-Fc (Cu2-4) sub-fragments were designed to be expressed in 
mammalian cells with various interchain disulphide bond configurations: an 
unmodified form (wt) and three mutants that contain cysteine residues in or one 
of two positions (C340S and C347S), or neither (C340S C347S). These 
residues may be involved in interchain disulphide bonds at the Cu2/Cu3 
boundary. Where a disulfide was to be removed, the specified cysteine codon 
was mutated to encode serine instead. Putative interchain disulphide bonds are 
shown in red and oligosaccharides are shown in blue. 
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4.3 Construction of mutant IgY-Fc expression vectors 
4.3.1 Overall strategy 
The IgE-Fc CE2-4 expression vector, pRY24 (Figure 4.3.1 i) was to be 
used as the basis for all IgY-Fc expression vectors. A cassette defined by 
Hindill restriction enzyme sites contains the leader sequence from the variable 
kappa light-chain of the mouse monoclonal antibody B72.3, the coding 
sequence (CDS) for human Cc2-4 and the 3' untranslated region (UTR), also 
from the human epsilon heavy chain. The overall cloning strategy was to adapt 
this cassette to allow sequences encoding IgY-Fc Cu2-4 and Cu3-4 amplified 
from a chicken splenocyte cDNA library to be switched with the CE2-4 CDS, 
keeping the other components of the cassette intact. In order to make the 
necessary changes to allow the IgY-Fc sequences to be inserted and modified, 
as outlined in section 4.2, without inadvertent disruption to the rest of the pRY24 
vector, the Hindlll cassette was transferred into a small holding plasmid, 
pSP64T (Figure 4.3.1 ii). A summary of the cloning strategy is shown in figure 
4.3.1 iii. 
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Figure 4.3.1 i 
lgE-Fc expression vector for NS-0 cells, pRY24 
Schematic diagram showing components of the mammalian expression vector 
pRY24, previously constructed in our group. pRY24 is based on pMRRO18, a 
vector designed for stable transfection of NS-0 cells. pRY24 transfected NS-Os 
are highly efficient producers of secreted lgE-Fc (CE2-4), whose expression is 
driven by the human cytomegalovirus immediate early promoter (hCMV). 
Expression of the glutamine synthetase (GS) gene (cDNA version) is driven by 
an SV40 early promoter (SVE) and allows selection of successfully transfected 
mammalian cells. The vector also contains an ampicillin resistance gene 
(ampR) in order to allow selection of transformed E. coli when cloning the 
plasmid. The IgE-Fc (CE2-4) construct is contained within a Hindill fragment 
(top) that contains the coding sequence for domains Cr; 2, Cß: 3 and Cß: 4 bounded 
by a 3' untranslated region (labelled U) and a 5' leader sequence, which is 
derived from the B72.3 mouse monoclonal antibody variable kappa light chain. 
The leader sequence encodes a signal peptide that tags the Fc for transport to 
the endoplasmic reticulum for subsequent secretion. 
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Hindill 
Figure 4.3.1 ii 
pSP64T plasmid 
Schematic diagram showing pSP64T, the plasmid used for subcloning of the 
IgE-Fc Hindlll cassette from pRY24 into the plasmid's multiple cloning site 
(MCS), before insertion of either IgY-Fc (Cu2-4) or IgY-Fc (Cu3-4) cDNA. All 
site-directed mutagenesis on the IgY-Fc cassettes was performed in this 
plasmid rather than the final mammalian expression vector in order to avoid 
introduction of unwanted mutations by errors during PCR. The plasmid contains 
an ampicillin resistance gene (ampR) in order to allow selection of transformed 
E. coli. 
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Figure 4.3.1 iii 
Cloning strategy used to construct IgY-Fc expression vectors 
Hindill restriction enzyme was used to excise a cassette consisting of the 
mouse monoclonal antibody B72.3 VK light chain leader sequence (L), the 
coding sequence (CDS) for human IgE-Fc (eFc) and the human epsilon heavy 
chain untranslated region (U) from the expression vector pRY24. The cassette 
was ligated into a small holding plasmid, pSP64T (1). Site-directed mutagenesis 
was used to introduce a Pmel recognition site (2) and a double digest with Pmel 
and EcoRV performed in order to remove the IgE-Fc CDS, which was then 
replaced with cDNA encoding chicken IgY-Fc (either Cu2-4 or Cu3-4) amplified 
by PCR from a chicken splenocyte cDNA library (3). Various mutations were 
made in different clones before the modified IgY-Fc cassettes were ligated in 
place of the lgE-Fc cassette in pRY24 to create a series of IgY-Fc expression 
vectors (4). 
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4.3.2 Modification of IgE-Fc CDS cassette 
pRY24 contains an EcoRV restriction site 3' of the mouse B72.3 variable 
kappa light-chain leader sequence, which was added to allow ligation to the 
Cc2-4 CDS (R. J. Young, 1994, PhD Thesis). In order to allow removal of the 
CE2-4 CDS whilst retaining the 3' UTR, another restriction site was added; 
pRY24 was transformed into competent E. coli and sufficient quantities for 
further cloning prepared by miniprep. The vector was digested using Hindill 
restriction endonuclease and the resulting 1.5kb fragment was separated using 
agarose gel electrophoresis. Ethidium bromide was used to visualise the DNA 
by UV transluminescence at 325nm, but was subsequently removed by 
phenol: chloroform extraction and ethanol precipitation. The Hindlll cassette was 
ligated into pSP64T and the complete sequence of this plasmid, pSP64T[EFc], 
was checked for restriction enzyme sites using NEBcutter software. The Pmel 
recognition sequence, GTTTAAAC (5' to 3'), was not found in the pRY24 Hind III 
cassette, pSP64T or the published Cu sequence (Pavari et al., 1988). A Pmel 
site was therefore introduced 3' of the human epsilon heavy chain stop codon, 
using PCR site-directed mutagenesis. The IgE-Fc CE2-4 CDS could then be 
removed from this plasmid, by performing a double digest with EcoRV and 
Pmel (Figure 4.3.2), followed by gel purification. 5' phosphates were removed 
using shrimp alkaline phosphatase in order to prevent formation of 'empty' 
plasmids in subsequent ligation reactions. 
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Preparation of the IgY-Fc expression cassette 
1% agarose gel showing restriction fragments or uncut plasmids at various 
stages in the insertion of a Pmel restriction site into the IgE-Fc Hindlll cassette 
from pRY24 in order to allow removal of the EFc CDS whilst retaining the 5' 
leader and the 3' UTR. (2) pSP64T plasmid without insert. (3) pSP64T cut with 
Hindill. (4) pSP64T incubated with EcoRV and Pmei. These enzymes have no 
restriction sites in the 'empty' plasmid. (5) pSP64T[EFc]. (6) pSP64T[cFc] cut 
with Hindill. (7) pSP64T[EFc+Pmel] cut with EcoRV and Pmel. Molecular weight 
markers: (1) 1 kb ladder (8) 100bp ladder. 
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4.3.3 Amplification of Cu2-4 and Cu3-4 cDNA and creation of mutagenic 
cassettes 
Fragments encoding Cu2-4 and Cu3-4 were amplified by PCR from a 
chicken splenocyte cDNA library (Figure 4.3.3 i). The forward primer used for 
amplification of the Cu2-4 cDNA was designed so that the sequence would 
include an EcoRV site immediately 5' of the start of the Cu2 CDS (see chapter 
2). The Cut/Cu2 junction was predicted by protein pattern recognition software 
(InterPro Scan, EMBL-EBI and ScanProsite, ExPASy) and ClustalW alignment 
of the amino acid sequences of the upsilon heavy chain with the epsilon heavy 
chain, for which the domain junctions have been established. The primer also 
changes the cysteine at position 232 to an alanine because this residue is 
orthologous to C225 in human Ce2, which forms a bridge to CE1 (after Young et 
al., 1995). 
The Cu2/Cu3 junction was predicted as above, but the forward primer 
used to amplify Cu3-4 cDNA was designed to begin the fragment at the 
penultimate residue in Cu2, in order to include cysteine 340, which may form an 
interchain disulphide bond and help to give a less artefactual representation of 
the IgY-Fc Cu3-4 fragment (after Shi et al., 1997). The modifications made to 
the IgY-Fc cDNA ends are detailed in figure 4.3.3 ii. 
The amplified cDNAs were digested with EcoRV and Pmel, then gel 
purified to prepare them for ligation into the cassette prepared in 4.3.2; 
successfully ligated plasmids were cloned by transformation of competent E. coli 
and selection on ampicillin LB-agar. Colonies containing plasmids with correctly 
oriented insert were selected by PCR screening and sequencing (data not 
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shown). The two resulting constructs were named pATHY24 and pATYH34 






Figure 4.3.3 i 
Amplification of lgY-Fc cDNA 
cDNAs encoding (2) Cu2-4 and (3) Cu3-4 bounded by EcoRV and Pmel 
restriction sites were amplified by PCR using a chicken splenocyte cDNA library 
as template. Lane 1 contains A/ EcoRl / Hindill molecular weight marker. 
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ATG AGT GTG CCC ACT CAG GTC CTG GGG TTG CTG CTG CTG 
TAC TCA CAC GGG TGA GTC CAG GAC CCC AAC GAC GAC GAC 
MSVPTQVLGLLLL 
EcoRV 
TGG CTT ACA GAT GCC AGA TGT GAT... 
ACC GAA TGT CTA CGG TCT ACA CTA... 
WLTDARCD 
1. Predicted Cu11Cu2 junction: 
5' 231 
... LYS GLU VAL GLN / VAL CYS ARG VAL ASP... 
... AAG GAG GTG CAG / GTC TGC CGG GTA GAT... 
2. Leader sequence-adapter/Cu2 junction: 
5' j. V232A 
MET... CYS ASP ILE / VAL ALA ARG VAL ASP... 
ATG... TGT GAT ATC / GTC GCC CGG GTA GAT... 
EcoRV 
3. Predicted Cu2/Cu3 junction: 
5' 340 342 347 
... LYS GLY CYS PRO / ASP GLY ALA GLN SER CYS... 
... AAG GGA TGC CCG / GAC GGC GCT CAG AGC TGC... 
4. Leader sequence-adapter/Cu3 junction: 
5' 1 340 
MET... CYS ASP ILE / CYS PRO ASP GLY ALA... 
ATG... TGT GAT ATC / TGC CCG GAC GGC GCT... 
EcoRV 
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C 
1. Natural Cc4/stop-UTR: 
5' 
... LYS SER ARG Ter 
... AAA TCC CGG TAA ATG ACG TAC TCC TGC CTC CCT... 
2. Cu4/stop-adapter-UTR: 
5' 
... GLN ALA GLY LYS Ter 
... CAG GCT GGT AAA TAA GTT TAA ACC TGC CTC CCT... Pmel 
Figure 4.3.3 ii (above and previous page) 
Adaptation of the chicken IgY-Fc sequences for secretion 
(A) The region encoding a signal peptide in the mouse variable kappa light 
chain leader sequence from monoclonal antibody B72.3, to which the IgY-FC 
sequences were ligated. The leader has been mutated to introduce an EcoRV 
site. 
(B) The residues at the inter domain junctions of the upsilon heavy chain (1,3) 
were predicted by motif identification software and alignment with the known 
boundaries of the epsilon heavy chain of human IgE. The presence of the 
EcoRV site and the location of the signal peptide processing site (marked with 
an arrow) means that all constructs have an aspartic acid residue and an 
isoleucine residue at the N-terminus. The Cu2-4 cDNA was amplified with 
primers that change the cysteine at position 232 to an alanine (2). The 
recombinant CE3-4 fragment used in previous studies (Shi et al., 1997) did not 
begin precisely at the Ce3 junction; the last two amino acids in C62 were 
included so as to allow an interchain disulphide to form. IgY contains two 
cysteines in this locale (C340 and C347) and in order to be able to investigate 
their effect on the Cu3-4 fragment, both were included by mimicking the Cc3-4 
and beginning the construct at the penultimate residue of Cu2 (4). 
(C) The 3' untranslated region (UTR) of the epsilon heavy chain (1) was spliced 
to IgY-Fc cDNA by insertion of a Pmel restriction site (2). 
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4.3.4 Mutation of IgY-Fc Cv2-4 and Cu3-4 cassettes 
Site-directed mutagenesis was used to make the mutations described in 
section 4.2. The mutagenic primers (see chapter 2) were designed to alter the 
encoded amino acid, with as few changes to the nucleotide sequence as 
possible. The changes are summarised in table 4.3.4 i and sequencing 
chromatograms are shown in figure 4.3.4 ii. 
Template Plasmid Mutation New Plasmid Name 
pATYH24 none pATYH24[wt 
pATYH24 N308Q ATYH24 N308Q 
pATYH24[N30SQ] N407Q pATYH24[N308Q N407Q] 
pATYH34 none ATYH34 wt 
pATYH34 C340S pATYH34[C340S] 
pATYH34 C347S pATYH34[C347S] 
pATYH34[C340S] C347S pATYH34[C340S C347S 
Table 4.3.4 i 
Summary of mutations made in Cu2-4 and CO-4 coding sequences 
As each mutation was made, the cassettes were sequenced (Figure 4.3.4 ii). 
The mutant and original `wild type' sequences were found to be identical except 
for the intended changes. 
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C340S C347S mutant 
Figure 4.3.4 ii (above and previous two pages) 
DNA sequencing to confirm IgY-Fc CDS mutations 
Chromatograms showing changes made to single codons (underlined) in the 
IgY-Fc coding sequences by site-directed mutagenesis in order to alter the 
encoded amino acid. Two N-glycosylation sites exist in the Cu2-4 fragment. 
Mutants were created with either N308 changed to glutamine (1A) or both N308 
and N407 changed to glutamine (1 B). Two possible interchain disulphide bonds 
exist between cysteines in the Cu3-4 fragment. Mutants were created with 
either C340 (2A), C347 (2B) or both (2C) changed to serine. Bases are 
numbered according to their positions in the complete upsilon heavy chain (see 
appendix 1). 
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4.3.5 Transfer of mutant IgY-Fc cassettes into expression vector 
The IgY-Fc (Cu2-4, Cu3-4 and mutants) Hindlil cassettes were 
transferred by digestion, purification and ligation from the pATYHx plasmids into 
`empty' pRY24, which had been produced by removal of the lgE-Fc Hindill 
cassette and subsequent gel purification. Successfully ligated vectors were 
cloned by transformation of competent E. coli and selection on ampicillin LB- 
agar. Colonies containing plasmids with correctly oriented insert were selected 
by PCR screening, sequencing (data not shown) and digestion with Hindill 
(Figure 4.3.5 i). The series of IgY-Fc expression vectors were termed pATY with 








Figure 4.3.5 i 
Confirmation of ligation of IgY-Fc cassettes into expression vector by 
digestion with Hindlll 
1% agarose gel showing digestion products of pATYx vectors with Hindill; (1) 
pATY24[wt]; (2) pATY24[N308Q]; (3) pATY24[N308Q / N407Q]; (4) pATY34 
[wt]; (5) pATY34 [C340S]; (6) pATY34[C347S]; (7) pATY34 [C340S / C347S]. A 
1 kb ladder molecular weight marker was run concurrently (M). All vectors 
produce only two fragments upon digestion; the pRY expression vector 
backbone (-8.8kb) and either the Lead er-Cu2-4-sUTR (1.3kb) or Leader-Cu3-4- 
cUTR (0.99kb) cassette. The mutations made in the IgY-Fc sequences were 
substitutions, so do not affect the cassette size. 
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Figure 4.3.5 ii 
IgY-Fc expression vector(s) for NS-0 cells, pATY24 & pATY34 
The archetypal Cu2-4 (pATY24) and Cu3-4 (pATY34) expression vectors differ 
only in how much of the IgY-Fc coding sequence is present. These vectors and 
a series of mutants (not shown) are based on the highly productive IgE-Fc 
expression vector pRY24 (Young et al., 1995). Expression of a construct of the 
mouse B72.3 monoclonal antibody variable kappa light chain 5' leader 
sequence, IgY-Fc CDS and the epsilon heavy chain 3' untranslated region (U) 
is driven by a human cytomegalovirus (hCMV) promoter. Expression of the 
glutamine synthetase (GS) gene (cDNA version) is driven by an SV40 early 
promoter (SVE) and allows selection of successfully transfected mammalian 
cells. The vector also contains an ampicillin resistance gene (ampR) in order to 
allow selection of transformed E. coli when cloning the plasmid. 
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4.4 Transient expression of IgY-Fcs in CHO cells 
Previous work in our group has shown that stably transfected CHO cells 
produce at best -2mg/litre of lgE-Fc fragments (R. J. Young, 1994, PhD Thesis) 
and that NS-0 cells stably transfected using the GS system are capable of much 
higher yields. However, transient expression in CHO cells provided a rapid way 
to test the viability of the vector constructs before the creation of NS-0 clones. 
The pATY vectors were transfected into CHO-K1 cells and supernatants 
analysed by an anti-IgY ELISA (see chapter 2). Purified IgY-Fc prepared by 
papain digestion (see chapter 3) was used to create a standard curve in order 
to quantify IgY-Fc in the harvested supernatants (Figure 4.4 i). All vectors were 
found to be capable of inducing secretion of their encoded IgY-Fc (Table 4.4 ii). 
Expression levels of '-100-250ng/1x106 cells/ml were observed. These levels 
are comparable to transient transfections of the pRY-based IgE-Fc vectors (R. J. 
Young, 1994, PhD Thesis), which were then used to create stable NS-0 
transfectants that produced IgE-Fc fragments at -100-600mg/litre (A. J. Henry, 
1996, PhD Thesis). 
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Figure 4.4 i 
IgY-Fc ELISA standard curve 
Typical ELISA standard curve used to determine IgY-Fc concentration in CHO- 
K1 culture supernatants. Known quantities of papain cleaved IgY-Fc (see 
chapter 3) were assayed in triplicate and mean optical densities at 492nm 
plotted as a function of log [IgY-Fc concentration in ng/ml]. A standard curve 
was generated for every ELISA plate and these data were obtained when the 
samples from the CHO transfections were tested (shown in table 4.4 ii). 
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Table 4.4 ii 
Yields of secreted IgY-Fc mutants from transiently transfected CHO-KI 
cells 
Two separate transfections were performed using each vector and specific 
production rates of transiently expressing cells determined by ELISA. 
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4.5 Discussion 
Vectors encoding a series of IgY-Fc mutants were designed, constructed 
and tested in order to produce recombinant fragments for structural and 
functional studies. Expression vectors for the complete IgY-Fc (Cu2-4) were 
created and found to successfully induce secretion of fully glycosylated, partially 
glycosylated (N308Q) and aglycosylated (N308Q N407Q) forms from 
mammalian cells. 
Glycosylation of IgG-Fc is an absolute requirement for receptor 
interaction. Receptor binding sites are disrupted due to changes in quaternary 
structure that occur when oligosaccharide is removed (Krapp et al., 2003; 
Wright and Morrison, 1997). By contrast, deglycosylated IgE-Fc retains 
substantial receptor binding capability, suggesting that binding site architecture 
may be less affected by oligosaccharide removal (Bjorklund et al., 1999). 
However, expression of aglycosylated lgE-Fc results in a fragment that lacks 
receptor binding capability (Nettleton and Kochan, 1995), which could indicate a 
role in initial folding of the lgE-Fc, but not maintenance of structure post- 
secretion. The structural similarities between IgY and IgE suggest that 
glycosylation of N407 in Cu3, the homologous residue to N394 in CE3, may play 
a similar role in IgY and IgE. However, an anti-IgY reactive product was 
detected in the supernatant of CHO cells transfected with the expression vector 
for aglycosylated Cu2-4 [N308Q N407Q]. Whether this fragment is produced by 
stably transfected cells and is indeed aglycosylated will be discussed in 
subsequent chapters. 
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A series of vectors were created that encode lgY-Fc (Cu3-4) with every 
combination of cysteine to serine mutations made at positions 340 and 347. All 
vectors were found to be capable of inducing expression of material from 
mammalian cells that was detectable by IgY-specific ELISA. 
The full length and truncated IgY-Fc fragments will allow comparative 
studies of the IgY-Fc with and without the Cu2 domains. Although very little is 
known how many types of IgY receptor exist in chicken and how they interact 
with the Fc, structural and functional analysis of the cysteine to serine mutants 
may allow the influence of putative interchain disulphide bonds to be studied. 
The levels of expression achieved with transient transfections of CHO-K1 
cells were impractical for further analysis of the recombinant IgY-Fcs. The CHO 
system, which can be highly productive for certain proteins (Cockett et al., 
1990), has previously been found to give poor yields of lgE-Fc CE2-4 (Young, 
1994). Stable secretors of IgY-Fc capable of producing milligram quantities of 
protein for techniques such as X-ray crystallography were required, so CHO 
cells were used solely as a means to verify the correct assembly and viability of 
the pATY expression vectors. 
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Chapter 5 
Recombinant IgY-Fc Production, Purification & Initial Structural Characterisation 
5.1 Overview 
Although sub-fragments of immunoglobulins have been produced in 
bacteria (Boss et al., 1984; Ishizaka et al., 1986; Kenten et al., 1984), yeast 
(Eldin et al., 1997) and baculovirus-infected insect cells (Bjorklund et al., 2000; 
Wurzburg et al., 2000), mammalian expression systems are often favoured in 
structural studies (Basu et aL, 1993; Young et al., 1995) as they avoid any 
potentially problematic refolding or post-translational modification issues that 
can occur in prokaryotic systems. In the previous chapter, a series of plasmid 
vectors were constructed to allow expression of recombinant IgY-Fc Cu2-4, 
Cu3-4 and several mutants in a mouse myeloma cell line, NS-0 (Bebbington et 
al., 1992). As described in chapter 4, this cell line was used to produce 
substantial quantities of various IgE-Fc fragments in previous reported studies 
(see section 4.1 for references). NS-0 cells lack glutamine synthetase (GS) and 
cannot grow in glutamine-free medium unless transfected with a vector which 
encodes the enzyme. This allows a cheap, non-toxic approach to selection of 
stable transfectants. The following chapter describes the production of IgY-Fc 
secreting cells and the subsequent purification and initial characterisation of 
recombinant IgY-Fc fragments. 
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5.2 Stable expression of IgY-Fc fragments from NS-0 cells 
5.2.1 Transfection and selection of stable NS-0 clones 
NS-0 cells were grown in antibiotic-free medium to -70-90% confluency 
before being transfected with a linearised pATY vector (see chapter 2). Stable 
transfectants were obtained by growth in glutamine-free selection medium and 
clones isolated by transfer of single colonies to new wells containing selection 
medium. Approximately 50-100 colonies were obtained per transfection, 
although only -50% were in separate wells and were considered clonal. 
Typically -25% of these clones would either fail to grow after transfer or would 
grow too slowly to be useful. Spent culture media of successfully propagated 
clones were harvested and assayed for the presence of IgY-Fc by ELISA (see 
chapter 2). Clones producing the highest levels of IgY-Fc were maintained in 
selection medium and subjected to further rounds of screening to ensure 
stability of expression. The majority of clones either lost expression (and/or 
died) after several weeks in culture or produced levels of IgY-Fc too low to be 
detected by ELISA. The remaining clones (typically fewer than 5) were then 
tested for specific production rate (see chapter 2) and aliquots stored in liquid 
nitrogen. The highest producers (Table 5.2.1) were expanded and used for 
subsequent IgY-Fc production. Transfections yielding no stable clones were 
repeated. 
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Mutation Clone Specific Production 
Rate 
06 cells/24hrs) 
wt 2-3 C12 8.5 
Cu2-4 N308Q 1-2 B12 20.1 
N308Q N407Q 2-2 A10 1.5 
wt 2-3 B11 6.0 
C 3 4 C340S 3-3 H10 7.0 u - C347S 3-1 H10 7.0 
C340S C347S 1-1 C11 7.8 
Table 5.2.1 
Specific IgY-Fc production rates of the best stable NS-0 transfectants 
NS-0 cells were transfected with the pATY vectors (described in chapter 4), 
which encode the various IgY-Fc constructs. Successful transfectants were 
expanded, maintained and screened for secretion of IgY-Fc using anti-IgY 
ELISA of culture media. Data for the clones with the highest specific production 
rate of each IgY-Fc construct are shown. These clones were used to produce all 
IgY-Fc fragments used in subsequent experiments. 
5.2.2 Growth of stable NS-0 clones and analysis of IgY-Fc secretion 
The stable NS-0 clones were only partially adherent, so could be 
transferred to one litre roller bottles without lengthy adaptation to growth in 
suspension. Growth and expression patterns of NS-0 cells that secrete IgE-Fc 
have been previously determined (R. J. Young, 1994, PhD Thesis). Cells were 
found to reach confluency after six days post seeding, but lgE-Fc continued to 
accumulate with minimal degradation for about ten days. Quantity and quality of 
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secreted IgY-Fc was determined over the same time-scale using SDS-PAGE 
and Western blotting (Figure 5.2.2 i). The concentration of lgY-Fc appeared to 
plateau around 8 days post seeding, with no degradation apparent after 10 
days, at which time no viable cells could be detected using trypan blue 
exclusion (data not shown). The concentration of each lgY-Fc accumulated was 
determined by ELISA (Table 5.2.2 ii). The rate of cell growth in rolling culture 
was not equal for all clones, so in some cases clones were able to accumulate 
more IgY-Fc than others whose specific production rates were apparently 
higher. Despite this, all IgY-Fc mutants were produced in sufficient quantities for 
further studies. 
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A 
B 
Figure 5.2.2 i 
Accumulation of recombinant IgY-Fc in stable NS-0 transfectant 1-1 C11 
Samples of medium were taken every 24 hours from stable NS-0 transfectants 
growing in roller bottles for 10 days and analysed by SDS-PAGE using a non- 
native 12% polyacrylamide gel. The samples were either stained with (A) 
Coomassie or transferred to nitrocellulose for (B) Western blotting using a goat 
polyclonal anti-IgY antibody. Although the culture medium contained numerous 
proteins, only one detectable -30kDa band appeared over the course of the 
culture (marked). Only bands at this molecular weight were detected by anti-IgY 
Western blot. -30Kda is consistent with a Cu3-4 fragment that is monomeric 
upon denaturation, which this clone (1-1 C11) was designed to produce. Like all 
of the recombinant IgY-Fc fragments produced (not shown), Cu3-4 [C340S 
C347S] showed maximal production at or around day 8 and minimal 
degradation even after 10 days. 
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IgY-Fc Mutation Clone Concentration of IgY-Fc 
after 10 days (mg/L) 
wt 2-3 C12 31 
Cu2-4 N308Q 1-2 B12 340 
N308Q N407Q 2-2 Al0 16 
wt 2-3 B11 94 
C 4 3 C340S 3-3 H10 260 u - C347S 3-1 H10 48 
C340S C347S 1-1 C11 250 
Table 5.2.2 ii 
Accumulation of recombinant IgY-Fc in large scale cultures of the best 
stable NS-0 transfectants 
The stable NS-0 transfectants with the highest specific IgY-Fc production rate 
were chosen to seed larger scale cultures in non-selective medium. The 
cultures were incubated for 10 days before supernatants were harvested and 
the concentration of accumulated IgY-Fc measured by ELISA. 
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5.3 Purification of recombinant IgY-Fc fragments 
5.3.1 Affinity purification of recombinant IgY-Fc fragments 
Supernatants from NS-0 cultures were harvested by centrifugation and 
sterile filtered. IgY-Fc was purified using an affinity column packed with rabbit 
anti-IgY antibodies coupled to agarose (see chapter 2). Although the capacity of 
the beads for whole IgY was 1.2mg/ml, the capacity for IgY-Fc was found to be 
-0.2mg/ml. For practical reasons, only -20mg was purified from each 
supernatant. The majority of impurities were removed by a single 
bind/wash/elute cycle, although traces of serum proteins were detected on an 
overloaded SDS-PAGE gel. Impurities were estimated by densitometry to be 
less than 1%, but for experiments where purity and accurate determination of 
concentration were crucial, homogeneity was further improved by a second 
affinity purification cycle. Although this method would not remove aggregated 
IgY-Fc, the quantity of large aggregates was determined to be negligible by UV 
absorbance at >320nm. 
5.3.2 Further purification of recombinant lgY-Fc fragments by size exclusion 
Due to time constraints, only one of the IgY-Fc mutants prepared in 5.3.1 
was selected for further purification by size exclusion chromatography in order 
to begin initial screening for crystallisation conditions. Co2-4 [N308Q] was 
chosen as this mutant is homologous to the recombinant lgE-Fc used to 
determine the Cc2-4 crystal structure (Wan et al., 2002). HPLC separated 
fractions containing the IgY-Fc, as determined by western blot (not shown), 
were pooled and re-analysed to confirm homogeneity (Figure 5.3.2). 
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Purification of IgY-Fc Cu2-4 [N308Q] by gel filtration chromatography 
Gel filtration profiles of double affinity purified IgY-Fc Cu2-4 [N308Q], before (A) 
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5.4 Initial structural characterisation of recombinant IgY-Fc mutants 
Some basic structural properties of the IgY-Fc mutants were investigated 
in order to assess the quality of the recombinant material and to confirm that the 
intended modifications encoded by each vector are evident in the expressed 
proteins. 
5.4.1 Determination of molecular weight of recombinant IgY-Fc mutants 
A series of protein standards were run through a Superdex 200 gel 
filtration matrix (GE Healthcare) and used to generate a calibration curve, from 
which the molecular weight of each IgY-Fc mutant was extrapolated (Figure 
5.4.1). 
The molecular weights are consistent with values predicted for dimers 
made up of four or six immunoglobulin domains for the Cv3-4 and Cu2-4 
fragments, respectively. The Cu2-4 glycosylation mutants could be 
discriminated easily, with a difference of -23 kDa and -8.5 kDa separating the 
wild type Cv2-4, the single N308Q mutant and the double (ostensibly 
aglycosylated) mutant. This implies that the oligosaccharide attached to 
asparagine 308 accounts for -11.5 kDa per chain, whereas the oligosaccharide 
on asparagine 407 accounts for only -4.25 kDa per chain. Glycosylation of IgY- 
Fc is reportedly complex type at N308 and high-mannose at N407 (Suzuki and 
Lee, 2004). Complex oligosaccharides have longer terminal regions than high- 
mannose, but high mannose has more branching so overall their sizes are 
similar (Hubbard and Ivatt, 1981). The difference in apparent molecular weight 
is likely due to the location of the glycosylation sites, which may differentially 
affect the overall shape of the Fc, and therefore gel retention time; if the sites in 
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IgY-Fc are equivalent to their IgE counterparts, the carbohydrate attached to 
N308 will be on the outer face of Cu2 so may provide a greater contribution to 
shape than N407-linked oligosaccharide, which may protrude into the core of 
the Fc. 
The Cu3-4 mutants were found to have similar molecular weights, 
including the mutant lacking interchain disulfide bonds, Cu3-4 [C340S / C347S]. 
This suggests that IgY-Fc is able to dimerise even in the absence of interchain 
disulphide bridges, as is the case for Fc regions of both IgG (Aschaffenburg et 
al., 1979; Fleischman et al., 1963) and IgE (Basu et al., 1993; Hunt et al., 2005). 
The Cy3: Cy3 and Cs4: Ce4 domain pairs form extensive (primarily hydrophobic) 
interactions (Deisenhofer, 1981; Wan et al., 2002), which are thought to provide 
the platform for dimerisation of the complete Fc. Conservation of these non- 
covalent interactions from IgY to IgG and IgE would imply crucial structural or 
functional importance, although these interactions may be weaker in IgY 
(Dreesman and Benedict, 1965b) 
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Estimation of the molecular weight of the IgY-Fc mutants using size 
exclusion chromatography 
(A) Gel filtration profile of IgY and IgY-Fc mutants. The volume necessary to 
elute each protein (Ve), divided by the dead volume of the column (VO) was 
compared to a calibration curve of standards eluted from the same column in 
the same buffer (B), in order to extrapolate the molecular weight for IgY and 
each IgY-Fc mutant (C). An antibody fragment comprised of only two 
immunoglobulin domains, single chain IgG-Fv (prepared by Dr. H. Harries and 
Dr. A. Davies), was included to show that the IgY-Fc fragment molecular 
weights are consistent with dimers of four (Cu3-4) or six (Cu2-4) 
immunoglobulin domains. NB. A different S200 column was used in this 
experiment than those reported in previous figures. 
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5.4.2 Determination of relative mobility of recombinant IgY-Fc mutants 
The relative mobility of each IgY-Fc mutant was assessed by denaturing 
SDS-PAGE, with or without reduction by 2% ß-mercaptoethanol (Figure 5.4.2). 
Each Cu2-4 mutant ran as a smeared major band, with one or more additional 
bands present. Typically, the presence of additional bands on SDS-PAGE gels 
is interpreted as impurity, minor degradation (Cookson and Beynon, 1987) or 
glycosylation heterogeneity (Young et a/., 1995). However, upon reduction, all 
three Cu2-4 mutants showed single anti-IgY reactive bands (Figure 5.4.2 B&D 
lanes 2,3 and 4). A similar phenomenon has been noted to occur when whole 
IgE (and to a lesser extent IgG) is heated in the presence of SIDS and is due to 
the formation of heterogeneous interdomain and interchain disulfide bond 
configurations (Ikeyama, 1987). 
The Cu2-4 [N308Q] and [N308Q N407Q] mutants appeared to have 
more disulfide heterogeneity than the fully glycosylated wild type Cu2-4. 
Glycosylation has been shown to be involved in maintaining immunoglobulin 
domain orientation and stability in IgG (Krapp et al., 2003; Lund et al., 1990; 
Mimura et aL, 2001) and, albeit less crucially, IgE (Bjorklund et aL, 1999). It is 
conceivable that even minor structural changes brought about by the removal of 
N-linked glycosylation could affect which sets of interdomain or interchain 
disulfides are possible or more energetically favourable. Whether these 
changes occur in the native protein or are simply an artefact of SDS-PAGE 
(Kumar et al., 1993), remains to be seen. 
SDS-PAGE analysis of the Cu3-4 mutants confirmed the lack of 
interchain disulfides in the [C340S / C347S] mutant; the denatured fragment 
had a mobility consistent with a monomer and was unaffected by reduction 
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(Figure 5.4.2 lane 8). Differences in migration between the unreduced [C340S] 
and [C347S] mutants, but not their reduced forms (Figure 5.4.2 lanes 6& 7), 
further highlight the influence of disulfide bonds on electrophoretic mobility. 
The analysis also showed that approximately half of the wild type Cu3-4, 
which was expected to possess two interchain disulfide bonds and therefore 
dimerise, in fact has a mobility consistent with a monomer (Figure 5.4.2 lane 5). 
It is likely that the S-S bonds have either failed to form, or have formed in an 
intrachain fashion, resulting in a lack of interchain covalent bonds. There is 
some evidence for the necessity of contacts from other domains in the IgE-Fc 
heavy chain for folding of Ce3 to occur efficiently (J. Hunt, 2004, PhD Thesis). In 
IgY-Fc, the presence of Cu2 may be required to prevent misfolding and/or 
incorrect pairing of cysteines at the Cu2/Cu3 interface. It is worth noting that 
even if a disulfide bond forms between cysteines at position 340, as may initially 
be expected, this could be artefactual. The 'correct' pairing in the full IgY-Fc 
may in fact be a crossed disulfide between C340 and C252 on the opposite 
heavy chain, as is the case for the homologous residues in CE2, C328 and 
C241 respectively (Wan et al., 2002). Efforts were made to separate the two 
species, but they could not be differentiated on the basis of size, charge or 
affinity for immobilised anti-IgY antibodies. It was decided that the protein would 
be used in further investigations, but with the caveat that some artefacts may 
arise. 
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Figure 5.4.2 
SDS-polyacrylamide gel electrophoresis and Western blot analysis of IgY- 
Fc fragments 
Whole IgY and recombinant IgY-Fc fragments secreted from NS-0 cells were 
run on denaturing 12% polyacrylamide gels and either stained with Coomassie 
(A & B) or transferred to nitrocellulose and Western blotted with polyclonal anti- 
IgY antibodies (C & D). Samples were either non-reduced (A & C) or reduced 
with 2% ß-mercaptoethanol (B & D). All gels were loaded as follows: Lane 1, 
IgY, whole molecule. Lane 2, Cu2-4 wild type. Lane 3, Cu2-4 [N308Q]. Lane 4, 
Cu2-4 [N308Q N407Q]. Lane 5, Cu3-4 wild type. Lane 6, Cu3-4 [C340S]. Lane 
7, Cu3-4 [C347S]. Lane 8, Cu3-4 [C340S C347S]. Molecular weight markers 
are shown in kDa. 
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5.4.3 Determination of recombinant IgY-Fc glycosylation state 
The carbohydrate content of the IgY-Fc mutants was qualitatively 
assessed using a glycoprotein staining technique, periodic acid-Schiff (PAS), on 
an SDS-PAGE gel identical to the one used for Coomassie staining in figure 
5.4.2 A. Cu2-4 [N308Q N407Q], the mutant lacking both predicted N- 
glycosylation sites in the Fc region, was not stained by PAS (Figure 5.4.3 lane 
4), confirming that this fragment had indeed been produced without 
glycosylation. 
The finding that IgY-Fc can be secreted from mammalian cells when 
lacking oligosaccharide is significant: correct folding of IgE-Fc in a similar 
system is dependent on core glycosylation (Nettleton and Kochan, 1995), 
whereas this is not the case for mutants of IgG or IgG-Fc (Hobbs et al., 1992; 
Lund et al., 2000; Tao and Morrison, 1989). IgY appears to be similar to IgG in 
this regard. Paradoxically, glycosylation has a crucial role in IgG-Fc function but 
appears to be less influential in IgE-Fc function post secretion. The effect of 
glycosylation on IgY-Fc function will be further discussed in chapter 7. 
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Qualitative assessment of IgY-Fc fragment glycosylation state 
Periodic acid-Schiff (PAS) stained 12% non-reduced SDS-PAGE gel. 10pg 
protein loaded per well. Lane 1, IgY, whole molecule. Lane 2, Cu2-4 wild type. 
Lane 3, Cu2-4 [N308Q]. Lane 4, Cu2-4 [N308Q N407Q]. Lane 5, Cu3-4 wild 
type. Lane 6, Cu3-4 [C340S). Lane 7, Cu3-4 [C347S]. Lane 8, Cu3-4 [C340S 
C347S]. Molecular weight markers are shown in kDa. 
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5.4.4 Quantification of free sulfhydryls in IgY and recombinant IgY-Fc 
The upsilon heavy chain of IgY has been found to contain three pairs of 
cysteine residues not predicted to be involved in intradomain bonds, in addition 
to cysteines orthologous to those forming covalent bonds to the light chain in 
IgE (Parvari et al., 1988). IgY may therefore possess up to three inter-heavy 
chain disulfide bonds, one more than the IgE heavy chain. The additional 
putative disulfide may have structural and functional significance. The Cu3-4 
mutants were designed to investigate the importance of the 'extra' cysteine pair, 
but in order to confirm whether all three pairs do indeed form disulfides in the 
complete Fc, free sulfhydryls were quantified using a modified Ellman assay 
(Ellman, 1958; Riddles et al., 1979). Whole IgY, Cu2-4[wt] and Cu3-4[C340S 
C347S] were assayed (Table 5.4.3). Bovine Serum Albumin (BSA), which 
contains one free sulfhydryl, was included as a positive control and human IgG 
and IgG-Fc, which contain none, as negative controls. 
The free sulfhydryl: protein ratios of whole IgY and both fragments 
assayed were well below the control value, which indicated that they contained 
no free sulfhydryls. The Cu3-4[C340S C347S] mutant lacks any predicted 
interchain disulfides, and was included as an additional negative control. The 
results for whole IgY and Cu2-4[wt] appear to confirm that all three interchain 
disulfides do indeed form, assuming that they would otherwise be free 
sulfhydryls. 
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TNB Protein Protein Free 
A280 TNB A280 A412 polarit molar polarity dr contribution y (Nmol L") extinction (Nmol L') protein ratio coefficient 
BSA (control) 0.94 0.016 0.204 14.42 43824 20.96 0.69 
IgG1 0.49 0.009 0.001 0.07 223400 2.16 0.03 
IgG1-Fc 0.79 0.014 0.001 0.07 71570 10.82 0.01 
IgY 0.55 0.010 0.001 0.06 209125 2.58 0.02 
Cv2-4 [wt] 0.35 0.006 0.005 0.34 90965 3.78 0.09 
Cv3-4 0.50 0.009 0.001 0.07 62380 7.91 0.01 [C340S C347S] 
Table 5.4.4 
Comparison of free suifhydryls in chicken and human serum 
immunoglobulins and their Fc fragments 
The number of free sulfhydryls was calculated by reacting them with Ellman's 
reagent, DTNB, then using photospectrometry to measure a coloured product 
released upon strong reduction. The value obtained for the positive control, 
BSA, is typical for this assay (Riener et al., 2002) and should be interpreted as 
one free sulfhydryl per molecule of BSA. 
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5.4.5 Heat-induced aggregation of IgY and recombinant IgY-Fc 
Dynamic light scattering (DLS) was used to evaluate thermal stability of 
IgY, IgG, IgE and/or their Fc fragments (see chapter 2). As an immunoglobulin 
unfolds, core hydrophobic regions are exposed leading to irreversible 
aggregation (Vermeer and Norde, 2000), which can be measured by an 
increase in the mean hydrodynamic radius of particles in solution. DLS does not 
directly measure unfolding, as more sophisticated methods like differential 
scanning calorimetry (DSC) or circular dichroism (CD) spectroscopy do, so 
detailed information about unfolding transitions of individual domains cannot be 
obtained. The technique does, however, provide an approximation of the 
'melting' temperature (Tm) at which unfolding has proceeded to such an extent 
that aggregation occurs. The results are shown in figure 5.4.5. 
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Figure 5.4.5 (above and previous page) 
Heat-induced aggregation of chicken and mammalian serum 
immunoglobulins monitored using DLS spectroscopy. 
Charts showing mean hydrodynamic radii of various antibodies and fragments 
when heated in increments of 5°C. Proteins were monitored using a Dynapro99 
DLS instrument (Protein Solutions Ltd. ) and radii at each temperature 
calculated using Dynamics software (version 5.26.37). Once a sample was 
heated beyond the melting temperature, aggregation occurred as marked by a 
sudden increase in the hydrodynamic radius. 
(A) Comparison of chicken IgY, human IgGl/IgGl-Fc, human IgE-Fc and rabbit 
IgG. (B) Comparison of chicken IgY-Fab and recombinant lgY-Fc Cu2-4 [wt] 
and mutants [N308Q] and [N308Q N407Q], which lack glycosylation at the 
site(s) specified. (C) Comparison of recombinant lgY-Fc Cv3-4 [wt] and mutants 
[C340S], [C347S] and [C340S C347S], which lack interchain disulfides at the 
residue(s) specified. 
- 156 - 
Chapter 5 IQY-Fc production purification & initial characterisation 
5.4.5.1 Relative melting temperatures (Tm) of chicken and mammalian serum 
immunoglobulins 
Approximate Tm were derived for chicken IgY (>70°C), human IgG1 (>65 
°C), rabbit IgG (Z75 °C) and human IgE-Fc (>55 °C) (Figure 5.4.5 A). The values 
are consistent with previous studies: chicken IgY, 73.9 °C (Hatta et al., 1993), 
human IgG1-Fc, 65.2 °C (Ghirlando et aL, 1999), rabbit IgG, 78 °C (Shimizu et 
al., 1993), human IgE, 56 °C (Dorrington and Bennich, 1978) and lgE-Fc, 57 °C 
(M. B. Keown, 1997, PhD Thesis). As IgE-Fc rather than whole antibody was 
used, IgG-Fc was included for comparison. Although this fragment did not form 
large aggregates within the temperature range of the instrument, an 
appreciation of the temperature at which aggregation begins to occur could be 
observed: -80 °C, which fits with the temperature of the second transition (Cy3 
melting) seen in microcalorimetry experiments, 83.3 °C at pH 8 (Tischenko et 
al., 1998). Fab and recombinant Fc fragments of IgY were also tested (Figure 
5.4.5 B). Like the homologous fragments of IgG (Vermeer and Norde, 2000), 
IgY-Fab (Tm >65 °C) was found to be less thermally stable than lgY-Fc (Tm >75 
°C). Aggregation of whole IgY and IgG will therefore occur through the Fab 
region rather than the Fc, as this region would be the first to unfold as the 
temperature is increased. This represents a significant difference between IgY 
and IgE, which has potentially important consequences. 
IgY and lgY-Fc appear to be more thermally stable than IgE-Fc; 
aggregation of IgY was found to occur at a higher temperature, in the same 
range as the mammalian IgGs tested. More than 80 years ago, IgE (then known 
as 'atopic reagin') was found to be susceptible to heat denaturation (Coca and 
Grove, 1925), more so than IgG. This has subsequently been shown to be due 
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to an unstable region in the Fc (Dorrington and Bennich, 1973). More recent 
studies using E. coli expressed individual Cc3 domains suggest that it exists as 
a 'molten globule', a state usually ascribed to protein folding intermediaries, with 
near-native secondary structure but poorly-defined tertiary structure (Price et 
al., 2005; Ptitsyn, 1995). Data obtained using NMR has led McDonnell et al. to 
suggest that complete folding of Cc3 may only occur upon receptor binding 
(FccRI, but not CD23), a process which may allow the specificity and affinity of 
the interaction to be optimised (Harwood et al., 2006). In the context of the 
complete IgE, this flexibility could go some way towards explaining how a 
conformational change may occur, which is postulated to be responsible for the 
high affinity and slow dissociation of the lgE: FceRI interaction (Harwood and 
McDonnell, 2007; Wan et al., 2002). The IgY results show that the same degree 
of thermal instability is not present in the homologous Cu3 domain, which 
suggests that this property was not found in the last common (IgY-like) ancestor 
of IgE and IgG. Receptor binding domain instability could therefore be one of 
the most important isotype-limited changes to have evolved since the 
divergence of the epsilon and gamma heavy chain genes. 
5.4.5.2 The effect of Cu2, glycosylation and interchain disulfide bonds on IgY-Fc 
melting temperature (Tm) 
The contribution of the presence of various structural elements on 
thermal stability of the IgY-Fc was determined by comparison of the IgY-Fc 
mutants prepared in section 5.3 (Figure 5.4.5 B& C). As with IgG-Fc mentioned 
above, several of the mutants did not show as marked an increase in mean 
hydrodynamic radius as other proteins. The most likely explanation is that 
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conditions were not quite favourable for formation of larger aggregates within 
the temperature range of the instrument. The melting temperature is actually the 
point at which unfolding begins to occur, therefore any increase in the radius 
reflects a collapse of the least stable domain, which is useful for comparative 
purposes. 
The position of interchain disulfide bonds (between cysteines at position 
340 or 347) and the presence or absence of the Cu2 domains appeared to have 
only minor effects on thermal stability, as Cu2-4 [wt] and the relevant Cu3-4 
disulfide mutants appeared to have similar Tms, all approximately 75°C (Figure 
5.4.5 B& C). However, the Tm of the [C340S C347S] mutant appears to be 
slightly lower, indicating that the complete absence of interchain disulfide bonds 
had a deleterious effect on the thermal stability. The removal of interchain 
disulfide bonds produces very similar results with IgG-Fc and lgE-Fc: DSC 
experiments comparing deglycosylated IgG-Fc to deglycosylated, reduced and 
alkylated IgG-Fc revealed a drop in the Tm of Cy2 from 65.7 °C to 63.9 °C 
(Mimura et al., 2001). Likewise, the Tm of deglycosylated IgE-Fc (CE3-4) and 
aglycosylated CE3-4AC (lacking an interchain disulfide) showed a greater 
difference by CD spectroscopy, 53 °C and 48 °C respectively (J. Hunt, 2004, 
PhD Thesis). 
The Cv2-4 glycosylation site mutants showed striking differences in their 
behaviour upon heating. Although it was difficult to make an accurate 
determination of the Tm of the fully glycosylated [wt] mutant, comparison of the 
traces in figure 5.4.5 B show that the [N308Q N407Q] mutant (which is 
aglycosylated as confirmed in section 5.4.3) had a far greater propensity to 
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aggregate, as demonstrated by an abrupt increase in the mean hydrodynamic 
radius, at temperatures that appeared to have very little effect on the [wt] Cv2-4. 
Carbohydrate plays an important role in the maintenance of IgG-Fc 
structure as its removal causes a conformational compaction and a significant 
reduction in thermal stability (Ghirlando et al., 1999; Krapp et al., 2003; Mimura 
et al., 2000). Similarly, removal of carbohydrate from lgE-Fc (Cc3-4) also 
reduces the thermal stability, although this is probably not accompanied by 
identical structural effects as CE3-4 is already rather more compact compared to 
IgG-Fc (Wurzburg et al., 2000). Although there are significant differences in the 
effect of carbohydrate on Fc folding (see section 5.4.3) and receptor binding 
(see chapter 7), the influence on stability and solubility would appear to be well 
conserved between IgG, IgE and IgY. 
5.4.6 Determination of sensitivity of IgY interchain disulphide bonds to reduction 
by DTT 
Interchain disulfides in the Fc region are not an absolute requirement for 
engagement of Fc receptor by IgE or IgG, although the affinity of the interaction 
is substantially weakened by their absence (Hunt et al., 2005; McCool et al., 
1985). Rather than direct involvement in the Fc binding site, this is likely 
explained by changes in quaternary conformation. The Cy2 and CE3 domain 
pairs have little or no interdomain protein contacts (Deisenhofer, 1981; 
Wurzburg et aL, 2000), so their orientation relative to one another could be 
dramatically altered by removal of covalent bonds. The functional implications of 
this are discussed further in chapter 7. 
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Whilst inter-heavy chain disulfides may have similar functional roles in 
human IgE and IgG1, a significant difference is their susceptibility to reduction 
by DTT: 10mM is the minimum concentration required to reduce inter-heavy 
chain disulfides in IgE (Takatsu et al., 1975), whereas less than half that is 
sufficient to have the same effect in IgG (Gall et al., 1968). The disparity is likely 
due to the accessibility of the relevant cysteine residues. The inter-heavy chain 
disulfides in IgG lie in the disordered hinge region (Harris et al., 1999), whereas 
in lgE-Fc they are rather more occluded between the CE2 domains (Wan et al., 
2002). Consistent with this observation, the interchain disulfide of an IgE-Fc 
(CE3-4) fragment (Shi et al., 1997) containing C328, but lacking any such 
obstruction by Cc2 domains, was found to be reduced in -0.5mM DTT (J. Hunt, 
2004, PhD Thesis). 
In IgY, interchain disulfides putatively occur between homologous residues in 
Cv2 and additionally in Cu3 (Parvari et al., 1988). The minimum concentration 
of DTT required to reduce inter-heavy chain disulfides was determined for 
chicken IgY and (to ensure comparability) reproduced for human IgGI and IgE- 
Fc using the same methodology and reagents (Figure 5.4.6 A, B& C). The 
order of susceptibility to reduction was found to be IgGl>IgY>IgE. An 
approximately ten fold higher concentration of DTT was required to reduce all of 
the inter-heavy chain bonds in IgY than IgG1, and ten fold higher again to 
reduce those of lgE-Fc. This suggests that the bonds are considerably less 
accessible in IgY than IgG1, but not to the same extent as in IgE. The structure 
of IgY in this region would therefore appear to be distinct from both mammalian 
isotypes, although greater similarity to IgE than IgG may be inferred, consistent 
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with the locations of two of the cysteine pairs, which are conserved between IgY 
and IgE, but not with IgG. 
5.4.6.1 Determination of sensitivity of lgY-Fc interchain disulphide bonds to 
reduction by DTT 
The possibility of differential susceptibility to DTT reduction of the IgY 
inter-heavy chain disulfide bonds was investigated in the context of IgY-Fc 
(Cu2-4 and Cu3-4) fragments. Slightly lower concentrations of DTT were found 
to reduce the interchain disulfides in the Cu2-4 [wt] Fc fragment (-0.5mM) than 
in the whole antibody (-1 mM) (Figure 5.4.6 C& D). This could indicate that 
domains in Fab region (such as Cut) contribute to the reduced accessibility 
observed in the complete IgY, either directly or by altering the orientation of the 
Cu2 domains. 
Significantly, the Cu2-4 [N308Q N407Q] mutant was reduced by a more 
than four-fold lower DTT concentration than the wild type Cu2-4, whereas the 
[N308Q] mutant required the same higher concentration (Figure 5.4.6 D, E& F). 
The removal of glycosylation at N407 therefore appears to influence the 
accessibility of the interchain disulfides, which further supports an important role 
in maintenance of quaternary structure for oligosaccharide at this position. 
The sensitivity of the non-conserved 'extra' C347 disulfide was determined in 
the context of a Cu3-4 fragment. Cu3-4 fragments disulfide bonded at either 
C340, C347 or both were all fully reduced by -0.3mM DTT. Comparison with 
the results obtained with whole IgY is difficult as these fragments lack Cu2, 
although it can be surmised that the disulfide at C347 has the same 
accessibility as that at C340. The residues around C347 are homologous to 
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those in IgE which form the binding site for FcERIa (Garman et al., 2000), as 
discussed in chapter 3, so it is interesting that they appear to be readily 
accessible in Cu3. 
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Figure 5.4.6 (previous two pages) 
DTT-induced reduction of interchain 
and various IgY-Fc mutants 
disulfide bonds in IgG, IgE-Fc, IgY 
10% SDS-PAGE gels showing the following proteins after incubation in 
specified concentrations of DTT followed by alkylation with 200mM 
iodoacetamide: (A) Human IgG1, (B) Recombinant human IgE-Fc Ce2-4, (C) 
Chicken serum IgY, (D) Recombinant IgY-Fc Cu2-4 'wild type', (E) 
Recombinant IgY-Fc Cu2-4 [N308Q] mutant, (F) Recombinant IgY-Fc Cu2-4 
[N308Q N407Q] mutant, (G) Recombinant IgY-Fc Cu3-4 'wild type', (H) 
Recombinant IgY-Fc Cu3-4 [C340S] mutant, (I) Recombinant IgY-Fc Cu3-4 
[C347S] mutant. The minimum concentration of DTT required to reduce inter- 
heavy chain disulfide bonds was determined by the disappearance of the band 
representing the unreduced species (0 DTT concentration) coincidental with the 
appearance of a band of approximately half the molecular weight. In the gels 
showing complete antibodies (A & C), additional bands can be seen which are 
the result of reduction of inter-heavy-light chain disulfides. 
5.4.7 Crystallisation of recombinant IgY-Fc 
In order to assess the potential of a recombinant IgY-Fc to be crystallised 
for future structural studies, the IgY-Fc [N308Q] mutant, purified by affinity and 
size exclusion chromatography in section 5.3.2, was screened using the sitting 
drop vapour diffusion method. 100 nL drops of 5 mg/mI protein were dispensed 
using a Cartesian Microsys robot (Genomic Solutions) and mixed with equal 
volume of a large variety of screening solutions prepared by the Oxford Protein 
Production Facility. Plates were stored in a temperature controlled vault (TAP 
HomeBase) and monitored using an automated Veeco imager. Several crystals 
were obtained, most of which appeared after one or two weeks. Some of the 
most promising hits are shown in figure 5.4.7, but have yet to be tested for 
protein content or ability to diffract X-rays. The crystal morphology of those in 
figure 5.4.7 B were very similar to crystals of papain-derived IgY-Fc (Figure 3.5 
B), which could imply a similar mode of molecular packing. 
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Figure 5.4.7 
Initial hits in an IgY-Fc crystallisation screen 
Crystals obtained in a sitting drop vapour diffusion screen of recombinant IgY- 
Fc Cu2-4 [N308Q]. Screening conditions were (A) O. 1 M Tris pH 8.5 + 6M 
Ammonium Nitrate, (B) 0.8M Ammonium Sulphate + 0.1M MES pH 6.0. Images 
were obtained using a Veeco automated plate imager. 
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5.5 Discussion 
In this chapter, the mammalian expression vectors designed and 
constructed in chapter 4 were used to create a series of stable cell lines which 
secrete recombinant IgY-Fc mutants. Cells were selected so that expression 
levels were high enough to allow practical quantities of purified material to be 
obtained for structural and functional studies, including screening for 
crystallisation conditions, which typically requires milligrams of protein. Except 
for the IgY-Fc coding sequence, the expression vectors had been designed to 
have as much sequence in common with vectors previously used to create 
stable cell lines expressing mutants of IgE-Fc to around 100mg/L or more (R. J. 
Young, 1994, PhD Thesis; A. J. Henry, 1996, PhD Thesis). As hoped, similar 
levels of production were achieved for four of the seven mutants (94-340mg/L). 
The remaining three were produced in lower levels (16-48mg/L), although this 
was still sufficient for initial analysis, so screening for higher producers was not 
performed. 
Material was purified to a sufficient standard to allow experimentation to 
determine various structural characteristics and to confirm whether the intended 
modifications to each IgY-Fc mutant have indeed been made. Molecular 
weights were determined using a combination of native and non-native 
techniques; size exclusion chromatography, DLS (not shown) and SDS-PAGE 
(reducing and non-reducing). The results for all of the Fc mutants were 
consistent with disulfide-linked homodimers of the expected size (containing 
either four or six Ig domains), although a substantial proportion of the Cv3-4 [wt] 
preparation appeared to be monomeric in SDS even in the absence of reducing 
agents, indicating that interchain disulfides had not formed. This suggests that 
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the presence of a complete Cu2 is necessary for the efficient formation of 
interchain disulfides. A scheme for the artefactual formation of a C340-C347 
intrachain bond as the protein is folding may be envisaged (Figure 5.5), which 
the presence of a folding or folded Cu2 would prevent. Mutation of one of these 
cysteines to serine precludes the problem and an intrachain bond is formed. 
The Cu3-4 sequence was engineered to include some residues from Cu2 in 
order to be homologous to the recombinant IgE CE3-4 fragment used in 
previous studies, which includes C328 (from CE2) so that disulfide linked 
homodimers form (Hunt et al., 2005; McDonnell of al., 2001; Shi et al., 1997). 
Whilst it would have been interesting to study the effect of two interchain 
disulfides in a Cu3-4 fragment, confirmation of the presence of a disulfide at 
C347 makes the inclusion of C340 unnecessary to achieve a dimeric fragment. 
Therefore, the IgY-Fc mutant most similar to the CE3-4 fragment is actually 
Cu3-4 [C340S]. 
The evidence for the existence of an inter-heavy chain disulfide at C347, 
potentially an 'extra' bond not present in IgE, was previously limited to 
observations made with papain-derived Cu3-4 Fc fragments (see chapter 3). 
Although a C347 interchain disulfide was inferred by the dimerisation of the 
Cu3-4 [C340S] mutant, this does not establish whether the same bond is 
present in the whole IgY molecule. To address this, an Elfiman assay of IgY and 
Cu2-4 [wt] was performed. The assay showed that no free sulfhydryls were 
present in the whole molecule or the Fc, which confirms that all cysteines are 
indeed involved in disulfide bonds. 
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ABC 
Figure 5.5 
Erroneous disulfide pairing in IgY-Fc Cu3-4 [wt] 
Schematic showing a possible explanation for the presence of fragments 
lacking interchain disulfide bonds in mammalian expressed Cu3-4 [wt]. In Cu2-4 
(A) disulfide bonds may form as shown, with C340 paired in a crossed fashion 
with C252, as occurs between the homologous pairs in CE2 of IgE (Wan et al., 
2002). When the Cu3-4 [wt] fragment was designed, a fragment with parallel 
disulfides was expected (B), although at least 50% of expressed material was 
found to contain only non-covalent interactions (shown between Cu4 pairs). 
This could be the result of misfolding and formation of an intradomain disulfide 
bond between C340 and C347 (C). An alternative explanation may be the 
formation of free sulfhydryls, although this seems unlikely as removal of one or 
the other cysteine results in a disulfide linked dimer. 
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The Cu2-4 [wt], [N308Q] and [N308Q N407Q] mutants were designed to 
differ in glycosylation state in order to study the structural and functional effects 
of N-linked carbohydrate. IgY-Fc is predicted to have two glycosylation sites, 
one or both of which were removed by mutagenesis of the appropriate 
asparagine codon. In order to confirm whether the mutations had had the 
desired effect, molecular weights were compared and carbohydrate content 
analysed using PAS stain. Differences in the molecular weights were consistent 
with the presence of varying amounts of oligosaccharide, as expected due to 
the difference in the type of glycosylation at the two sites (Suzuki and Lee, 
2004). PAS staining confirmed the absence of carbohydrate in the mutant 
lacking both glycosylation sites, Cu2-4 [N308Q N407Q]. The significance of the 
production of this fragment will be discussed further in chapter 7. 
Once the presence of the intended differences between the mutants had 
been examined, some preliminary studies into their structural properties were 
performed. A rough comparison of melting temperatures made using DLS 
revealed that the role of glycosylation and disulfide linkage in the maintenance 
of thermal stability appears to be well conserved between IgG, IgE and IgY. 
Overall, however, the melting temperature of IgY was found to be more similar 
to IgG than IgE, which could indicate that the instability of CE3 in IgE is not a 
feature of the homologous Cu3 domains in IgY. This may imply a significant 
difference between their Fc receptor interactions as this property of CE3 has 
been suggested to represent a means of fine tuning the (high) affinity and 
specificity of the interaction with FccRI (Price et al., 2005). However, other 
investigators have noted that chicken IgY is more sensitive than cow, goat and 
pig IgG to pH- or guanidine-induced denaturation (Shimizu et al., 1993). Further 
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experiments are therefore required to better establish the stability of IgY-Fc. 
The cloning and expression of individual Cu3 domains would allow emulation of 
the experiments performed with Ce3 by Price et al. (2005), particularly ANS dye 
binding (which can be used to confirm the 'molten globule' state), although 
soluble IgY-Fc receptor would be required for characterisation of changes 
occurring upon binding using NMR spectroscopy (Harwood et al., 2006). 
Ultimately, an important question to answer is whether IgY shares the 
acutely bent, asymmetrical conformation of IgE in its unbound state (Wan et al., 
2002). Differences in the accessibility of the inter-heavy chain disulfides in IgY 
and IgE (determined by susceptibility to reduction with DTT) suggests that their 
structures are not identical. The bend in unbound IgE can be observed using 
electron microscopy and is consistent with X-ray and neutron scattering data in 
solution (B. J. Sutton and A. J. Beavil, personal communication). Noll et al. noted 
that IgY bound to ribosomes (via their Fab regions) had an IgG-like structure 
(Noll et al., 1982), although IgY has been suggested to alter the conformation of 
its Fc upon binding to antigens, due to the exposure of Staphylococcal protein A 
reactive sites (Barkas and Watson, 1979). Determination of the crystal structure 
of IgY-Fc using X-ray diffraction data would provide an answer to this question 
and allow a far more detailed comparison of structural differences between the 
Fc fragments of IgY, IgG and IgE to be made. Crystal structures of each of the 
mutants would also afford insights into nature of the structural contributions of 
glycosylation and disulfide linkage. 
In order to asses whether IgY undergoes a conformational change upon 
receptor binding, as IgE is hypothesised to do in order to facilitate its distinctive 
kinetics, a complex of IgY-Fc bound to a soluble form of Fc receptor could be 
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crystallised, as has been achieved for IgE-Fc (CE3-4) and FccRI (Garman et al., 
2000). As a soluble IgY-Fc receptor has yet to be produced, this is not yet 
possible. Alternatively, a system to visualise the conformational change in IgE- 
Fc has been developed (J. Hunt and A. J. Beavil, personal communication) 
which could be adapted easily for IgY-Fc and used with IgY-Fc receptor-bearing 
cells (see chapter 6) rather than soluble receptor. Briefly, the technique relies 
on the abrogation of a Fluorescence (Förster) Resonance Energy Transfer 
(FRET) signal between donor and acceptor fluorophores linked to the N- and C- 
termini of each heavy chain Fc. Unbound, the pair are within the molecular 
distance required for FRET, but they move too far apart for energy transfer 
upon binding. It would be interesting to discover whether the same behaviour is 
observed with IgY-Fc. 
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Chapter 6 
Search for IgY Fc Receptors and Cloning of the First Avian Fc Receptor Family 
Member, chFcR/L 
6.1 Overview 
In order to study the kinetics of the interaction between antibodies and 
their Fc receptors (FcR) using modern biophysical techniques such as Surface 
Plasmon Resonance (SPR) and Analytical Ultracentrifugation (AUC), soluble 
receptor and ligand is required (Hunt et al., 2005; Paetz et al., 2005). 
The previous chapters detail the production of recombinant soluble IgY- 
Fc and various mutants. The present chapter describes attempts to identify and 
isolate receptors for lgY-Fc, which are functionally equivalent to the mammalian 
FcR for IgG, and/or IgE, with the aim of allowing recombinant soluble forms to 
be produced in future studies. 
How IgY is apparently able to mediate functions attributed specifically to 
IgG or IgE in mammals is currently unknown. Although IgY is found in several 
vertebrate classes, at the time of this investigation the only IgY receptor 
identified is exclusively expressed on the chicken yolk sac (West et al., 2004); 
no known leukocyte IgY-Fc receptors have been sequenced. There is ample 
functional evidence to confirm the existence of such receptors; various avian 
immune cell effector responses are triggered by recognition of IgY-coated 
pathogens and IgY can be used to passively sensitise avian tissues (Chand et 
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al., 1976; Faith and Clem, 1973; Kogut et al., 2001; Qureshi et al., 2000). In 
mammals, these mechanisms involve FcyRs and FcERs. 
In addition to the chicken yolk sac receptor, two non-mammalian Fc 
receptors have been characterised, both of which recognise non-IgY isotypes: a 
receptor for IgM in the channel catfish, IpFcR (Stafford et al., 2006) and a 
receptor for secretory IgA in the chicken, GG-plgR (Wieland et al., 2004). 
Interestingly, all three of these receptors have functional analogues in 
mammals, but only GG-plgR is also homologous to its mammalian counterpart. 
Although FcRY provides a means of maternal antibody transfer to the 
developing chick, just as FcRn does for embryonic mammals (Matre et al., 
1981), the receptors are actually members of non-homologous protein families 
(West et al., 2004). 
Convergent evolution of sequences, where unrelated proteins are 
selected to perform identical functions, dictates caution when formulating 
strategies to identify them using certain techniques. The first approach was to 
exploit the affinity and specificity of receptor for ligand by attempting to purify 
complexes of IgY bound to its receptor from solubilized cell membranes. This 
method was used to successfully isolate FccRl, the high affinity receptor for IgE 
(Conrad and Froese, 1978). The second approach involved data mining of the 
recently released chicken genome (Hillier et al., 2004) and expressed sequence 
tag (EST) databases for potential Fc receptor sequences. This method relies on 
sequence similarity with mammalian FcRs to identify chicken orthologues. As 
outlined above, this assumption could lead to failure to spot receptors with little 
or no homology. This problem would not apply to the protein purification 
strategy. Genome/EST analysis is nevertheless worthwhile, as some receptors 
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can prove particularly recalcitrant to isolation using protein methods. Mouse 
FcyRIV was recently identified using this approach (Nimmerjahn et al., 2005). 
6.2 Affinity purification of avian IgY-Fc receptors analogous to mammalian 
FcyR and FIER 
6.2.1 Indirect evidence for an IgY-Fc receptor on chicken basophils 
Whilst some facets of the immune system appear to be absent or 
markedly different in birds, many key features are well conserved with 
mammals. Indeed, much of our early understanding of human cellular immunity 
was derived from parallels with the chicken system. In mammals, the high 
affinity receptor for IgE, FcERI, is found in greatest numbers on mast cells and 
basophils - several hundred thousand molecules per cell (Conrad et al., 1975; 
Conroy et al., 1977; Ishizaka et al., 1973). Historically, a rat basophilic 
leukaemia (RBL) cell line was used to isolate FccRI protein (Conrad et al., 
1976) as these cell types are found in relatively low numbers in vivo. 
In birds, Th1/Th2 polarisation has been demonstrated (Degen et al., 
2005). The repertoire of bird white blood cells and immune chemistry is also 
known to include basophilic granulocytes and homologues of many of the key 
T2/Th2 cytokines, which in mammals regulate the branch of the immune system 
involving these effector cells (Avery et al., 2004). The lack of a functional IL-5 
gene led some researchers to speculate that certain types of granulocyte may 
be non-functional in the chicken (Kaiser et al., 2005), although a protein with 
some similarity to IL-5, KK34, may perform the same role (Koskela et al., 2004). 
The presence of basophil infiltrates in avian anaphylactic responses (Carlson 
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and Allen, 1969; Chand et al., 1976) and the potential for basophils to be 
passively sensitized (Wilson and Heller, 1976) suggest that bird basophils are 
important effector cells in antibody-mediated inflammatory reactions. It therefore 
seemed probable that chicken basophils were strong a priori candidates for the 
presence of IgY-Fc receptors. 
Cell sorting was used to establish which cell type in chicken peripheral 
blood possessed the highest quantity of IgY-Fc receptors per cell. Briefly, buffy 
coat layer cells were isolated, stained with fluorescently labelled anti-IgY 
antibodies and separated on the basis of fluorescence intensity using a FAGS 
Aria cell sorter. The experiment assumed that the cell population with the 
highest fluorescence intensity had the greatest number of anti-IgY antibodies 
bound, and thus the greatest number of IgY molecules ostensibly bound to Fc 
receptors. The sorted population were stained with Giemsa and identified as 
predominantly basophils (Figure 6.2.1). Attempts were then made to isolate 
peripheral blood basophils in a more practical way, in order to obtain sufficient 
quantities for further studies. 
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Figure 6.2.1 
Basophils FACS sorted from chicken peripheral blood on the basis of 
bound IgY 
Chicken buffy coat layer cells displaying the brightest fluorescence when 
stained with anti-IgY-FITC antibodies (inset) were sorted using a FACS Aria 
(BD Biosciences). Cells were mounted on slides using a cytospin centrifuge 
(Shandon) and stained with Giemsa (main field). Darkly staining granules and 
multi-lobed nuclei are characteristic of basophils. Scale bar = 10µm (main field 
and inset). 
Several methods are well established for the purification of basophils 
from human peripheral blood. Erythrocytes can be removed easily by lysis in 
hypotonic solutions, to which white cells are less susceptible. Basophils can be 
enriched by adsorption onto magnetic beads using antibodies specific for 
surface markers or by depleting all other leukocytes in the same manner (Bjerke 
et al., 1993; Haisch et al., 1999). Alternatively, density gradient centrifugation 
exploits the difference in density between leukocytes to separate them in layers 
of a liquid phase such as sucrose (Kepley et al., 1994). 
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Unfortunately, these methods were found to be problematic for 
separation of bird leukocytes: avian basophil surface markers are poorly studied 
and there are currently no commercially available anti-basophil antibodies. 
Antibodies directed against a surface marker of human basophils, CD123, did 
not cross react with avian basophils (data not shown). A Percoll (Amersham) 
density gradient was found to be able to separate chicken peripheral blood 
mononuclear cells (PBMCs), but was hampered by the apparent similarity in 
density between avian basophils and red blood cells, which consistently 
migrated to the same density layer upon centrifugation. In birds, red blood cells 
are nucleated and could not be lysed using the methods usually employed to 
prepare white blood cells from mammalian blood. Centrifugation to separate the 
buffy coat layer, which contains most white cells, prior to density gradient 
separation was found to be the most effective means of preparing avian 
basophils to -70-80% purity. However, this method was found to be impractical 
for purification of the quantities of cells that would be required for more detailed 
studies. 
In order to perform cell binding studies, acidic conditions can be used to 
strip endogenously bound IgE from human basophils (Pruzansky et aL, 1983). 
The use of both lactic acid and glycine was investigated for the removal of IgY 
from chicken basophils, but this method failed to remove a satisfactory quantity 
without severely damaging the cells (data not shown). 
A chicken basophil cell line adapted to IgY-free medium would be the 
most obvious solution to the problem of receptor occupancy and would, in 
principle, provide an unlimited number of cells without laborious purification 
procedures from chicken peripheral blood. Unfortunately, only one avian 
-178- 
Chapter 6 Chicken Fc receptor homologues 
basophil-like cell line has been reported in the literature (Moscovici et al., 1989), 
stocks of which no longer exist (G. Moscovici, personal communication). 
6.2.2 Identification of a chicken monocyte Fc receptor 
Monocytes in both birds and mammals are important blood-borne 
leukocytes, which phagocytose antibody-coated pathogens and mediate 
antibody-dependent cellular cytotoxicity (ADCC) of infected or cancerous cells. 
An IgY-Fc receptor analogous to the high affinity receptor for IgG, FcyRI, may 
therefore be present on chicken monocytes. 
Different values appear in the literature for the number of FcyRI 
molecules per cell on human monocytes: 4,300 ± 1,304 (Karagiannis et al., 
2003), 45,000 ± 10,700 (Jungi and Hafner, 1986). Mouse monocytes appear to 
express much higher levels, -100,000 FcyRl per cell (Unkeless and Eisen, 
1975). It was therefore difficult to predict how many IgY receptors should be 
expected on avian monocytes, which proved to be a crucial determinant of the 
practicability of certain protein methods. 
A chicken monocyte cell line, MQ-NCSU, for which functional evidence 
for IgY-mediated phagocytic activity has been demonstrated (Qureshi et al., 
1990), was used to confirm the existence of Fc receptors for IgY using flow 
cytometry (Figure 6.2.2). MQ-NCSU cells were adapted for growth in media 
containing foetal bovine serum (FBS), but not chicken serum, so IgY would not 
be present to occupy receptors. Cells were able to bind IgY (Figure 6.2.2 B& C) 
even in the presence of a 400-fold excess of IgY-Fab fragments (Figure 6.2.2 
D), confirming that binding is dependent upon the presence of IgY-Fc. 
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Figure 6.2.2 (previous page) 
IgY binds to MQ-NCSU chicken monocytes and is dependent on the Fc 
region 
(A) FAGS profile of MQ-NCSU cells showing the gate used to exclude dead 
cells. Cells were incubated with 50nM chicken serum IgY, followed by goat anti- 
lgY-Fc then anti-goat-FITC antibodies. The cells were then fixed and analysed 
by (B) fluorescence microscopy (Axioscope, Zeiss, Scale bar = 10pm) or (C) 
flow cytometry (FACS Calibur, BD Biosciences). IgY coated cells (filled) are 
shown in comparison with control cells incubated with anti-IgY-Fc / secondary 
antibodies alone (unfilled). 
(D) Prior to incubation with mouse anti-Cu2 followed by anti-mouse-FITC, cells 
were incubated with either 50nM IgY+20µM IgY-Fab (blue), 50nM IgY alone 
(green), 20µM IgY-Fab alone (red) or incubation buffer alone (black). 
Values shown are ratios of mean fluorescence intensity over that of control cells 
incubated with anti-IgY-Fc or anti-Cu2 and secondary antibodies alone. 
6.2.3 Maintenance of IgY-Fc receptor bearing cells in culture 
Whilst stocks of MQ-NCSU cells were preserved in freeze medium under 
liquid nitrogen, one batch was maintained in culture with passages every three 
days for over 18 months, using only medium containing ultra-low 
immunoglobulin FBS (UL-FBS), but not chicken serum. Cells maintained the 
ability to bind IgY as determined by FACS analysis, so levels of IgY-Fc receptor 
were not diminished by lengthy culture in medium lacking IgY. This observation 
is in stark contrast with the behaviour of the high affinity Fc receptor for IgE, 
FccRl, which requires the presence of its ligand in order to stabilise it in the cell 
membrane and prevent internalisation (Maurer at al., 1996). 
6.2.4 Attempts to purify IgY-Fc receptor complexes using affinity 
chromatography 
Previous attempts have been made to isolate IgY receptors from chicken 
monocytes using immobilised IgY, but these were unsuccessful and 
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inconclusive (Morkowski and Nowak, 1981). A similar method did prove to be 
suitable for preparation of yolk sac IgY receptors, however (West et al., 2004), 
and so a modified version was investigated for purification of receptors from 
MQ-NCSU cells. Briefly, cell membrane proteins from MQ-NCSU cells pre- 
incubated in saturating levels of IgY were solublised using a non-ionic 
surfactant, NP-40, which has been shown to allow solublisation without 
disruption of ligand: receptor (and receptor subunit) interactions (Conrad et al., 
1976). Preparations were then incubated with anti-IgY coupled to agarose 
beads in order to purify complexes of IgY bound to receptor. The quantity of 
cells required to obtain sufficient material for visualisation on SDS-PAGE gel 
stained with Coomassie Brilliant Blue (-lpg) was calculated using an estimate 
of the receptor molecular weight (50 kDa) and an approximation of the number 
of receptors per cell (10,000), as determined by quantitation of bound IgY by 
Western blot of cell lysates, assuming 1: 1 stoichiometry (experiment performed 
by Dr. R. A. Calvert, Randall Division, King's College London). A more accurate 
determination of receptor number per cell was subsequently performed and is 
discussed in chapter 7. 
Unfortunately, despite numerous attempts to solve the problem by 
varying agarose bead washing conditions, a large number of proteins were 
eluted which could be ruled out as receptor candidates due to their presence in 
control preparations lacking IgY (Figure 6.2.4). Several faint bands can be seen 
in the eluate from IgY positive cell preparations (Figure 6.2.4 lane 4). A band of 
roughly 55kDa from a larger preparation was transferred onto PVDF membrane 
for N-terminal sequencing (performed by Dr. J. N. Keen, University of Leeds). An 
accurate sequence could not be obtained due to the presence of multiple 
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proteins, despite the lack of any other clearly defined bands on the excised strip 
of PVDF when stained with Ponceau Red. 
The presence of so many bands in the negative control casts doubt on 
the feasibility of the technique. As there is currently no structural information 
about the receptor, it is very difficult to judge which bands are any more likely to 
be a receptor than others. For example, the mammalian high affinity receptor for 
IgE, FccRIa, appears as a diffuse smear on SDS-PAGE gels due to multiple N- 
glycosylation sites, which highlights the further problem that an IgY-Fc receptor 
may not necessarily appear as a tightly resolved band. For practical reasons, 











Attempted affinity purification of IgY receptor from MQ-NCSU cells 
12% SDS-PAGE gel stained with Coomassie showing IgY (lanes 1& 3) and 
purified eluate from anti-IgY agarose beads incubated with MQ-NCSU 
solublised total cell protein prepared from cells incubated in buffer alone 
followed by washing (lane 2) or IgY followed by washing (lane 4). 
-183- 
Chapter 6 Chicken Fc receptor homologues 
6.3 Identification and cloning of a chicken Fc receptor homologue 
The following section details a bioinformatics-based approach to the 
search for IgY-Fc receptors. Whilst not without its limitations (as outlined in 
section 6.1), the strategy has nevertheless yielded some interesting results, 
some of which have subsequently been published (Taylor et al., 2007) and 
confirmed by other investigators (Fayngerts et al., 2007). 
6.3.1 Data mining of chicken genome and EST libraries 
Mammalian Fc receptor (FcR) sequences were used with the Basic Local 
Alignment Search Tool (BLAST) to search the chicken (Gallus gallus) genome 
(http: //www. ensembl. org/Gallus_gallusAndex. html) and BBSRC chickEST 
database (http: //www. chick. umist. ac. uk/). Two contigs (7652.1 and 3134.3 in 
the February 2004 genome assembly) and several corroborating ESTs were 
identified by the criterion of best reciprocal hit. Exons were predicted using 
Genscan (Burge and Karlin, 1997; Zdobnov and Apweiler, 2001). Partial 
sequence duplication suggested that these contigs were overlapping, covering 
four exons of a larger gene. 
The presence of only one FcR-like sequence in the chicken genome is 
surprising and could prove to be an unusual feature of avian immunology. 
However, it may simply be that other Fc receptors in the bird are unrelated to 
mammalian analogues or that the genome and EST libraries are incomplete. 
Indeed, many immune-related families that consist of numerous closely related 
sequences (such as the LRC and MHC) have proven difficult to fully sequence 
by the shotgun approach used for the chicken genome (Burt, 2005). 
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6.3.2 PCR cloning of a chicken Fc receptor homologue, chFcR/L 
Primers specific for exons identified in the sequences were designed and 
used in 5' and 3' RACE PCR reactions (see chapter 2) on cDNA derived from a 
splenocyte cDNA library (a gift from Dr. J. Young, Institute for Animal Health). 
Sequences were aligned in ChromasPro to produce a contiguous sequence for 
the full-length transcript. 
6.3.3 Analysis of chFcR/L coding sequence (CDS) 
The full-length cDNA was translated using the ExPasy Translate tool 
(Swiss Institute of Bioinformatics) and the amino acid sequence analysed using 
several software packages. The cDNA contained a 1,308bp CDS (Figure 6.3.3 
i), which putatively encoded a 19 amino acid (aa) signal peptide, predicted 
using SignaIP3.0, http: //www. cbs. dtu. dk/services/SignaIP/ (Bendtsen et al., 
2004), and a novel 416aa transmembrane glycoprotein consisting of four 
extracellular domains that belong to the immunoglobulin (Ig) superfamily, a 
transmembrane helix, and a short cytoplasmic tail were identified using 
InterProScan (Burge and Karlin, 1997; Zdobnov and Apweiler, 2001). The 
protein was termed chFcR/L, adapting recently established terminology 
guidelines (Maltais et al., 2006). 
The amino acid sequence of chFcR/L was used to BLAST search the 
NCBI non-redundant protein database, which confirmed that the protein is 
homologous to many important immunological players (Table 6.3.3 ii): the 
mammalian Fc receptor (FcR) family, including the high affinity receptors for 
both IgG and IgE, and the IgM-binding catfish Fc receptor (Stafford et al., 2006), 
as well as several potential FcR-related sequences from Xenopus (Guselnikov 
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et al., 2004). The search also identified several members of a family of proteins 
recently discovered in mouse and human, which genomic proximity and 
homology to the FcR classifies as `Fc receptor-like' (FCRL). Although they 
possess Ig domains closely related to those responsible for Fc binding in FcyRI- 
IV and FccRl, the FCRL appear to lack the ability to bind any Fc isotype (Davis 
et a!., 2002). As yet, no ligands have been found, but the preferential 
expression of FCRLs on B cells (Davis et al., 2001; Hatzivassiliou et al., 2001; 
Miller et a!., 2002) and the presence of one or more functional immunoreceptor 
tyrosine-based activation (ITAM) or inhibitory (ITIM) signalling motifs (Ehrhardt 
et aL, 2003; Leu et al., 2005), is consistent with an immunoregulatory role. A 
link between polymorphisms in FCRLs and autoimmune disease is also 
suggestive of such a function (Ikari et al., 2006; Kochi et al., 2005; Umemura et 
a!., 2006). 
The putative extracellular Ig domains of chFcR/L have up to 48% amino 
acid identity with Ig domains of the mammalian FcR and FCRL, which is 
consistent with the level of conservation of other immune-related homologues 
observed between birds and mammals (Hillier et al., 2004; Kaiser et al., 2005). 
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Figure 6.3.3 i 
The complete coding sequence (CDS) of chFcR/L 
Nucleotide sequence (numbered) and predicted amino acid s, 
above) of cloned chFcR/L transcript cDNA. Predicted sii 
immunoglobulin domains and transmembrane region are mark 
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Receptor Accession No Score E Value 
FCRL4 Human AAK93970 212 2e-53 
FCRL3 Human CAH73059 212 2e-53 
FcgRI Mouse BAD97676 174 7e-42 
FcgRI Dog NP 001002976 174 9e-42 
FcgRI Macaque AAL92095 174 le-41 
MMAN-g Mouse BAB18569 173 1 e-41 
FCRL2 Human CAH73062 172 3e-41 
FCRLS Mouse NP_109632 171 4e-41 
FcgRI Human NP_000557 162 2e-38 
MGC82906 Xenopus AAH73602 160 9e-38 
FCRL5 Mouse NP_899045 158 5e-37 
FcgRI Bovine AA112692 155 3e-36 
XFL1.6 Xenopus AAQ63873 153 2e-35 
FCRL5 Human AA101070 139 4e-31 
MGC82866 Xenopus AAH78060 135 5e-30 
XFLI. 4 Xenopus AAQ56585 135 5e-30 
XFL1.2b Xenopus AAQ56585 133 2e-29 
FCRLB Mouse NP_001025155 127 le-27 
Fcgrl-prov Xenopus AAH88875 126 2e-27 
FCRLA Human CAH74158 123 2e-26 
FCRLI Human AAH33690 119 2e-25 
FCRL6 Human NP_001004310 118 5e-25 
XFL1.5 Xenopus AAQ56586 109 2e-22 
FceRI Human 1 F6A_A 100 le-19 
XFLI. lb Xenopus AAQ56584 99.0 4e-19 
XFLI. 2a Xenopus AAQ56582 97.8 9e-19 
XFLI. 3 Xenopus AAQ63874 96.3 2e-18 
FcgRII Guinea Pig A34636 92.4 4e-17 
FcgRil Human AAH20823 91.7 6e-17 
FCRLB Human AAT77991 91.7 5e-17 
FcgRII Macaque AAL92097 90.1 2e-16 
XFL2 Xenopus AAQ56587 88.6 6e-16 
FcgRlll Bovine CAA68026 87.4 le-15 
FcgRII Mouse AAH38070 85.5 5e-15 
FcgRIll Mouse NP 034318 84 le-14 
FcgRIV Mouse NP 653142 83.2 2e-14 
FceRI Mouse NP 034314 82.8 3e-14 
FcRI Catfish ABB89215 81.6 6e-14 
Table 6.3.3 ii 
Homologues of chFcR/L 
The top hits from a BLAST search of the NCBI non-redundant protein database 
show that chFcR/L is closely related to Fc receptors (Fc_R) and Fc receptor-like 
(FCRL) sequences from mammals, amphibians and bony fish. 
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6.3.4 Analysis of chFcRJL exon structure 
The complete cDNA sequence of chFcR/L was used to re-screen the 
chicken genome. Two contigs were identified in addition to the two described in 
section 6.3.1, which extended the genomic coverage and allowed the gene 
structure of chFcR/L to be deduced. The contigs were unassigned to any 
chromosome in the February 2004 release of the chicken genome, but have 
since been anchored to chromosome 25 in the March 2006 assembly. However, 
in both assemblies they are incorrectly ordered. The correct order was 
determined by alignment of overlapping sequences (Figure 6.3.4). 
At -'3670bp, chFcRIL is smaller than any mammalian FcR or FCRL gene 
due to introns that, whilst they conform to the GT-AG rule (Breathnach et al., 
1978; Catterall et al., 1978), are less than 25% of the size of their mammalian 
counterparts. chFcR/L has 7 exons, with exons III, IV, V and VI encoding one 
extracellular Ig domain each (EC1.4); the exons follow the phase 1 splicing 
typical for Ig & Ig-like domains (Davis et al., 2002; Ravetch and Kinet, 1991). 
The transmembrane domain (TM), cytoplasmic tail (C) and 3' untranslated 
region (UT) are all encoded by exon VII. The signal peptide is split between two 
exons: S1, which also encodes the 5'UT and the ATG translation initiation 
codon, and S2. S2 is 21 bp in length, a feature that distinguishes members of the 
FcR and FCRL families from other Ig-containing immunoreceptor gene families, 
such as the LRC (Davis et al., 2002). 
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A 
II III IV V VI VII 
5'UT Si S2 EC1 EC2 EC3 EC4 TM /C 3'UT 
B 300bp 
ýContig 
7652.2 Contig 3134.3 II Contig 11625.1 
1 
rr 
1 Contig 7652.1 
Figure 6.3.4 
Exon structure of chFcR/L and coverage by the published chicken 
genome 
(A) Introns are shown as lines, exons as boxes (filled denotes putative 
translated sequence). UT = Untranslated region, S= Exon encoding part of 
signal peptide, EC = Exon encoding extracellular immunoglobulin domain, TM = 
Exon encoding transmembrane domain, C= Exon encoding cytoplasmic region. 
(B) Corrected order of contig coverage of chFcR/L in the chicken genome. 2004 
assembly ID codes are shown. (//) denotes continuation of contig. *The gap 
between contigs 7652.2 and 3134.3 was covered by an immature transcript, 
which had not yet had any introns spliced out (the -3.5kb band in figure 6.3.5 A 
lane 1). 
6.3.5 Splice variants of chFcR/L 
cDNA was prepared by reverse transcription of total RNA isolated from MQ- 
NCSU chicken monocytes and crude preparations of chicken basophils. 
Primers complementary to 5' and 3' sequences of the chFcR/L CDS were then 
used to PCR amplify transcript variants differing in which splice sites had been 
joined (Figure 6.3.5). 
Although several chFcR/L transcripts containing introns were isolated from both 
MQ-NCSU cells and the basophil preparation (unmarked bands in Figure 6.3.5 
A), three distinct splice variants were identified with a marked difference in their 
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distribution (Figure 6.3.5): The 'complete' chFcR/L transcript and a variant 
lacking the second Ig domain, chFcR/L AEC2, were cloned from MQ-NCSU 
monocytes but were not detected in the basophil preparation. Conversely, a 
variant lacking 67 nucleotides from the same domain, which causes a reading 
frame shift leading to an early termination (chFcR/L DEC27 , 4), was isolated from 
the basophil preparation but was not detected in MQ-NCSU cells. As this 
sequence lacks the transmembrane and cytoplasmic domains, the translated 
protein would be secreted, rather like a splice variant of a low affinity IgG 
receptor (Teillaud et al., 1994). Despite the possibility that this sequence was 
derived from a different cell type due to contamination of the preparation 
(predominantly with red blood cells), its existence nevertheless suggests a 
physiological role. Others researchers have subsequently detected all three 
chFcR/L variants, but no others (Fayngerts et al., 2007). 
The presence of three different forms of chFcR/L could represent a 
higher level of sophistication in ligand interaction and regulation. It should be 
noted, however, that although numerous transcript variants have been 
described for the FcyRs, few are both translated and expressed on the cell 
surface (Ernst et al., 1998; van Vugt et al., 1999). 
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Figure 6.3.5 
Identification of chFcR/L transcript splice variants 
(A) 1% agarose showing products of PCR reactions using chFcR/L-specific 
primers stained with ethidium bromide / UV transillumination (left, 1& 2) or 
Southern blotted with radiolabelled probes complementary to EC3 (right, 3& 4). 
Lanes 1&3, products of PCR reaction using cDNA derived from chicken blood 
basophil RNA. Lanes 2&4, products of PCR reaction using cDNA derived from 
MQ-NCSU chicken monocytes. The labelled bands were identified as mature 
transcript splice variants by gel extraction and cloning using a TOPO TA vector, 
pCR4 (Invitrogen). M2, M3 and B3 sequences were found to be complete 
transcript, AEC2 and DEC2', 3,4 respectively. Unmarked bands were immature 
transcripts containing unspliced introns. Predicted features of each sequence 
are shown (B) with cartoons depicting the encoded protein. SP = Signal 
peptide, EC = Extracellular immunoglobulin domain, T= Transmembrane 
domain, C= Cytoplasmic region, Ter = Termination codon. 
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6.3.6 Sequence & phylogenetic analysis of chFcR/L 
chFcR/L has a number of similarities and differences to both the FcR and FCRL 
families: the protein contains more Ig domains than any known FcR a-chain, 
one of which (EC4) shares highest homology with a type found only in certain 
FCRLs (Figure 6.3.6 i). However, in contrast to all surface-expressed members 
of the FCRL, which contain one or more putative immunoreceptor tyrosine- 
based inhibitory or activatory motifs (ITIM or ITAM), chFcR/L lacks any known 
signalling motif in its cytoplasmic region. Two potential N-glycosylation sites 
exist in chFcR/L, both in domain EC3. There appears to be a trend towards 
more glycosylation sites in FcRs than FCRLs, especially in the three domain 
'types' homologous to those of FcyRl, although their positions appear to be 
poorly conserved (data not shown). chFcR/L appears to combine features of 
both mammalian FcR and FCRL, making it unique amongst all FcR-related 
sequences currently known. 
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Figure 6.3.6 i 
chFcRIL contains Ig domains found in mammalian FcR and FCRL 
Left, schematic representation of chFcR/L in the cell membrane (left), putatively 
in association with a signalling subunit, the chicken orthologue of FcRy, which is 
shown as a disulfide-linked homodimer as occurs in mammalian FcR 
complexes. EC = extracellular Ig domain, TM = transmembrane domain, C= 
cytoplasmic region. 
Right, schematic representations of mammalian FcR and selected FCRL with 
the longest stretches of alignment to chFcR/L. Ig domains are coloured 
according to their relatedness to chFcR/L. 
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Amino acid sequences of individual Ig domains of chFcR/L, mammalian 
FcR, FCRL, catfish IpFcRI and an outlier only distantly related to the FcR 
family, CD89, were aligned using ClustalW (Thompson et al., 1994). A 
phylogenetic tree was drawn using the neighbour-joining bootstrap resampling 
method with MEGA 3.1 (Kumar et al., 2004), in order to analyse the 
evolutionary relationship between chFcR/L and mammalian FcR and FCRL 
(Figure 6.3.6 ii). 
The relatedness of Ig domains within the FcR and FCRL (denoted by 
colours in Figures 6.3.6 i and 6.3.6 ii) indicates that these genes have 
undergone profuse 'domain swapping' or exon duplication events in a 
somewhat lineage-restricted fashion. This means that even closely related 
species such as mouse and human show considerable diversity in the number 
of copies of each domain 'subfamily'. The individual Ig domains of chFcR/L 
were found to be related to one of these 'subfamilies', so that each has a 
related counterpart that variously occurs throughout the FcR and FCRL. 
Domains EC1-EC3 have relatives in both FcR and FCRL and are outliers to one 
or both families. EC4 is only distantly related to any mammalian FcR domain, 
although an EC4-like domain may have simply been lost in the mammalian 
lineage. These factors, compounded by sequence divergence due to 
evolutionary distance, means that the analysis cannot determine absolutely 
whether chFcR/L is more closely related to one family than the other, although a 
common ancestry seems certain. 
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Figure 6.3.6 ii 
Evolutionary relationships of Ig domains in chFcR/L, Fc receptors and 
FCRL 
Phylogenetic tree of individual Ig domains from chFcR/L, catfish IpFcRI and all 
currently identified mammalian FcR & FCRL. The tree was drawn using the 
neighbour joining method with 1000 bootstrap replicates. Domains are coloured 
according to their relatedness. 
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6.3.7 Fc binding potential of chFcR/L 
A single homologous domain type is responsible for Ig binding in each of 
the FcRs (coloured blue in Figure 6.3.6 i). Domain EC2 of chFcR/L was found to 
share greatest homology with this domain, and several key residues (Davis et 
al., 2002) are conserved. ClustalW alignment of FccRI and FcyRI-III binding 
sites with chFcR/L (Figure 6.3.7 A) shows that of the residues implicated in Fc 
contact, only a trytophan is present in chFcR/L (W128). In the crystal structure 
of human FcERI bound to IgE-Fc (CE3-4), this residue forms part of a 
hydrophobic pocket that tightly sandwiches a proline (P426) in the Fc (Garman 
et al., 2000). This proline is conserved between IgE, all IgG subclasses and IgY 
(Figure 6.3.7 B), which suggests that part of the Fc/FcR interaction may be 
similar for all three isotypes. However, the 'proline sandwich' also involves 
another tryptophan in FccRl, W110. Whilst this residue is well conserved in the 
FcyRs, it appears to be replaced by leucine in the chFcR/L sequence. Most 
FCRL lack conservation of binding site residues, which helps to explain their 
alleged lack of Ig binding (Davis et al., 2002). These findings could suggest that 
chFcR/L lacks the ability to bind Fc, although the lack of conservation in IgY of 
several other residues involved in IgG and IgE binding strongly suggests that 
the IgY/Fc receptor interaction is not identical to the mammalian equivalents. 
Indeed, if binding to IgY-Fc occurs exclusively through EC2 in the same way as 
mammalian FcRs, the presence of splice variants lacking most, if not all of this 
domain would be somewhat inexplicable (see section 6.3.5). EC, is the only 
domain to occur in all three chFcR/L variants, so it might be argued that this is a 
more reasonable candidate for the Fc binding domain. However, a splice variant 
of a receptor for IgA, FcaR has been observed lacking the binding domain, 
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which also happens to be the second extracellular domain (Suzuki et al., 1999). 
Regulation of ligand binding by transcriptional control of receptor was 
postulated to explain the appearance of these variants, and this may true of 
chFcR/L also. 
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A 
chFcR/L : YDLLILQVPSHAVFEGELLQMQCRG KVGSLAAVRFYRDGADITKPYTSAMQLSIPQAKA 162 
FcgRI : -LLLQVSSRVFTEGEPLALRCH KDILVYIVIYYRNGK, FKM-. NSNLTILKTNI 160 
FcgRII : SEWLVLQTPHLEFQEGETIVLRCHS KDKPLVKVTFFQNGKSKKFS-RSDPNFSIPQANH 178 
FcgRIII : -LLLQAPRWVFKEEDPIHLRCHS NlALHIVIYLQNGK, RKE-SNSDFYIPKATL 200 
FceRIa : SDWLLLQASAEVVMEGQPLFLRCHG RNWDVYKVIYYKDGEALKYW-YENHNISITNATV 143 
chFcR/L HHSGRYHCSADMHSYLSLK-RRESQGLYISIK- 193 
FcgRI : SHNGTYHCSG-MMR----- YTSAGISVTVK- 186 
FcgRII : SHSGDYHCTGNIGYTL-----YSSKPVTITVQ- 205 
FcgRIII : KDSGSYFCRGLF-N----- VSSETVNITITQ 228 
FceRIa : EDSGTYYCTGKVWQLD-----YESEPLNITVIK 171 
B 
Gammal ----------------------------------------- SVFLFPPKPKDTLM 252 
Epsilon SELTLSQKHWLSDRTYTCQVTYQG--HTFEDSTKKCAD--S SAYLSRPSPFD-LF 349 
Upsilon : SRVNVSGTDWREGKSYSCRVRHPATNTVVEDHVKGCPDGAQSCSPIQLYAIPPSPGE-LY 363 
Gammal ISRTPEVTCVVVIVIEDPEVKFNWYVDGVEVHNAKTKPREEQ YRVVSVLTVLHQD 312 
Epsilon IRKSPTITCLVV L PSKGTVNLTWSRASGKPVNHSTRKEEKQ LTVTSTLPVGTRD 409 
Upsilon : ISLDAKLRCLVVNLP-SDSSLSVTWTREKSGNLRPDPMVLQEHF GTYSASSAVPVSTQD 422 
Gammal : WLNGKEYKCKVSNK PIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGF 372 
Epsilon : WIEGETYQCRVTHP LMRSTTKTSGPRAAPEVYAFATPEWPGSRDKRTLACLIQNF 469 
Upsilon : WLSGERFTCTVQHEE LPLSKSVYRNTGPTTPPLIYPFAPHPEELSLSRVTLSCLVRGF 482 
Figure 6.3.7 
Alignment of binding sites in IgG and IgE Fc regions and their receptors 
with homologous sequences in IgY and chFcR/L 
Amino acid sequences aligned with ClustalW. (A) chFcR/L (EC2) and binding 
sites in Fc receptors whose ligand interactions are supported by 
crystallographic data. (B) IgY (upsilon) heavy chain (Cu3) and binding sites in 
IgG1 (gammal) and IgE (epsilon) heavy chains. Residues making direct contact 
with Fc or receptor are highlighted. Conserved contact residues are highlighted 
in red. 
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6.4 Identification and cloning of a putative chicken FcRy 
In mammals, the FcRy subunit was initially identified as part of the FccRI 
complex (Blank et aL, 1989; Perez-Montfort et aL, 1983), but has subsequently 
been found to be a common component of most Fc receptor complexes and 
provides their means of intracellular signalling (Hulett and Hogarth, 1994). The 
a-chains of FceRI and FcyRIll have been found to require interaction with FcRy 
in order to be expressed on the cell surface (Kurosaki and Ravetch, 1989; Miller 
et al., 1989; Ra et al., 1989). FcyRla can be expressed transiently in the 
absence of FcRy (Allen and Seed, 1989), although they are associated in vivo 
and may be required for maintenance of expression and proper function (Ernst 
et al., 1993; Masuda and Roos, 1993; Miller et al., 1996; Takai et al., 1994; van 
Vugt et al., 1996). 
Orthologues of mammalian FcRy have been identified in a teleost 
(Cyprius carpio) and an amphibian (Xenopus laevis), indicating that this subunit 
appears to be well conserved throughout the jawed vertebrates (Guselnikov et 
al., 2003). At the time of these experiments, there was no record of an avian 
FcRy orthologue in the literature, but these findings and the presence of a 
closely related signalling subunit, TCR4, in the chicken (Gobel and Bolliger, 
1998), suggested that one may exist. 
In order to be able to test the possibility of subunit dependence for in 
vitro expression of chFcR/L and to expand the range of possible future 
experiments should this be the case, an orthologue of FcRy was identified and 
cloned. Independent investigators have subsequently reported cloning of the 
same sequence (Viertlboeck et al., 2005). 
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6.4.1 Data mining of chicken genome and EST libraries 
In a similar approach to the identification of chFcR/L, the amino acid 
sequence of mammalian FcRy was used to BLAST search the chicken genome 
and EST libraries. Whilst the genome did not contain any candidate sequences, 
several ESTs were identified using NCBI dbEST (Boguski et al., 1993). 
Translated amino acid sequences from these ESTs gave a best reciprocal hit to 
mammalian FcRy sequences, indicating that the encoded protein is very likely to 
be the orthologue of FcRy in the chicken. Consistent with this assertion, other 
returned BLAST hits included the adaptor subunit CD3/TCR4, (Gobel and 
Bolliger, 1998), which is closely related to FcRy. 
6.4.2 Cloning of putative chFcRy 
Primers were designed from the identified ESTs and the complete coding 
sequence amplified by PCR from MQ-NCSU-derived cDNA (Figure 6.4.2 A) and 
cloned into a TOPO TA vector, pCR4 (Invitrogen). The translated amino acid 
sequence of chFcRy was aligned to those of FcRy orthologues from several 
mammals as well as frog (Guselnikov, 2004) and carp (Fujiki et al., 2000) using 
ClustalW (Figure 6.4.2 B). 
The chicken orthologue shows surprisingly high sequence identity to 
human (62%), which is even higher in the transmembrane region (85%) and the 
ITAM motif (72%). This is likely to be reflection of this molecule's crucial role, 
providing the capacity to initiate signalling cascades in numerous immune 
receptor complexes. The interaction between ITAM motifs and tyrosine kinase 
SH2 domains does not tolerate mutations well, and so has therefore been 
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highly conserved between vertebrate classes. Interestingly, absolute 
conservation of all residues implicated in key protein: protein interactions in the 
transmembrane domain (Figure 6.4.2 B) implies that the chicken FcRy would 
form a homodimer (as shown in figure 6.3.6 i) and make contacts with other 
receptor subunits in an identical fashion to its mammalian orthologues. Although 
there does not appear to be a common motif required for FcRy interaction, the 
a-chains of FccRI, FcyRI and FcyRIII contain a charged residue in their 
transmembrane regions. FcyRIIa, which does not interact with FcR7, has no 
such residue. The chFcR/L transmembrane region contains glutamic acid (-), 
arginine (+) and histidine (+), which were predicted by SOSUI (Hirokawa et al., 
1998) to be on opposite faces of the transmembrane helix, and thus gamma 
subunit interaction appeared to be possible. 
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L RLKMRSSGDKAFS ------------- 
< ITAM > 
Chicken : ---AKKP-------- EEGI TGLSTEHQET EMLQ-HKA---- 
Human ---YEKS--------- DGV TGLSTRNQET ETLK-HEKPPQ- 
Boar : ---YEKS---------DGV TGLSTRNQET ETLK-HEKPPQ- 
Dog : ---YEKP--------- DGI TGLSTRNQET ETLK-HEKPPQ- 
Mouse : ---REKA---------DAV TGLNTRSQET ETLK-HEKPPQ- 
Opposum ---YEKS---------EEV TGLSTRTQET ETLK-YEKSPQ- 
Frog : KQIIEKIGEEAQKKGEEGE TGLESVDKGT ETIK-GESKKN- 
Carp : ----EKR--------EGDI DLGRRDVDT DTLHPGKKKPLA 
Figure 6.4.2 
A putative orthologue of the FcRy subunit in the chicken 
(A) Nucleotide sequence (numbered) and predicted amino acid sequence (line 
above) of cloned chFcRy transcript cDNA. Predicted signal peptide and 
transmembrane region are marked (<> above amino acid sequence). Predicted 
signal peptide cleavage site is marked (/). A canonical ITAM motif is highlighted 
in grey. Initiation and termination codons and polyadenylation sequence are 
underlined. 
(B) ClustalW alignment of amino acid sequences of various FcRy orthologues. 
Residues in the transmembrane (TM) region of human FcRy have been studied 
by mutagenesis (Wines et al., 2006): those responsible for subunit 
homodimerisation are highlighted in black, those required for FccRla 
association are highlighted in green and those which interact with FcaRl are 
shown in red. Tyrosines involved in canonical ITAM motifs are highlighted in 
blue. Frog FcRy has two putative ITAM motifs (Guselnikov et al., 2003). 
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6.5 Expression of chFcR/L and chFcRy 
6.5.1 Adaptation of sequences for expression with N-terminal epitope tags in 
mammalian cells 
The full length chFcR/L and chFcRy cDNA sequences (previously cloned 
in pCR4-TOPO) were used as templates in PCR reactions with primers 
designed to incorporate restriction sites 5' and 3' of the coding sequence for the 
mature peptide. The chFcR/L and chFcRy sequences were amplified with the 
addition of sequences encoding in-frame N-terminal V5 and FLAG epitope tags 
between the codons for the predicted signal peptide cleavage site (Figure 6.5.1 
A& B). Epitope tags are short amino acid motifs for which specific antibodies 
are commercially available and which have the advantage over larger tags 
(such as Green Fluorescent Protein) that they are less likely to cause structural 
or functional artefacts. Both of these tags have been successfully used in 
similar applications: an N-terminal V5-tagged receptor containing Ig domains 
(Viertlboeck et al., 2005) and an N-terminal FLAG-tagged gamma subunit (Wu 
et al., 2000). 
The sequences were cloned into the pRY mammalian expression vector 
(Young et al., 1995), following the same cloning strategy used for the IgY-Fc 
cDNA sequences (see chapter 4, figure 4.3.1 iii); the B72.3 VK light chain leader 
sequence and epsilon heavy chain untranslated region were ligated 5' and 3' of 
the chFcR/L CDS respectively (Figure 6.5.1 C). 
-204- 
Chapter 6 Chicken Fc receptor homologues 
A 
1. Natural leader sequence 1 chFcR! L N-terminus: 
5' 
MET... ALA VAL ALA / GLU MET ALA LEU LEU... 
ATG... GCT GTT GCA / GAG ATG GCC CTG CTG... 




MET... CYS ASP ILE / GLY LYS PRO ILE PRO ASN PRO 
ATG... TGT GAT ATC / GGT AAG CCT ATC CCT AAC CCT 
EcoRV 
LEU LEU GLY LEU ASP SER THR-GLU MET ALA LEU LEU... 
CTC CTC GGT CTC GAT TCT ACG-GAG ATG GCC CTG CTG... 
3. Natural chFcRIL C-terminus / stop-UTR: 
5' 
... GLY ASP VAL Ter 
... GGG GAT GTT TGA GGA GCG CCG TAA ACC CAC TGC... 
4. chFcRIL C-terminus/stop-adapter-872.3 UTR: 
5' 
... GLY ASP VAL Ter 
... GGG GAT GTT TGA GTT TAA ACC TGC CTC CCT... 
Pmel 
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B 
1. Natural leader sequence / chFcRy N-terminus: 
5' 
MET... ALA LEU ALA / 
ATG... GCG GAG GCA / 
GLU PRO ALA LEU CYS... 
GAG CCG GCC CTG TGC... 




MET... CYS ASP ILE / ASP TYR LYS ASP ASP ASP ASP 
ATG... TGT GAT ATC / GAC TAT AAG GAC GAT GAT GAC 
EcoRV 
LYS-GLU PRO GLU CYS... 
AAG-GAG CCG GAG TGC... 
3. Natural chFcRy C-terminus / stop-UTR: 
5' 
... HIS LYS ALA Ter 
... CAC AAA GCC TGA GTT CGG ACC CCC CCA CCA CCA... 
4. chFcRy C-terminus/stop-adapter-B72.3 UTR: 
5' 
... HIS LYS ALA Ter 
... CAC AAA GCC TGA GTT TAA ACC TGC CTC CCT... 
Pmel 
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C 
Hindill EcoRV Pmel Hindill 
[V5]chFcR/L "L 1 V5 EC, EC. 
HindIll EcoRV Pmel Hindill 
[V5] chFcR/L AEC2 V5 EC, EC. MEJEJ 













Figure 6.5.1 (above and previous two pages) 
Adaptation of chFcR/L and chFcRy cDNA sequences for mammalian 
expression with N-terminal epitope tags 
Nucleotide and encoded amino acid sequences of regions modified by PCR in 
chFcR/L (A) and chFcRy (B). Bases around the original predicted signal peptide 
cleavage site (1) were altered to include an N-terminal V5 or FLAG tag and an 
EcoRV restriction site (shown bold & underlined), which was used to ligate the 
mature peptide coding sequence 3' of the mouse B72.3 VK light chain leader 
sequence (2). Similarly, bases around the original termination codon (3) were 
altered to include a Pmel restriction site, which was used to ligate the mature 
peptide coding sequence to the 5' end of the epsilon heavy chain untranslated 
region. (C) A summary schematic showing the encoded elements of the 
generated expression cassettes, with representations of the expected proteins. 
VKL = leader sequence (encoding signal peptide), V5/FLAG = epitope tag, EC = 
extracellular Ig domain, T/TM = transmembrane region, C= cytoplasmic region, 
U= untranslated region. 
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6.5.2 Transient expression of chFcR/L 
The feasibility of the [V5-chFcR/L] expression cassette was tested by 
transient transfection of CHO-K1 cells with the pRY-based vector prepared in 
section 6.5.1. Intracellular V5 was detected in approximately 30% of transfected 
cells using anti-V5 antibodies (not shown). However, cell surface V5 was 
detected when cells were co-transfected with the [V5-chFcR/L] and [FLAG- 
chFcRy] pRY vectors, but not when cells were transfected with [V5-chFcR/L] 
vector alone (Figure 6.5.2). 
This finding not only appears to confirm that the tagged constructs are 
capable of expression, but also that insertion of chFcR/L in the cell membrane 
requires an accessory subunit. Association with an ITAM-containing gamma 
subunit would explain how chFcR/L acquires signalling potential in vivo. As 
outlined above, the high affinity receptors for IgG (FcyRla) and IgE (FccRIa) also 
associate with FcRy, although unlike FccRla and chFcR/L, FcyRIa can be 
expressed (albeit transiently) in its absence. 
Presumably due to the difficulty of achieving co-expression of both 
chFcR/L and chFcRy in the same cell, less than 5% of cells were positive for 
chFcR/L surface expression. IgY binding potential was tested, but due to the 
low level of surface expression and a fairly high level of background in this 
assay format (as judged by IgY/anti-IgY-FITC staining of untransfected CHO-KI 
cells), the results were inconclusive. 
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_+ 
Mouse Anti-V5 





Transient expression of chFcR/L in CHO-K1 cells 
Immunofluorescent anti-V5 staining of CHO-K1 cells grown on chamber slides 
transiently transfected with vectors encoding N-terminal tagged chFcR/L alone 
(top two images) or in concert with chFcRy (bottom two images). Cells were 
incubated with mouse monoclonal anti-V5 antibodies (right two images) or 
buffer alone (left two images), followed by anti-mouse antibodies conjugated to 
FITC (Dako). Cells were analysed using an Axioscope fluorescence microscope 
and images collected using an Axiocam CCD and Axiovision software (Zeiss). 
Untransfected cells did not stain with anti-V5 (not shown). Scale = 100µm. 
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6.5.3 Stable expression of [FLAG]chFcRy and [V5]chFcR/L 
The selection of clones stably expressing the chFcR/L and chFcRy 
constructs offers a solution to the problem of poor co-expression in transient 
transfections and potentially allows a host of further experiments to be 
performed. To allow dual selection of transfected cells, the chFcR/L and chFcRy 
cassettes (Figure 6.5.1 C) were cloned into two commercially available 
mammalian expression vectors containing different antibiotic selection markers, 
pCDNA3 and pCDNA3.1/Hygro respectively (not shown). These vectors 
constitutively express from a CMV promoter and are practically identical except 
that pCDNA3 contains a gene which confers resistance to neomycin (or an 
analogue G418/Geneticin), whereas pCDNA3.1/Hygro contains a gene which 
confers resistance to hygromycin. 
Several mammalian cell types commonly used to produce stable 
transfectants were screened for IgY binding. Whilst all were essentially 
negative, some cell types were found to have higher background fluorescence 
than others. A human embryonic kidney cell line, HEK 293, was chosen as it 
had low background, is only mildly adherent (so could be tapped off the culture 
flask surface easily for subsequent flow cytometry rather than requiring harsher 
methods of detachment, such as trypsin) and has been reported to be suitable 
for expression of chicken immune-type receptors in the literature (Viertlboeck et 
al., 2004). 
At the time of writing, stable transfectants have been selected which 
express [FLAG-chFcRy] and [V5-chFcR/L] alone, as determined by FACS 
analysis (Figures 6.5.3 i and 6.5.3 ii), but a cell line expressing both 
concurrently has yet to be produced. 
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Figure 6.5.3 i 
Stable expression of N-terminal FLAG tagged chFcRy in HEK 293 cells 
FACS profiles showing HEK 293 cells gated to exclude dead cells (A & D) 
following incubation with 1µg/ml mouse monoclonal anti-FLAG antibodies 
followed by 10µg/ml anti-mouse-FITC (filled peaks) or with buffer alone followed 
by 10µg/ml anti-mouse-FITC (unfilled peaks). Cells were fixed, washed and 
incubated in the presence (A, B& C) or absence (D, E& F) of 0.1 % saponin for 
intracellular or extracellular staining respectively. The staining pattern of cells 
stably transfected with the vector for the [FLAG]chFcRy construct (C & F) are 
shown in comparison with that of untransfected cells (B & E). 
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Figure 6.5.3 ii 
Stable expression of N-terminal V5 tagged chFcR/L in HEK 293 cells 
FACS profiles showing HEK 293 cells gated to exclude dead cells (A & D) 
following incubation with 1 µg/ml mouse monoclonal anti-V5 antibodies followed 
by 10µg/ml anti-mouse-FITC (filled peaks) or with buffer alone followed by 
10µg/ml anti-mouse-FITC (unfilled peaks). Cells were fixed, washed and 
incubated in the presence (A, B& C) or absence (D, E& F) of 0.1 % saponin for 
intracellular or extracellular staining respectively. The staining pattern of cells 
stably transfected with the vector for the [V5]chFcR/L construct (C & F) are 
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6.6 Discussion 
In this chapter, IgY-Fc receptors analogous to the high affinity receptors 
for IgG and IgE were identified on chicken leukocytes. Attempts were made to 
isolate a receptor as protein in order to obtain an N-terminal sequence for cDNA 
cloning, with the aim of greatly broadening the scope of possible experiments to 
characterise their interaction with IgY. In a similar method developed by Weil et 
al. to sort human basophils labelled with fluorescent anti-IgE (Weil et al., 1983), 
avian PBMCs were stained with anti-IgY-FITC and sorted using flow cytometry. 
Basophilic granulocytes were found to have the most bound IgY relative to all 
other peripheral blood cell types, so presumably they express the greatest 
levels of IgY receptor. Although chickens typically carry greater numbers of 
basophils in their blood than humans, -8x105 / ml (Cook, 1937), even assuming 
100% recovery in a purification process, this still makes the preparation of a 
useful quantity of Fc receptor practically untenable. In order to obtain a long 
enough N-terminal sequence to allow degenerate RACE-PCR primers to be 
designed to clone the receptor cDNA sequence, around 100 picomoles is 
required (J. N. Keen, personal communication). Assuming 200,000 receptors per 
basophil, each preparation would require an impractical amount of chicken 
blood: 
(1 x10'10moles x 6.022x1023) 
x 
2.0x105 molecules/cell 
= 376 ml blood 
8.2x105 basophils/ml 
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IgY-Fc receptors were shown to be present on a chicken monocyte cell 
line, MQ-NCSU. Although the use of a cell line solves the practical issues with 
obtaining purified cells, the low level of receptor expression (1-2x104 molecules 
per cell) means that at least 3-6x109 cells (-5-10 litres of culture) would be 
required to obtain 100 pmol receptor. Small preparations were performed using 
affinity purification in an attempt to visualise receptor using SDS-PAGE. 
Unfortunately, too many contaminating proteins were found which could not be 
adequately removed by increased column wash volume or wash buffer ionic 
strength. 
As protein-based approaches therefore seemed unfeasible with available 
resources, an in silico strategy was pursued to identify candidate Fc receptors 
in chicken EST databases and the chicken genome sequence, the first draft of 
which had recently been released (Hillier et al., 2004). A single gene belonging 
to the Fc receptor family, chFcRIL, was identified by (translated nucleotide) 
BLAST searches using the amino acid sequences of mammalian FceRI and all 
FcyRs, then cloned by RACE-PCR (Taylor et al., 2007). Searches of 
subsequent drafts of the genome and all available bird EST libraries, including 
duck (Xia et al., 2006), have not revealed any additional FcR-like genes. 
Fayngerts et al. cloned the same sequence and showed by Southern blot of 
restriction digested genomic DNA that this would appear to be the only 
sequence of its kind (Fayngerts et al., 2007), although this is not conclusive. 
The presence of only one FcR family member in the chicken is rather surprising 
given that there are numerous homologues in amphibians, whose lineage 
diverged before the subdivision of birds and mammals (Guselnikov, 2004). 
Indeed, it would be unwise to assume there are no other homologues on the 
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basis of their absence from the database alone; many immune-related 
multigene families that consist of closely related sequences have proven difficult 
to fully sequence by the shotgun approach used for the chicken genome and 
thus show artefactual under-representation (Burt, 2005; Viertlboeck et al., 
2005). The IgY upsilon heavy chain gene is itself absent except for a single 
exon. 
The chFcR(L gene and the encoded protein share several features 
characteristic of two important FcR subfamilies: the `classical' Fc receptors, 
whose ligands are antibodies, and FCRL, whose ligands are currently unknown. 
As the genes in both of these families are essentially made up from the same 
pool of closely related exons, phylogenetic analysis was unable to conclusively 
place chFcR/L as a member of one or the other. 
If just a single FcRIFCRL gene is present in the chicken, it would suggest 
that either all other genes have been lost in the avian lineage or that all 
mammalian members are derived from a chFcR/L-like ancestor - i. e. gene 
duplication events have occurred in the mammalian lineage, but not the avian 
lineage. Several FCRL members contain a domain 'type' which does not occur 
in chFcR/L (coloured green in figure 6.3.6). This type has either been lost in the 
avian lineage or is the result of divergence from one of the other domain 
subfamilies. Perhaps the most plausible explanation is a combination of both of 
these; the FcR/FCRL subdivision occurred in the mammalian lineage following 
the split from the avian lineage (-300 million years ago), but (unlike the 
IgY/IgG/IgE situation) part or all of the ancestral gene or genes have been lost 
in modern day birds. 
-215- 
Chapter 6 Chicken Fc receptor homologues 
Comparison of binding domains in FcR with the most closely related 
domain in chFcR/L is of limited use to predict IgY binding potential. In order to 
determine whether chFcR/L is an IgY-Fc receptor it is therefore necessary to 
express the sequence and assay IgY binding directly. When transiently 
expressed in CHO cells, surface translocation of chFcR/L was found to require 
the co-expression of an accessory subunit, the chicken orthologue of FcRy, to 
allow translocation to the cell surface. In mammals, several FcR require this 
subunit in order to be expressed on the cell surface and/or acquire signalling 
potential, unlike any known FCRL, which carry their own (functional) 
cytoplasmic signalling motifs (Davis et al., 2002; Leu et al., 2005). Co- 
expression was, however, found to be too inefficient to allow adequate 
characterisation of IgY-binding potential. To overcome this problem, steps were 
made toward the creation of a stable cell line co-expressing sufficient levels of 
chFcR/L and chFcRy, which should allow a conclusive appraisal of IgY-binding. 
Should chFcR/L prove to be an IgY-Fc receptor, it will be interesting to 
discover whether chFcR/L AEC2 is also capable of binding, as this splice variant 
lacks the domain homologous to the mammalian FcR binding domains. The 
kinetics of IgY binding could then be investigated by cell binding assay and 
compared to that of the monocyte IgY-Fc receptor, which may be the same 
molecule. Preparation of anti-chFcR/L specific antibodies would allow this issue 
to be resolved. 
Should chFcR/L prove not to be an IgY-Fc receptor, the findings 
described in this chapter allow a new approach to be taken; expression libraries 
could be created using cDNA derived from FACS sorted chicken basophils and 
MQ-NCSU monocytes, then transfected into the HEK 293 cells stably 
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expressing chFcRy, in order to increase the chance of discovering receptors 
whose surface expression requires subunit association. The cells would then be 
screened for the ability to bind IgY, and cDNA isolated from positive hits. This 
technique was used to clone and sequence the human high affinity receptor for 
IgG, FcyRl. 
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Chapter 7 
Functional Characterisation of IgY-Fc Receptor Interaction on Chicken 
Monocytes 
7.1 Overview 
Previous chapters detail the design, expression and purification of a 
series of recombinant IgY-Fc mutants. Although a recombinant soluble lgY-Fc 
receptor has yet to be produced, lgY-Fc receptors are expressed by a 
monocyte cell line, MQ-NCSU, indicated by IgY-dependent effector functions 
(Qureshi et al., 1990) and monomeric IgY binding using flow cytometry (see 
chapter 6, section 6.2.2). These cells therefore provide a means to make some 
preliminary studies on various properties of an IgY-Fc receptor, including the 
interaction with IgY-Fc. 
For comparative purposes, there are a host of published cell binding data 
for IgG and IgE, including interactions with mammalian monocytes specifically 
(McCool et al., 1985; Raychaudhuri et al., 1985; Unkeless and Eisen, 1975). 
The effects of various structural features on the kinetics of IgE binding to FccRla 
have been investigated using surface plasmon resonance (SPR) or analytical 
ultracentrifuge (AUC) techniques (Henry et al., 1997; Hunt et al., 2005; 
McDonnell et al., 2001). There are often discrepancies between data obtained 
using these techniques and data obtained using cell binding assays. 
Comparisons between data collected using the same methodology are 
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therefore the most reliable, although for completeness, it is nevertheless 
important to consider all related findings. 
The present chapter details initial studies into the effects of the various 
structural differences between the IgY-Fc mutants from a functional viewpoint. 
The factors investigated influence the Fc receptor interactions of IgG and IgE in 
markedly different ways, and thus characterisation of their role in IgY biology 
was an important aim. 
7.2 Specificity of IgY and a chicken monocyte Fc receptor 
Cross-species reactivity was investigated by attempting to bind (1) 
chicken IgY to cells expressing human Fc receptors for IgG or IgE and (2) 
human IgG or IgE-Fc to chicken monocytes (Figure 7.2). 
Although rat IgE binds to human FccRl (Conrad et al., 1983), human IgE 
will not bind to rat FccRl (Froese, 1980). Human IgG, by contrast, is more 
promiscuous and all but one subclass can bind to mouse FcyRl (Haeffner- 
Cavaillon et al., 1979a; Haeffner-Cavaillon et al., 1979b). Both chicken antibody 
and Fc receptor were found to be species specific. Neither IgG nor IgE-Fc were 
able to bind to MQ-NCSU cells and chicken IgY did not bind to cells expressing 
FccRI or FcyRI. Over the course of the investigation, IgG antibodies from 
mouse, rabbit and goat were also tested and found to be non-reactive (not 
shown). 
Lack of cross-species reactivity is likely to be the result of poor sequence 
identity in the antibody and Fc receptor binding sites due to the relatively large 
evolutionary distance between birds and mammals. This diversity may be more 
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due to differences in the (immune-type) receptors. Sufficient homology in 
certain surface loops exists between human IgG and chicken IgY to allow cross- 
reactivity with an IgY receptor that mediates transport into the yolk when human 
IgG is injected intravenously (Morrison et aL, 2002), although this is inconsistent 
with the finding that the recently cloned yolk sac IgY receptor does not bind 
human IgG or IgE in an SPR assay (West et al., 2004). 
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Flow cytometry (FACS) profiles showing binding of secondary fluorescent 
conjugates to three different cell lines (rows) following incubation with chicken 
IgY, human IgG1 and recombinant human lgE-Fc (columns). MQ-NCSU are 
chicken monocytes, U937 are human monocytes and RBL-SX38 are rat 
basophils expressing the human high affinity receptor for IgE. Values shown are 
ratios of mean fluorescence intensity of cells incubated with tested protein then 
secondary conjugate (filled peaks) over that of control cells incubated with 
conjugate alone (unfilled peaks). Cell types were gated as marked in the dot 
plots. 
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7.3 Fc receptor binding potential of IgY-Fc mutants 
The potential of the IgY-Fc mutants (designed in chapter 4) to bind MQ- 
NCSU chicken monocytes was assayed by immunofluorescence and flow 
cytometry (Figure 7.3). All mutants were found to bind, with signals comparable 
to whole IgY using the same antibody (Figure 6.2.2). Some important 
conclusions can therefore be drawn: 
1. Absence of Fab, Cut or Cu2 does not abrogate binding as Cu3-4 
fragments retained cytophilic activity. In both IgG and IgE, the majority of 
classical Fc receptor contact residues are clustered in roughly 
homologous sites at the N-terminus of Cy2 or CE3 (Garman et al., 2000; 
Jefferis and Lund, 2002), so that IgG-Fc (Cy2-3) and truncated IgE-Fc 
(CE3-4) have a binding affinity equal to or greater than the whole 
antibody (Keown et al., 1997; Keown et al., 1995; Raychaudhuri et al., 
1985). Conservation of the approximate location of the receptor binding 
site in IgY (Cu3) seems likely and is consistent with the observed binding 
potential of Cu3-4 fragments. 
2. An inter-heavy chain disulfide bond is not an absolute requirement for 
binding as the Cu3-4 [C340S C347S] mutant was able to bind to MQ- 
NCSU monocytes. Fc fragments of IgG and IgE also retain the ability to 
bind to their receptors when interchain disulfides are absent (Basu et al., 
1993; Helm et al., 1991; Lund et al., 1993), albeit with lower affinity (Hunt 
et al., 2005; McCool et al., 1985). 
3. Absence of glycosylation at one or both sites (N308 and N407) does not 
abrogate binding as the Cu2-4 [N308Q] mutant and the aglycosylated 
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Cu2-4 [N308Q N407Q] mutant were both able to bind to MQ-NCSU 
monocytes. This is perhaps the most unexpected finding as it highlights a 
significant difference between the role of carbohydrate in IgY and IgG. 
Deglycosylated IgG is unable to engage Fc receptors (Walker et at, 
1989), whereas IgE stripped of carbohydrate is still able to bind with high 
affinity (Hunt et al., 2005). 
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Figure 7.3 
Receptor binding potential of IgY-Fc mutants to MQ-NCSU chicken 
monocytes 
Flow cytometry (FACS) profiles showing binding of antibodies specific for IgY- 
Fc followed by secondary fluorescent conjugates to MQ-NCSU cells. Cells were 
first incubated with Cu2-4 mutants (top), [wt] (red), [N308Q] (green), [N308Q 
N407Q] (blue) or Cu3-4 mutants (bottom) [wt] (orange), [C340S] (purple), 
[C347S] (cyan), [C340S C347S] (magenta), or buffer alone (black). Values 
shown are ratios of mean fluorescence intensity of cells incubated with IgY-Fc 
then secondary antibody/conjugate over that of control cells incubated with 
buffer alone then secondary antibody/conjugate. 
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7.3.1 Effect of glycosylation of IgY-Fc on monocyte receptor binding 
To further investigate the influence of glycosylation on IgY-Fc receptor 
binding, whole serum IgY and Cu2-4 [wt] IgY-Fc were treated with an 
endoglycosidase, PNGase F (see chapter 2). Both proteins were found to retain 
receptor binding potential (Figure 7.3.1 i) even though carbohydrate removal 
was virtually complete, as verified using PAS staining of an SDS-PAGE gel 
(Figure 7.3.1 ii). 
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Figure 7.3 i 
Receptor binding potential of chicken IgY and human IgGI following 
treatment with PNGase 
Flow cytometry (FACS) profiles showing binding of chicken serum IgY or IgY-Fc 
Cu2-4 [wt] to MQ-NCSU cells (A) before and (B) after incubation with PNGase F 
(NEB) for 3 days at 37°C. Cells were incubated with IgY (red) or IgY-Fc (blue) 
followed by antibodies specific for Cu2 then secondary fluorescent conjugates. 
For comparison, a profile of human IgG1 binding to U937 human monocytes is 
shown (C), before (blue) and after (red) the same PNGase F treatment. Values 
shown are ratios of mean fluorescence intensity of cells incubated with tested 
protein then secondary antibody/conjugate over that of control cells incubated 
with buffer then secondary antibody/conjugate alone (black trace in all profiles). 
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Figure 7.3.1 ii 
Analysis of native deglycosylation of chicken IgY and IgY-Fc using 
PNGase F 
Identical SDS-PAGE gels stained with (A) Periodic acid-Schiff or (B) Coomassie 
blue. IgY (Lanes 1& 2), IgY-Fc Cu2-4 [wt] (Lanes 3& 4) or PBS (Lanes 5& 6) 
were incubated for 3 days at 37°C in non-denaturing deglycosylation buffer 
without (Lanes 1,3 & 5) or with (Lanes 2,4 & 6) PNGase F (NEB). Molecular 
weight is shown in kDa. PNGase F enzyme has a molecular weight of -36kDa; 
bands approximately equivalent to this can be seen in (B), lanes 2,4 & 6. 
7.3.2 Effect of IgY-Fc glycosylation on heat-induced abrogation of receptor 
binding potential 
Whole serum IgY, IgY-Fc Cu2-4 [wt] and the Cu2-4 glycosylation site 
mutants were heated for four hours at a series of temperatures around their 
melting temperatures (see section 5.4.5) using a PCR block. Proteins were then 
cooled to 4°C and incubated with MQ-NCSU monocytes. Binding was assayed 
using immunofluorescence and flow cytometry (Table 7.3.2). 
At 82.5°C, all four molecules exhibited loss of receptor binding, which is 
likely the result of unfolding or occlusion of binding sites due to thermally- 
induced aggregation, consistent with data obtained using DLS (Figure 5.4.4). A 
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significant difference was seen between Cu2-4 [wt] and the glycosylation site 
mutants at temperatures too low to induce aggregation, however. Binding of 
Cu2-4 [wt] was completely precluded by heating to 72.5°C, whereas both Cu2-4 
[N308Q] and Cu2-4 [N308Q N407Q] retained their binding potential, as did 
whole IgY. Only the single (non-core) glycosylation site mutant, Cu2-4 [N308Q], 
was still able to bind following heating to 77.5°C. 
Temperature of ligand pre-treatment (°C) 
4 67.5 72.5 77.5 82.5 
Whole 4 83 67 3 3.00 1.32 1.06 IgY . . 
wt 4.21 3.66 1.21 1.14 1.11 N 
N308Q 3.84 3.66 3.42 2.74 1.16 U 
LL 
N308Q 3.52 2.83 2.37 1.36 1.11 N407Q 
Table 7.3.2 
Chicken monocyte binding potential of heat treated IgY and IgY-Fc 
glycosylation site mutants 
Whole serum IgY and recombinant IgY-Fc mutants were heated to the 
temperatures shown at 0.1 mg/ml then cooled to 4°C and incubated with MQ- 
NCSU cells at 0.01 mg/ml. Cells were then incubated with mouse monoclonal 
anti-Cv2 specific antibodies followed anti-mouse FITC, then assayed by FACS. 
Values shown are ratios of mean fluorescence intensity of cells incubated with 
tested protein then secondary antibody/conjugate over that of control cells 
incubated with buffer then secondary antibody/conjugate alone. 
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7.4 Determination of kinetics of IgY and IgY-Fc binding to chicken 
monocytes 
Cell binding assays were performed to evaluate the kinetics of IgY and 
recombinant IgY-Fc binding to MQ-NCSU monocytes. A well established 
method is to monitor binding using radiolabelled ('hot') ligand. Fluorescent 
labelling measured using flow cytometry has been shown to be effective for 
relative measurement of antibody: antigen affinities (Geuijen et al., 2005) and 
was initially investigated as a safer alternative. 
IgY labelled directly with fluorescein isothiocyanate (FITC) was found to 
bind to MQ-NCSU cells, but the fluorescence signal was insufficient for kinetic 
studies (not shown). To solve this, IgY was biotinylated and the signal amplified 
using streptavidin conjugated to phycoerythrin (RPE). 
Although this provided a reasonable signal for IgY (a dissociation 
experiment is shown in appendix 1), the signals from biotinylated versions of the 
IgY-Fc mutants were too low to allow accurate measurement of bound material 
(not shown), presumably due to the smaller number of lysine residues available 
for reaction with biotin in the Fc fragment compared with the whole antibody. 
Radiolabelling was therefore deemed to be more suitable for studies involving 
the IgY-Fc mutants. IgY or recombinant IgY-Fc were labelled with radioactive 
iodine-125 (1251) using chloramine T (McConahey and Dixon, 1980). Cells 
saturated with either whole antibody or IgY-Fc were found to have radioactivity 
levels well within the sensitivity of the automatic gamma counter used, a Wizard 
1480 (Perkin Elmer). 
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7.4.1 Determination of receptor numbers on MQ-NCSU chicken monocytes 
1251 incorporation was determined by measurement of the mean counts 
per minute (cpm) of a known concentration of labelled IgY. IgY (and all IgY-Fc 
mutants) were found to have a specific activity of -1x109 cpm/mg. 106 MQ- 
NCSU cells cultured in IgY-free media were saturated with hot IgY, separated 
from unbound free ligand and their mean cpm measured. Assuming 1: 1 binding 
stoichiometry, the mean number of bound IgY molecules equal to the mean 
number of receptor sites was calculated to be 15,000 ± 5,000. This is 
comparable to the number of FcyRl molecules reported on primary human 
monocytes, 4,300 - 45,000 (Jungi and Hafner, 1986; Karagiannis et al., 2003), 
and a human monocyte cell line (U937), which express 18,000 receptors per 
cell (Anderson and Abraham, 1980). 
7.4.2 Binding kinetics of radioiodinated IgY and recombinant IgY-Fc mutants to 
chicken monocytes 
The association rate constant (on-rate or k+, ) and dissociation rate 
constant (off-rate or k-1) were determined for IgY and all recombinant IgY-Fc 
mutants binding to MQ-NCSU monocytes by experiments monitoring the 
change in bound 125I-labelled ligand over time. Briefly, for association 
experiments, MQ-NCSU cells were incubated with radiolabelled ligand and cells 
were removed at regular intervals for gamma counting. For dissociation 
experiments, cells were first saturated with hot ligand then incubated with an 
excess of unlabelled 'cold' ligand in order to prevent re-binding of dissociated 
material. The rate constants were determined by non-linear regression analysis 
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of the scintillation counts per minute (proportional to the concentration of bound 
ligand) as a function of time (see chapter 2 for equations used). 
Figures of plots obtained with IgY (Figure 7.4.2 i) and IgY-Fc Cu2-4 [wt] 
(Figure 7.4.2 ii) are shown as exemplars; figures for the remaining IgY-Fc 
mutants can be found in appendix 1. The results collected so far are 
summarised in table 7.4.2 iii. Some initial observations can be made from the 
data collected so far, although it should be noted that these results are 
preliminary as more replicates and additional experiments are required to 
reduce errors and increase statistical significance. The limitations and caveats 
of these assays are discussed in section 7.5. 
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Kinetics of IgY binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+, ) and (B) dissociation rate constant (k. 1) for chicken serum IgY 
binding to MQ-NCSU cells. Assays were performed in duplicate and data are 
shown as mean ± s. e. m. 
In (A) cells were incubated in 1OnM 125I-labelled ligand. In (B) cells were first 
saturated with 1251-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1.0 being a perfect fit. 
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Figure 7.4.2 ii 
Kinetics of IgY-Fc Cu2-4 [wt] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+, ) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cu2-4 [wt] binding to MQ-NCSU cells. Assays were performed in duplicate 
and data are shown as meant s. e. m. 
In (A) cells were incubated in 1OnM 125I-labelled ligand. In (B) cells were first 
saturated with 125l-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1.0 being a perfect fit. 
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I Protein k+, (M-' s') k_, (s') KA (M') 
LWhole IgY (1.41 ± 0.03) x 105 (2.90 t 0.30) x 10"3 4.9 x 10' 
1 wt (4.73 ± 0.08) x 10' (2.30 ± 0.50) x 10-° 1 2.1 x 10° J 
v 
N 
Ü N308Q (2.38 ± 0.07) x 105 (3.60 t 0.40) x 10 3 6.6 x 10 
N308Q (8.26 1.02) x 104 (6.20 ± 0.80) x 10-3 1.3 x 107 N407Q 
(7.40 ± 1.70) x 10,3 5.6 x 107 
Table 7.4.2 iii 
Summary of IgY and IgY-Fc monocyte interaction kinetics derived from 
cell binding assays 
On-rates (k+1) and off-rates (k_, ) derived from regression analysis of MQ-NCSU 
cell binding data using 125I-labelled IgY and recombinant IgY-Fc mutants. 
Values are means of duplicate experiments shown ± standard error, determined 
using SigmaPlot 3.0 (SPSS). 
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The kinetics of the chicken IgY (complete antibody) binding to chicken 
monocytes were compared with the results of homologous interactions reported 
in the literature. Although there is some variation in the published values, the 
on-rate of IgY binding to monocytes (= 1.4 x 105 M"'s'') was found to be similar 
to human IgG binding to monocytes, 1.9 x 105 M''s"' and 2.1 x 105 M''s"' 
(Raychaudhuri et al., 1985; Shopes et al., 1990). However, the off-rates 
determined in these studies were 20-50 fold slower (5.5 x 10"5 s'' and 1.1 x 10-4 
s"') than the dissociation of IgY (2.9 x 10"3 s"'). Despite this difference, the 
binding parameters of IgY are within the range of mammalian IgGs; mouse 
IgG2a (the principal serum isotype) binds to P388D mouse monocytes with an 
on-rate of -105 M-'s' and an off-rate of 3.5 x 10-3S-1 (Unkeless and Eisen, 
1975). 
The IgY-Fc Cu2-4 [wt] fragment was found to have a four-fold higher 
affinity than the complete IgY, predominantly due to a faster on-rate (4.7 x 105 
M-'s"' ). An almost identical difference (i. e. higher affinity for Fc compared with 
whole antibody) has been reported for the high-affinity receptor interactions of 
both human IgG and IgG-Fc (Raychaudhuri et al., 1985) and human IgE and 
IgE-Fc (CE2-4) using cell binding assays (Young et al., 1995) as well as SPR 
(Henry et al., 1997). As the binding sites in all three isotypes map to the Fc 
region, removal of the Fab moieties probably results in increased accessibility, 
which would increase the probability of ligand-receptor interactions in solution. 
Interestingly, this is not the case for the interaction between IgE and its low 
affinity receptor, CD23 (a C-type lectin, not an FcR family member). The IgE-Fc 
CE2-4 fragment reportedly binds to CD23 with ten-fold lower affinity than the 
whole antibody (McDonnell et al., 2001). 
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Although glycosylation was found not to be an absolute requirement for 
receptor binding in section 7.3, the absence of putative core glycosylation from 
Cu2-4 fragment was found to have a significant effect on the receptor binding 
affinity. For the Cu2-4 [N308Q] mutant, only minor differences were observed 
(k+, = 2.4 x 105 M"s-1, k_1 = 3.6 x 10-3S-1) compared to the wild type Cu2-4 (k+i 
= 4.7 x 105 M"1 s", k_1 = 2.3 x 10"3 s''). For the aglycosylated Cu2-4 [N308Q 
N407Q] mutant, however, a six-fold slower on-rate (8.3 x 104 M-'s"1) and a 
three-fold faster off-rate (6.2 x 10"3 s') were observed. In studies of the kinetics 
of differentially glycosylated IgE-Fc fragments for FccRI (either expressed on 
the surface of CHO cells or immobilised on an SPR chip), similar results were 
obtained: a recombinant IgE-Fc homologous to the IgY-Fc [N308Q] mutant, 
CE2-4 [N265Q N371Q], was found to have only slightly lower affinity than a wild- 
type fragment in a cell binding assay, 5.0 x 1010 M'1 compared to 8.1 x 1010 M'1 
(Young et al., 1995). Although deglycosylation of IgG-Fc caused it to lose the 
ability to bind to receptors (Radaev and Sun, 2001), treatment of an IgE-Fc CE3- 
4 fragment with PNGase reduced the affinity constant by only four-fold in an 
SPR assay, mainly by increasing the off-rate (Hunt et aL, 2005). 
A comparison of the binding kinetics of Cu2-4 and Cu3-4 fragments was 
made in order to assess the involvement of the Cu2 domains, which were 
suspected to be important due to the influence of the homologous CE2 domains 
in stabilisation of the IgE high affinity receptor interaction (McDonnell et al., 
2001). As the recombinant IgY-Fc Cu3-4 [wt] fragment was found to be 
somewhat artefactual (see chapter 5), the fragment most representative of an 
IgY-Fc with the Cu2 domains removed is arguably the Cu3-4 [C340S] mutant. 
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This mutant lacks the interchain disulfide located in Cu2, but remains a 
covalently linked dimer by way of a disulfide between cysteines at position 347. 
Compared to Cu2-4 [wt], this fragment has a roughly two-fold slower on-rate 
(2.2 x 105 M"1s'') and roughly two-fold faster off-rate (5.2 x 105 s'1). By contrast, 
compared to a CE2-4 IgE-Fc, a Cc3-4 fragment has a three-fold faster on-rate 
and a five to ten-fold faster off-rate (Cook et al., 1997; McDonnell et aL, 2001). 
These results appear to show that Cu2 does not influence receptor binding 
kinetics to the same degree as CE2 in IgE, although the lower on-rate could 
imply a role in maintenance of proper binding site orientation. 
The presence and position of interchain disulfides were investigated 
using Cu3-4 fragments. The Cu3-4 [C347S] mutant, which has the interchain 
disulfide between a different, although ostensibly nearby, cysteine pair has a 
similar on-rate to the [C340S] mutant (2.0 x 105 M'1s'1), but a considerably 
faster off-rate (2.2 x 10-2 s'1). A non-covalently linked Cu3-4 mutant, [C340S 
C347S] was found to have a faster on-rate than either of the single disulfide 
Cu3-4 mutants (4.1 x 105 Ws"'), but a similar off-rate to the [C340S] mutant 
(7.4 x 10-3 s''). These results indicate that whilst interchain disulfides are not 
essential for Fc receptor engagement, the kinetics of Fc receptor binding are 
affected by either their location or absence. Reduced IgG and IgE are able to 
bind to cells expressing their high-affinity receptors, but with diminished affinity 
(McCool of al., 1985; Takatsu et al., 1975). In the case of IgE-Fc, a reduced 
Cc3-4 fragment was found to bind with 2: 1 stoichiometry in solution (using AUC) 
and the affinity of a single binding sub-site (on a single CE3 domain) could 
therefore be determined (Hunt et al., 2005). 
- 237 - 
Chapter 7 IgY-Fc functional characterisation 
7.5 Discussion 
In this chapter, the interaction between chicken serum IgY and Fc 
receptor(s) on a chicken monocyte cell line was investigated, with some 
preliminary characterisation of the influence of various structural features made 
using the recombinant IgY-Fc mutants designed and produced in the preceding 
chapters. 
Specificity of the interaction was demonstrated by a lack of cross- 
reactivity between human and chicken antibodies and Fc receptors. This 
phenomenon has been previously noted at an effector response level and is 
one of the advantages of IgY technology in various immunological applications 
(Carlander et al., 1999). Consistent with the assertion that the specificity is due 
to primary structure diversity between IgY and its mammalian homologues, 
rabbit polyclonal anti-human IgE was found to be unreactive with IgY adsorbed 
onto nitrocellulose (not shown). 
The effect of IgY glycosylation on Fc receptor binding potential was 
extensively studied using mutagenesis of N-linked glycosylation sites in the Fc 
region or by enzymatic deglycosylation. At least one Fc glycosylation site is well 
conserved between IgY, IgG and IgE. As discussed in chapter 5 (sections 5.4.3 
and 5.4.5.2), glycosylation appears to influence IgG and IgE structure in 
different ways, which has important functional consequences. Although 
glycosylation at asparagine 394 in CE3 appears to be a requirement for 
production of a functional IgE-Fc in mammalian cells (Nettleton and Kochan, 
1995), material (a) refolded from E. coli, which does not add glycosylation, and 
(b) expressed as a glycoprotein in mammalian cells and then enzymatically 
deglycosylated, both retain high affinity binding (Basu et al., 1993; Geha et al., 
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1985; Helm et al., 1988; Hunt et al., 2005). The Fc receptor binding potential of 
IgG and its Fc fragment, however, is effectively abrogated by deglycosylation 
with PNGase (Radaev and Sun, 2001), as shown as a control in figure 7.3.1 i. 
Similarly, Fc receptor recognition is completely lacking in aglycosylated forms 
produced in E. coli (Nose et al., 1990) or in mammalian cells by mutagenesis of 
the homologous Cy2 glycosylation site, asparagine 297 (Lund et al., 2000; Tao 
and Morrison, 1989), or by inhibition of cellular glycosylation machinery using 
tunicamycin (Lund et al., 1990; Walker et al., 1989). 
The influence of glycosylation on Fc receptor recognition in IgY therefore 
appears to be more like that of IgE than IgG. The pattern of glycosylation in IgY- 
Fc is most similar to that of IgE-Fc in terms of location and type of attached 
carbohydrate (Suzuki and Lee, 2004), so it might be expected that their sugars 
play similar roles. It is therefore somewhat surprising that aglycosylated IgY-Fc 
can be expressed by mammalian cells with the capacity to bind to monocyte Fc 
receptor, whereas IgE-Fc cannot - in order to retain receptor binding potential 
IgE-Fc fragments must be expressed with core glycosylation (Nettleton and 
Kochan, 1995) or subjected to refolding procedures (Geha et al., 1985; Kenten 
et al., 1984). 
The effect of deglycosylation on receptor binding in IgG is the result of 
conformational changes which alter the orientation of the Cy2 domains, making 
the horseshoe-like structure of the Fc more compact and the binding site 
sterically difficult to access (Krapp et al., 2003; Mimura et al., 2001). The 
structure of the Fc region in IgE, with its shorter high-mannose core 
oligosaccharide is already more 'closed' by comparison (Wan et al., 2002; 
Wurzburg et al., 2000), so its removal may have relatively minor conformational 
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consequences (Figure 7.5). Non-core glycosylation was found to have little 
effect on IgY-Fc receptor binding, whereas aglycosylated IgY-Fc had diminished 
binding affinity compared to native, by the same order of magnitude as 
deglycosylation of IgE-Fc. The similarity in the functional consequences when 
core oligosaccharides are removed from IgE-Fc and IgY-Fc suggests that the 
Fc region in IgY has a compact quaternary structure closer to that of IgE than 
IgG. 
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Structural changes in IgG-Fc and IgE-Fc induced by deglycosylation 
Schematic showing alterations in quaternary structure of IgG-Fc (A) and lgE-Fc 
Cc3-4 (B) upon removal of core oligosaccharide. Crystal structures of IgG-Fc 
glycoforms with successively truncated oligosaccharide chains showed a 
gradual `closure' of the C72 domains (Krapp et al., 2003). Removal of core 
oligosaccharide results in severely reduced receptor binding site accessibility 
(the region containing the binding site is shown in red). Compared to IgG-Fc, 
lgE-Fc has a shorter core oligosaccharide and adopts a more compact structure 
(Wurzburg et al., 2000). As lgE-Fc is therefore already 'closed', deglycosylation 
causes a smaller conformational shift and receptor binding is only marginally 
affected. 
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Some unusual observations were made upon heating of IgY and the IgY- 
Fc glycosylation site mutants at temperatures around the point of thermally- 
induced aggregation (determined in chapter 5). Surprisingly, IgY-Fc (Cu2-4) 
lacking glycosylation of asparagine 308 was still able to bind to MQ-NCSU 
monocytes following heating at 77.5°C, whereas both IgY-Fc Cu2-4 [wt] and 
[N308Q N407Q] lost binding at lower temperatures. 
These results seem inconsistent with the relationship between 
glycosylation state and melting temperature observed using DLS in chapter 5. 
However, DLS is unable to provide any indication of minor structural changes 
that do not result in aggregation events, therefore alterations could occur that 
precede complete unfolding. If structural rearrangements occur in the vicinity of 
the Cu2 glycosylation site, this could explain the observed functional 
consequences. Depending on where the receptor binding site lies in IgY-Fc, it 
might be possible that N308-attached complex carbohydrate adopts a 
conformation after heating that sterically hinders receptor binding. This 
phenomenon could, however, be an artefact limited to the Fc fragment, as 
whole IgY did not behave in the same manner as Cu2-4 [wt]. 
The presence of Cu2 domains in IgY-Fc was unnecessary for the 
expression of a functional Cu3-4 fragment and the cell binding kinetics were 
comparable, with only minor differences in the rates of association and 
dissociation. This shows that the major functional consequences observed 
when the homologous Cc2 domains are absent from lgE-Fc fragments were not 
found in IgY-Fc. However, a precise comparison of the influence of Cu2 and 
CE2 is difficult as IgY has a lower affinity than human IgE. The CE2 domains are 
thought to contribute to the slow dissociation of IgE from its high affinity 
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receptor, FceRI (McDonnell et al., 2001). A conformational change in IgE upon 
receptor engagement has been postulated, in which the CE2 domains, which 
are bent back to lie almost parallel with one of the Ce3 domains in the 
uncomplexed Fc (Wan et aL, 2002), swing out in order to form additional 
contacts with the receptor. In addition to suggestive crystallographic data, one 
of the strongest pieces of evidence for the involvement of Cc2 in the kinetics of 
IgE binding is the finding that Cs3-4 fragments dissociate ten times faster from 
FccRIa than CE2-4 fragments (Cook et al., 1997; McDonnell et al., 2001), 
although not all reports show such a dramatic difference (Henry et al., 1997). It 
cannot be concluded that a conformational change in IgY-Fc does not occur 
upon receptor binding, although it would appear that Cu2 is not as crucial a 
determinant of binding kinetics for IgY-Fc as is the homologous Ce2 for lgE-Fc. 
The Cu2 domains may instead play a more important role in determining 
correct folding (see chapter 5) and orientation of the putative binding domains, 
Cu3. A four-fold increase in the off-rate of a Cu3-4 fragment was observed 
when an interchain disulfide bond was introduced between cysteines at position 
340, compared to an identical fragment with the cysteines at 347 instead. If the 
interchain disulfides in Cu2 are crossed as they are in CE2 (Wan et al., 2002), 
then the C340 disulfide included in the engineered Cu3-4 fragment would be 
artefactual, whereas the C347 disulfide (which does not have a homologue in 
IgE) would not. The observed effects of the C340 disulfide bridge could 
therefore be due to artefact-associated problems such as misfolding of Cu3 in 
the region of the binding site or deleterious alteration of Cu3 orientation, both of 
which are prevented by the presence of Cu2. 
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A Cu3-4 fragment lacking any covalent interchain bonds, [C340S 
C347S], was found to have slightly faster on- and off-rates compared to Cu3-4 
[C340S]. An E. coli produced lgE-Fc CE3-4 fragment lacking an interchain 
disulfide (CE3-4 AC) also has faster on- and off-rates compared to a 
deglycosylated disulfide-linked CE3-4 produced in NS-0 cells, although 
considerably more so (Hunt et al., 2005). Interestingly, the reported affinity of 
CE3-4 AC for FccRIa (4.14 x 107 M") is similar to the affinity of Cu3-4 [C340S 
C347S] for chicken monocytes (5.6 x 107 M"1), although the assays used were 
different. For CE3-4 AC, this was postulated to represent the affinity of a single 
binding site. If this is also the case for Cu3-4 [C340S C347S], then the affinity of 
the individual binding sites may be remarkably similar in IgY-Fc and IgE-Fc. 
The difference between the magnitude of the effect of disulfide removal 
in IgY-Fc and IgE-Fc may be due to structural differences. Gel filtration of CE3-4 
and CE3-4 AC showed that the non-disulfide linked fragment eluted more 
slowly, despite identical migration on an SDS-PAGE gel, indicative of a more 
compact native structure (J. Hunt, 2004, PhD thesis). A mechanism in which 
disulfide linkage prevents the Cc3 domains 'rolling' past one another to adopt a 
more compact structure was envisioned. By contrast, the Cu3-4 mutants were 
found to have almost identical gel filtration profiles (see chapter 5), which 
suggests that gross conformational differences do not occur in lgY-Fc when 
interchain disulfide bridges are removed. The influence of inter-heavy chain 
disulfide on IgY binding may be more similar to their influence in IgG; reduction 
of human IgGI only lowers its capacity to activate U937 monocytes by -20% 
(Lund et al., 2000). As the inter-heavy chain disulfides in IgG occur in the 
disordered hinge region and Fc dimerisation occurs independently of them 
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(through non-covalent interactions between Cy3 domains), it is perhaps not 
unexpected that the Cy2 domains are largely unaffected by their absence. 
Although IgY does not contain a hinge region, the mode of binding could 
therefore be similar to that of IgG. 
The next steps in these cell binding studies will be (a) to perform more 
replicates in order to increase the statistical significance of the observed 
differences, (b) to use a variety of methods to assess the binding parameters 
(for example, competition assays could be used to determine affinity constants 
in order to verify the values calculated from on- and off-rates) and (c) to take 
further measures to reduce errors; the two major limitations of the reported cell 
binding data are (i) the proportion of radioligand that has been inactivated by 
1251 incorporation ('bindability') and (ii) the proportion of binding that is due to 
non-specific interactions - i. e. binding of radioligand to cells other than through 
their Fc receptors. 
The majority of studies of this kind do not make adequate provision for 
the bindability of labelled proteins (Kermode, 1988). The labelling process can 
reduce the number of receptor-reactive species, so that the ligand concentration 
is over-estimated. Whilst this ought to have no effect on dissociation 
experiments, which are concentration independent, an accurate measure of the 
free ligand is crucial for determination of the rate of association. As receptor- 
reactivity ('bindability') was not determined, the dissociation data should 
therefore be considered the more reliable. Quality of radioligand is thought to be 
dependent upon the batch of 1251 used for labelling (Melson et al., 1987). As all 
125I-labelled proteins used in this investigation were prepared at the same time, 
using the same batch of 1251 and used within a week, source decay and 
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bindability should be similar. Bindability can be determined by incubation of a 
fixed concentration of radioligand with increasing concentrations of receptor (i. e. 
receptor-bearing cells) to near excess. The percentage of reactive species is 
defined as the reciprocal of the extrapolated infinite receptor concentration 
(Kermode, 1988). Alternatively, if another system for ligand detection is 
available, equivalence between native and radiolabelled material can be 
measured, assuming native ligand has 100% bindability. 
Non-specific binding was compensated for by subtraction of the quantity 
of radioligand bound to cells pre-blocked with unlabelled ligand following 
incubation over the timescale of each experiment. However, this method does 
not account for non-specific binding sites which have been blocked by 
unlabelled ligand, and it assumes that the proportion of non-specific to specific 
binding is constant, which is not necessarily the case. A reduction in error could 
be achieved using an improved method of compensation, although as non- 
specific binding was determined to be at most 10-15% of the total, the results 
presented would not be significantly different. 
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Chapter 8 
Final discussion 
8.1 Summary of reported findings 
The overall aim of the work presented in this thesis was to perform some 
preliminary investigations into the structure and function of avian IgY, due to its 
phylogenetic relationship to both mammalian IgG and IgE. The preparation of 
homogeneous IgY-Fc fragments was highlighted as a crucial first step towards 
characterisation of the invariant portion of the antibody. IgY purified from 
chicken egg yolk was used to test the efficacy of papain digestion, which has 
historically been used to produce IgG-Fc for many structural and functional 
studies, including X-ray crystallographic determination of the Fc structure to 
high resolution (Deisenhofer, 1981). The Fc fragments yielded using this 
method comprised Cu3-4, but were found to lack the Cu2 domains. Crystals 
grown from papain-derived IgY-Fc were found to diffract X-rays, but to a 
resolution unsuitable for structural analysis. This was ascribed to protein 
heterogeneity resulting from an ill-defined proteolytic cleavage site. 
To solve this problem, a recombinant 'full-length' IgY-Fc was engineered 
consisting of all three domains of the upsilon heavy chain that make up the Fc 
region, Cu2-4. This approach had the added advantage that mutations could be 
made in order to increase homogeneity (with respect to glycosylation) and to 
study various structural elements within the Fc region. A mammalian 
expression system was developed so that large quantities of high-quality lgY-Fc 
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could be secreted into culture supernatants, from which purification was 
possible using affinity chromatography. Hits were obtained in crystallisation 
screens of full length IgY-Fc and efforts to optimise their growth and 
cryopreservation for use in X-ray diffraction studies are now underway. 
The presence of IgY-Fc receptors analogous to Fc receptors for IgG and 
IgE were demonstrated on two important types of chicken leukocyte. Although 
these receptors could not be isolated as protein during the time of this 
investigation, two novel sequences homologous to Fc receptor subunits in 
mammals were cloned from chicken monocytes. Efforts were made to stably 
express the sequences in order to assay lgY-Fc binding, which will be 
completed in future experiments. 
The combination of a receptor-expressing cell line and the production of 
mutant IgY-Fc fragments allowed several structural and functional observations 
to be made, in addition to the important step of confirming the functionality of 
the recombinant proteins. The finding that an lgY-Fc fragment consisting of 
Cu3-4 was able to retain a comparable affinity for chicken monocytes as 
'complete' IgY-Fc (Cu2-4) suggests that Cu2 is not involved IgY-Fc receptor 
binding. However, a lgE-Fc Cs3-4 fragment has also been shown to bind to 
FccRl with a similar affinity to a CE2-4 fragment (Cook et al., 1997), although 
with markedly different kinetics (McDonnell et al., 2001). 
IgY, like IgG and IgE, is a heterotetrameric glycoprotein joined by 
covalent disulfide bonds. The number of heavy chain constant domains, the 
pattern and type of N-linked glycosylation and the location of putative inter- 
heavy chain disulfide bonds has been suggested to be more similar to that of 
IgE than IgG (Parvari et al., 1988; Suzuki and Lee, 2004), which could indicate 
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that their structures are similar. However, the affinity and kinetics of lgY-Fc 
receptor binding, as reported in this thesis, were found to be closer to that of 
IgG, which makes determination of the structure of IgY highly informative. The 
influence of several structural features was examined in comparison with similar 
experiments previously reported for both IgG and IgE. 
IgY-Fc was found to retain the capacity to bind to its monocyte receptor 
despite removal of carbohydrate using a deglycosylating enzyme, or 
mutagenesis of glycosylation sites to produce an aglycosylated form. By 
contrast, similar experiments with mammalian IgG demonstrated that receptor 
binding is completely abrogated (Lund et al., 1990; Radaev and Sun, 2001; Tao 
and Morrison, 1989). Radiolabelled, aglycosylated IgY-Fc was found to bind to 
chicken monocytes with more than ten fold lower affinity than IgY-Fc containing 
two glycosylation sites per chain, primarily due to a significantly faster on-rate. 
Although a lesser effect is seen when IgE-Fc is deglycosylated (Hunt et al., 
2005), the structural contribution of glycosylation appears to be similar in IgY 
and IgE. 
A series of dynamic light scattering (DLS) experiments determined that 
the thermal stability of IgY was more IgG-like; the approximate melting 
temperature of IgY was found to lie between that of human and rabbit IgG, 
whereas IgE has been shown to be significantly more susceptible to heat 
inactivation. This was further confirmed by comparison CE2-4 and Co2-4 
fragments using the same technique. Glycosylation of the lgY-Fc region was 
shown to be important in maintenance of Fc stability and solubility. 
The sequence of the upsilon heavy chain suggests that IgY may possess 
one additional inter-heavy chain disulfide bond than IgE, which was supported 
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by the finding that no free sulfhydryls were detected using an Ellman assay. A 
series of Cu3-4 fragments were used to examine the consequences of removal 
of inter-heavy chain disulfides on receptor recognition. Surprisingly, inclusion of 
C340 and C347 in the same Cu3-4 fragment caused the production of IgY-Fc 
fragments lacking inter-heavy chain disulfide bonds (i. e. an intra-chain bond 
may have formed instead). This was not the case in fragments containing Cu2 
domains or when one or the other of these cysteine residues was mutated to 
serine. A Cv3-4 fragment with a single inter-heavy chain disulfide bond between 
cysteines at position 340 had a significantly faster rate of dissociation from 
chicken monocytes compared to a similar fragment with the disulfide bond 
between cysteines at position 347 instead. Taken together, these results 
suggest that the disulfide bond between C340 forms in an artefactual manner in 
IgY-Fc fragments lacking complete Cu2 domains. In the complete Fc, the 
cysteine at position 340 may form a crossed inter-heavy chain disulfide bond 
with cysteine 252 in the opposite chain, not with C340, which would be 
homologous to C241 and C328 in IgE-Fc, as revealed by the crystal structure of 
a Cc2-4 fragment (Wan et al., 2002). Whilst the artefactual formation of a C340- 
C340 parallel disulfide bond does not entirely abrogate binding to cells, the 
affinity is somewhat lowered. Given that the Fc receptor binding sites in IgG and 
IgE reside in this region (the CH3 N-terminus), this result might imply that the 
receptor binding site maps to a similar region in lgY-Fc. 
A Cu3-4 fragment lacking inter-heavy chain disulfides produced by 
mutation of both cysteine 340 and cysteine 347 to serine was found to have 
comparable affinity to Cu3-4 linked by a single inter-heavy chain bond. 
Experiments reported in the literature with IgE-Fc and IgG-Fc, albeit using 
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different methodology, suggest that disulfide linkage is more important in 
maintenance of receptor binding kinetics in IgE than IgG (Hunt et al., 2005; 
Lund et al., 2000), which would make IgY more like IgG in this regard. 
Furthermore, removal of inter-heavy chain disulfide bonds made little or no 
difference to the gel filtration behaviour of Cu3-4 fragments, whereas a 
significant shift in gel retention time was observed when an lgE-Fc CE3-4 
fragment was compared to a similar fragment lacking inter-heavy chain disulfide 
bonds (J. Hunt, 2004, PhD Thesis), which was interpreted as a change in CE3 
domain orientation and overall Fc shape. For IgY, this suggests that removal of 
inter-heavy chain disulfides has less of an impact upon IgY-Fc structure and/or 
the mode of Fc receptor binding is different to the IgE: FccRI interaction and 
more like that of an IgG: FcyR. 
The function of Cu2 in IgY-Fc was an interesting question to address 
given the importance of the equivalent domain in IgE, Ce2, in determining the 
kinetics of the interaction with FccRI. Although a difference in the cell binding 
kinetics was noted between a Cu2-4 fragment (wt) and a Cu3-4 fragment (the 
C340S mutant, which is probably the best representation of a Cu2-deleted IgY- 
Fc), the change in the rate of dissociation when Cu2 is absent (-2 fold faster) 
was relatively minor compared to the -10 fold or greater increase in dissociation 
rate when the binding of Cc3-4 fragments is compared to that of the complete 
IgE"Fc (Ce2-4) using surface plasmon resonance (Cook et al., 1997; McDonnell 
et al., 2001). Thus Cu2 may not play the same role in IgY as Cc2 does in IgE. 
-251- 
Chapter 8 Final discussion 
8.2 Insights into the evolution of IgG and IgE 
One of the reasons for studying IgY was to help to elucidate further the 
various structural and functional developments specific to IgG and IgE in order 
to gain a better appreciation of how these isotypes evolved such disparate roles 
in mammals. The work presented in this thesis provides crucial materials and a 
useful framework for the design of future experiments to address this aim. 
Several key differences between IgY and IgE revealed by this investigation are 
worthy of further study. 
IgE has been known to be substantially more heat labile than IgG for 
many years, with instability mapping to the Fc region (Dorrington and Bennich, 
1978). Recently, experiments using ANS dye fluorimetry and NMR 
spectroscopy have suggested that this may be the result of the C63 domains 
existing in a partially unfolded 'molten globule' state, with receptor (FcERI) 
engagement required for complete folding (Harwood et al., 2006; Price of al., 
2005). This may allow the IgE-Fc: FccRl interaction to be fine-tuned in order to 
increase specificity and affinity (Harwood and McDonnell, 2007). Although 
identical experiments have yet to be performed using the homologous Cu3 
domains in IgY, the melting temperature of the IgY-Fc region was found to be 
significantly higher than that of the IgE-Fc region, which would suggest that Cu3 
is not as thermally unstable as CE3 and may not be a molten globule. The 
'molten globule' state of Ce3 could therefore represent one of the major 
adaptations of IgE-Fc to a high affinity binding mode. 
A number of results reported in this thesis imply similarities between the 
structure of IgY-Fc and lgE-Fc; work is underway to use the recombinant 
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functional Cu2-4 fragments prepared in this investigation to solve the crystal 
structure of the complete Fc region of IgY. Cell binding experiments reported in 
chapter 7 show that the absence of Cu2 from an IgY-Fc fragment did not have 
the same degree of functional consequence as has been demonstrated when 
Cc2 domains are absent from an IgE-Fc fragment. One of the most striking 
features of IgE compared to IgG is the acute bend and asymmetry of the Fc 
region. A change in this structure upon IgE-Fc binding to receptor is believed to 
play an important role in determining the receptor binding kinetics. A detailed 
analysis of the structural differences between Cu2 and Ce2 in the context of 
complete Fc fragments, in order to discover the precise cause of their functional 
differences, could therefore be highly informative. 
The kinetics of IgY-Fc binding to monocyte Fc receptor was shown to be 
dependent on the number and location of inter-heavy chain disulfide bonds. 
Although the locations of most disulfide bonds in IgY-Fc are conserved in IgE- 
Fc, there are differences; a third inter-heavy chain bond is present in IgY-Fc in a 
location equivalent to the binding site for FccRl in lgE-Fc. Subtle alterations in 
the pattern of disulfide bonds during the divergence of IgG and IgE may have 
had important consequences for their Fc receptor interactions. 
Similarly, the pattern of glycosylation was found to play an important role 
in the maintenance of both IgY-Fc structure and function, just as in both IgE-Fc 
and IgG-Fc. In IgG-Fc, however, a modification of the type of core 
oligosaccharide has been made, i. e. complex-type rather than high mannose, 
with significant consequences for the quaternary structure of the Ig domains. 
The composition of attached carbohydrates has recently been proposed as 
another level of control over the nature of effector responses induced by 
- 253 - 
Chapter 8 Final discussion 
antibody-dependent mechanisms (Davies et al., 2001; Matsumiya et al., 2007; 
Shields et al., 2002; Shinkawa et al., 2003; Umana et al., 1999). 
8.3 Addendum: new developments 
Two new developments have occurred too close to the date of 
submission of this thesis to have been included elsewhere. Firstly, as a 
continuation of the results reported in chapter 6, a cell line stably expressing 
both human FccRIa and the chicken homologue of FcRy has been created. The 
residues in human FcRy that interact with human FccRIa to allow subunit 
association, which is required for FccRIa surface expression (Wines et al., 
2006), are conserved in the chicken homologue of FcRy. FccRIa was detected 
both internally and externally, which suggests that chimeric chicken/human 
receptor complexes have been formed (Figure 8.3). These cells will be used to 
confirm the signalling potential of the putative chicken FcR7 orthologue. 
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Figure 8.3 
Chicken FcRy can substitute for human FcRy in a chimeric Fci. RI complex 
FACS profiles showing HEK 293 cells gated to exclude dead cells (A & D) 
following incubation with 1µg/ml mouse monoclonal anti-Fcf: Rla (15.1) 
antibodies followed by 10µg/ml anti-mouse-FITC (filled peaks) or with buffer 
alone followed by 10µg/ml anti-mouse-FITC (unfilled peaks). Cells were fixed, 
washed and incubated in the presence (A, B& C) or absence (D, E& F) of 
0.1% saponin for intracellular or extracellular staining respectively. The staining 
pattern of cells stably transfected with both the vector for the [FLAG]chFcRy 
construct and a pCDNA3-based vector encoding human Fct: Rla (C & F) are 
shown in comparison with cells transfected with the vector for the 
[FLAG]chFcRy construct alone (B & E). 
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The second development is that Viertlboeck et al. have reported the 
identification of a functional IgY-binding Fc receptor in chicken, CHIR-ABI 
(Viertlboeck et aL, 2007). Although the transcript was detectable in chicken 
monocytes and bound IgY-Fc with a similar affinity to that reported in chapter 7, 
CHIR-AB1 has yet to be confirmed to be the only Fc receptor expressed in this 
cell type. It is difficult to establish from the cell binding data described in chapter 
7 whether more than one receptor type is involved, as it appears likely that the 
receptors may not differ significantly in their affinity for IgY-Fc. Interestingly, 
CHIR-AB1 is a member of the chicken leukocyte receptor complex (LRC), a 
family of more than 60 paired Ig-like receptors related to, but distinct from, the 
FcR family. In mammals, the LRC homologues perform a variety of 
immunoregulatory functions and include the Fc receptor for IgA, FcaR / CD89 
(Offen and van Egmond, 2004; Woof and Kerr, 2006). Together with published 
data reported in this thesis (Taylor et al., 2007), this could suggest that birds 
and mammals exhibit a major difference in which families of Ig-like receptors 
have been expanded and provide convergent antibody Fc recognition. The 
separation and specialisation of function in mammalian antibody isotypes may 
therefore have evolved not only through structural alterations in the antibodies 
themselves, but also through changes in their receptors. 
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Upsilon heavy chain amino acid sequence numbering system 
A complete upsilon heavy chain sequence was assembled (including the signal 
peptide) using published cDNA sequences; accession numbers M30350 
(Reynaud et al., 1989) and X07174 (Parvari et al., 1988). Amino acid numbering 
used in this thesis begins with the first methionine in the translated sequence. 
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Figure A1.2 
Dissociation of IgY from chicken monocytes monitored using flow 
cytometry 
Graph showing mean fluorescence intensity of MQ-NCSU cells saturated with 
50nM biotinylated chicken serum IgY then incubated with an excess of 
unlabelled IgY for the times shown before being stained with streptavidin-RPE 
for 20 minutes. All steps were carried out at 4°C. The data were fitted to a 
modified exponential decay model (see chapter 2) using SigmaPlot 6.0 (SPSS). 
-280- 






























k., = (3.60 t 0.40) x 10 
3 
R' = 0.990 




Kinetics of IgY-Fc Cu2-4 [N308Q] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+1) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cv2-4 [N308Q] binding to MQ-NCSU cells. Assays were performed in 
duplicate and data is shown as mean i s. e. m. 
In (A) cells were incubated in 1OnM 1251-labelled ligand. In (B) cells were first 
saturated with 1251-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Figure AI A 
Kinetics of IgY-Fc Cu2-4 IN308Q N407Q] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+1) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cu2-4 [N308Q N407Q] binding to MQ-NCSU cells. Assays were performed 
in duplicate and data is shown as mean ± s. e. m. 
In (A) cells were incubated in 1OnM 125I-labelled ligand. In (B) cells were first 
saturated with 125I-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Kinetics of IgY-Fc Cu3-4 [wt] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+, ) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cu3-4 [wt] binding to MQ-NCSU cells. Assays were performed in duplicate 
and data is shown as mean ± s. e. m. 
In (A) cells were incubated in 1OnM 125I-labelled ligand. In (B) cells were first 
saturated with 125I-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Kinetics of IgY-Fc Cu3-4 [C340S] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+1) and (B) dissociation rate constant (k1) for recombinant IgY- 
Fc Cu3-4 [C340S] binding to MQ-NCSU cells. Assays were performed in 
duplicate and data is shown as mean ± s. e. m. 
In (A) cells were incubated in 1OnM 1251-labelled ligand. In (B) cells were first 
saturated with 125I-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Figure A1.7 
Kinetics of IgY-Fc Cu3-4 [C347S] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+, ) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cu3-4 [C347S] binding to MQ-NCSU cells. Assays were performed in 
duplicate and data is shown as mean ± s. e. m, except for (A) for which a single 
experiment was performed. 
In (A) cells were incubated in 1OnM 1251-labelled ligand. In (B) cells were first 
saturated with 125I-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Kinetics of IgY-Fc Cu3-4 [C340S C347S] binding to chicken monocytes 
Cell binding assays showing experiments used to determine (A) association 
rate constant (k+, ) and (B) dissociation rate constant (k. 1) for recombinant IgY- 
Fc Cu3-4 [C340S C347S] binding to MQ-NCSU cells. Assays were performed in 
duplicate and data is shown as meant s. e. m. 
In (A) cells were incubated in 1OnM 1251-labelled ligand. In (B) cells were first 
saturated with 125I-labelled ligand then washed and incubated with excess 
unlabelled ligand. In both experiments, 106 cells were removed at the times 
shown, spun through phthalate oil and their radioactivity measured using an 
automatic gamma counter. Regression analysis was used to fit the data to non- 
linear models (see chapter 2). The R2 value provides a measure of how well the 
models fit the data, with 1 being a perfect fit. 
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Species or Author Fragment modifications Expression Type k+, k+ K+ (Year) T system 
Fce3-4 mammalian BlAcore 3.08E+05 6.26E- 04 4.92E+08 
Hunt 
(2005) RT 







interchain S- E. coli BlAcore 2.76E+06 
E_ 6' 4 14E+07 Hunt RT 2: 1 stoic 
S 02 . (0 05) 
IgE human BlAcore 2.40E+05 1'04E- 1.33E+09 McDonnell (2001) RT 
Fce2-4 mammalian BlAcore 3.00E+05 1.90E- 1.58E+09 McDonnell RT 04 (2001) 
Fce3-4 mammalian BlAcore 9.20E+05 - 303.40E 2'71E+08 McDonnell (2001) RT 
IgE human BlAcore 4.60E+03 1.90E- 04 2.42E+07 
McDonnell 
(2001) RT CD23 
Fce2-4 mammalian BlAcore 4.80E+03 2.30E- 2 09E+06 McDonnell RT CD23 03 . (2001) 
Fce3-4 mammalian BlAcore 1.20E+04 3.20E- 3.75E+06 McDonnell RT CD23 03 (2001) 
Fce2-4 mammalian BlAcore 2.50E+05 6.50E- 40E+09 5 Henry RT transiently 05 . (1997) expressed 
IgE human BlAcore 8.60E+04 3.60E ' 04 2.40E+08 (1997 RT 
Fce2-4 mammalian BlAcore 2.50E+05 
2.00E- 1.20E+09 Henry RT 04 1 













3.20E+07 Henry (1997) RT? CD23 
line) 
cell 
IgE human binding 3.10E+05 9.00E- 3 40E+10 Young 37? (stable cell 06 . (1995) 
line) 
cell 
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4.10E+06 Young (1995) 37? CD23 




3.20E+07 Young (1995) 37? CD23 




Fce2-4 E. coll cell 
binding 
(basophils) 3.75E+05 6.58E-05 5.68E+09 
Ishizaka 
(1986) 37 
IgE rat cell 
binding 
(RBL) 8.80E+04 1.40E-05 6.00E+09 
Kulczycki 
(1974) 37 
IgE rat cell 
binding 
(RBL) 5.70E+04 4.70E-06 1.20E+10 
Kulczycki 
(1974) 24 
IgE rat cell 
binding 
(RBL) 2.10E+04 - 
Kulczyckl 
(1974) 4 
IgE human cell binding (mast cells) 
1.90E+05 6.90E-05 2.75E+09 Ogawa (1983) 37 
IgE human BlAcore 8.60E+04 3.30E-05 2.70E+09 Cook (1997) RT 
Fce2-4 mammalian BlAcore 2.50E+05 7.50E-05 3.30E+09 Cook (1997) RT 
Fce3-4 mammalian BlAcore 9.60E+05 6.30E-04 1.50E+09 Cook (1997) RT 
IgG human cell binding (U937) 2.10E+05 1.10E-04 1.90E+09 
Shopes 
(1990) RT 
IgG human cell binding (U937) 2.70E+05 4.50E-04 6.00E+08 
Shopes 
(1995) 37 
IgG human cell binding (U937) 9.70E+04 9.00E-06 1.10E+10 
Shopes 
(1995) 4 
IgG human cell binding (U937) 1.88E+05 5.50E-05 9.80E+08 
Raychaudhurl 
(1985) RT 
lgG-Fc human cell binding (U937) 6.08E+05 9.50E-05 3.10E+09 
Raychaudhurl 
(1985) RT 
lgG2a mouse cell 
binding 1.40E-03 Unkeless 4 (P388D) (1975) 
IgG2a mouse cell 
binding 
_101 50E-03 3 
Unkeless RT (P388D) . (1975) 
lgG2a mouse cell 
binding 4 30E-03 Unkeless 37 (P388D) . (1975) 
hu/mo 
IgG1 chimeric BlAcore 1.70E+06 1.80E-04 9.44E+09 Paetz (2005) RT 
(hu Fc) 
IgG1 human BlAcore 1.50E+06 3.80E-04 3.95E+09 Paetz (2005) RT 
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Table A1.9 (previous two pages) 
Reported binding Fc receptor binding kinetics of IgE, IgG and various Fc 
fragments 
Data reported in the literature from SPR (BlAcore) or cell binding assays of high 
affinity receptor interactions (FcyRl or FceRI), unless specified otherwise. T= 
temperature of experiment, RT = room temp. 
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SeqA Name Len(aa) SeqB Name Len(aa) %ID 
1 CU1 105 2 CU2 94 06 
1 CU1 105 3 CU3 109 07 
1 CU1 105 4 CU4 118 12 
1 CU1 105 5 CE1 103 18 
1 CU1 105 6 CE2 105 08 
1 CU1 105 7 CE3 110 12 
1 CU1 105 8 CE4 111 06 
1 CU1 105 9 G1-CG1 98 18 
1 CU1 105 10 G1-CG2 104 05 
1 CU1 105 11 G1-CG3 111 02 
1 CU1 105 12 G2-CG1 98 13 
1 CU1 105 13 G2-CG2 102 13 
1 CU1 105 14 G2-CG3 112 02 
1 CU1 105 15 G3-CG1 99 13 
1 CU1 105 16 G3-CG2 104 06 
1 CU1 105 17 G3-CG3 111 03 
1 CU1 105 18 G4-CG1 98 13 
1 CU1 105 19 G4-CG2 104 06 
1 CU1 105 20 G4-CG3 111 02 
2 CU2 94 3 CU3 109 27 
2 CU2 94 4 CU4 118 25 
2 CU2 94 5 CE1 103 24 
2 CU2 94 6 CE2 105 21 
2 CU2 94 7 CE3 110 24 
2 CU2 94 8 CE4 111 22 
2 CU2 94 9 G1-CG1 98 26 
2 CU2 94 10 G1-CG2 104 22 
2 CU2 94 11 G1-CG3 111 27 
2 CU2 94 12 G2-CG1 98 25 
2 CU2 94 13 G2-CG2 102 20 
2 CU2 94 14 G2-CG3 112 27 
2 CU2 94 15 G3-CG1 99 25 
2 CU2 94 16 G3-CG2 104 21 
2 CU2 94 17 G3-CG3 111 27 
2 CU2 94 18 G4-CG1 98 26 
2 CU2 94 19 G4-CG2 104 26 
2 CU2 94 20 G4-CG3 111 29 
3 CU3 109 4 CU4 118 23 
3 CU3 109 5 CE1 103 10 
3 CU3 109 6 CE2 105 10 
3 CU3 109 7 CE3 110 31 
3 CU3 109 8 CE4 111 18 
3 CU3 109 9 G1-CG1 98 22 
3 CU3 109 10 G1-CG2 104 25 
3 CU3 109 11 G1-CG3 111 22 
3 CU3 109 12 G2-CG1 98 22 
3 CU3 109 13 G2-CG2 102 26 
3 CU3 109 14 G2-CG3 112 21 
3 CU3 109 15 G3-CG1 99 23 
3 CU3 109 16 G3-CG2 104 25 
3 CU3 109 17 G3-CG3 111 21 
3 CU3 109 18 G4-CG1 98 23 
3 CU3 109 19 G4-CG2 104 25 
3 CU3 109 20 G4-CG3 111 22 
4 CU4 118 5 CE1 103 10 
4 CU4 118 6 CE2 105 16 
4 CU4 118 7 CE3 110 18 
4 CU4 118 8 CE4 111 31 
4 CU4 118 9 G1-CG1 98 17 
4 CU4 118 10 G1-CG2 104 17 
4 CU4 118 11 G1-CG3 111 32 
4 CU4 118 12 G2-CG1 98 18 
4 CU4 118 13 G2-CG2 102 21 
4 CU4 118 14 G2-CG3 112 34 
4 CU4 118 15 G3-CG1 99 18 
4 CU4 118 16 G3-CG2 104 18 
4 CU4 118 17 G3-CG3 111 36 
4 CU4 118 18 G4-CG1 98 19 
4 CU4 118 19 G4-CG2 104 16 
4 CU4 118 20 G4-CG3 111 31 
5 CE1 103 6 CE2 105 19 
5 CE1 103 7 CE3 110 15 
5 CE1 103 8 CE4 111 19 
5 CE1 103 9 G1-CG1 98 34 
5 CE1 103 10 G1-CG2 104 14 
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SeqA Name Len(aa) SeqB Name Len(aa) %ID 
5 CE1 103 11 G1-CG3 111 22 
5 CE1 103 12 G2-CG1 98 35 
5 CE1 103 13 G2-CG2 102 13 
5 CE1 103 14 G2-CG3 112 22 
5 CE1 103 15 G3-CG1 99 36 
5 CE1 103 16 G3-CG2 104 13 
5 CE1 103 17 G3-CG3 111 22 
5 CE1 103 18 G4-CG1 98 34 
5 CE1 103 19 G4-CG2 104 14 
5 CE1 103 20 G4-CG3 111 21 
6 CE2 105 7 CE3 110 17 
6 CE2 105 8 CE4 111 12 
6 CE2 105 9 G1-CG1 98 15 
6 CE2 105 10 G1-CG2 104 12 
6 CE2 105 11 G1-CG3 111 16 
6 CE2 105 12 G2-CG1 98 15 
6 CE2 105 13 G2-CG2 102 13 
6 CE2 105 14 G2-CG3 112 16 
6 CE2 105 15 G3-CG1 99 16 
6 CE2 105 16 G3-CG2 104 12 
6 CE2 105 17 G3-CG3 111 16 
6 CE2 105 18 G4-CG1 98 16 
6 CE2 105 19 G4-CG2 104 13 
6 CE2 105 20 G4-CG3 111 16 
7 CE3 110 8 CE4 111 20 
7 CE3 110 9 G1-CG1 98 16 
7 CE3 110 10 G1-CG2 104 32 
7 CE3 110 11 G1-CG3 111 19 
7 CE3 110 12 G2-CG1 98 16 
7 CE3 110 13 G2-CG2 102 33 
7 CE3 110 14 G2-CG3 112 18 
7 CE3 110 15 G3-CG1 99 16 
7 CE3 110 16 G3-CG2 104 32 
7 CE3 110 17 G3-CG3 111 18 
7 CE3 110 18 G4-CG1 98 16 
7 CE3 110 19 G4-CG2 104 32 
7 CE3 110 20 G4-CG3 111 19 
8 CE4 111 9 G1-CG1 98 19 
8 CE4 111 10 G1-CG2 104 13 
8 CE4 111 11 G1-CG3 111 31 
8 CE4 111 12 G2-CG1 98 18 
8 CE4 111 13 G2-CG2 102 21 
8 CE4 111 14 G2-CG3 112 31 
8 CE4 111 15 G3-CG1 99 18 
8 CE4 111 16 G3-CG2 104 15 
8 CE4 111 17 G3-CG3 111 30 
8 CE4 111 18 G4-CG1 98 18 
8 CE4 111 19 G4-CG2 104 14 
8 CE4 111 20 G4-CG3 111 27 
9 G1-CG1 98 10 G1-CG2 104 25 
9 G1-CG1 98 11 G1-CG3 111 30 
9 G1-CG1 98 12 G2-CG1 98 90 
9 G1-CG1 98 13 G2-CG2 102 24 
9 G1-CG1 98 14 G2-CG3 112 29 
9 G1-CG1 98 15 G3-CG1 99 95 
9 G1-CG1 98 16 G3-CG2 104 23 
9 G1-CG1 98 17 G3-CG3 111 29 
9 G1-CG1 98 18 G4-CG1 98 91 
9 G1-CG1 98 19 G4-CG2 104 25 
9 G1-CG1 98 20 G4-CG3 111 30 
10 G1-CG2 104 11 G1-CG3 111 20 
10 G1-CG2 104 12 G2-CG1 98 25 
10 G1-CG2 104 13 G2-CG2 102 92 
10 G1-CG2 104 14 G2-CG3 112 20 
10 G1-CG2 104 15 G3-CG1 99 25 
10 G1-CG2 104 16 G3-CG2 104 97 
10 G1-CG2 104 17 G3-CG3 111 19 
10 G1-CG2 104 18 G4-CG1 98 26 
10 G1-CG2 104 19 G4-CG2 104 93 
10 G1-CG2 104 20 G4-CG3 111 20 
11 G1-CG3 111 12 G2-CG1 98 28 
11 G1-CG3 111 13 G2-CG2 102 20 
11 G1-CG3 111 14 G2-CG3 112 96 
11 G1-CG3 111 15 G3-CG1 99 28 
11 G1-CG3 111 16 G3-CG2 104 21 
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SeqA Name Len(aa) SegB Name Len(aa) %ID 
11 G1-CG3 111 17 G3-CG3 111 91 
11 G1-CG3 111 18 G4-CG1 98 28 
11 G1-CG3 111 19 G4-CG2 104 22 
11 G1-CG3 111 20 G4-CG3 111 94 
12 G2-CG1 98 13 G2-CG2 102 24 
12 G2-CG1 98 14 G2-CG3 112 27 
12 G2-CG1 98 15 G3-CG1 99 93 
12 G2-CG1 98 16 G3-CG2 104 23 
12 G2-CG1 98 17 G3-CG3 111 27 
12 G2-CG1 98 18 G4-CG1 98 95 
12 G2-CG1 98 19 G4-CG2 104 25 
12 G2-CG1 98 20 G4-CG3 111 28 
13 G2-CG2 102 14 G2-CG3 112 20 
13 G2-CG2 102 15 G3-CG1 99 24 
13 G2-CG2 102 16 G3-CG2 104 93 
13 G2-CG2 102 17 G3-CG3 111 19 
13 G2-CG2 102 18 G4-CG1 98 25 
13 G2-CG2 102 19 G4-CG2 104 92 
13 G2-CG2 102 20 G4-CG3 111 20 
14 G2-CG3 112 15 G3-CG1 99 27 
14 G2-CG3 112 16 G3-CG2 104 21 
14 G2-CG3 112 17 G3-CG3 111 95 
14 G2-CG3 112 18 G4-CG1 98 27 
14 G2-CG3 112 19 G4-CG2 104 23 
14 G2-CG3 112 20 G4-CG3 111 94 
15 G3-CG1 99 16 G3-CG2 104 23 
15 G3-CG1 99 17 G3-CG3 111 27 
15 G3-CG1 99 18 G4-CG1 98 95 
15 G3-CG1 99 19 G4-CG2 104 25 
15 G3-CG1 99 20 G4-CG3 111 28 
16 G3-CG2 104 17 G3-CG3 111 20 
16 G3-CG2 104 18 G4-CG1 98 24 
16 G3-CG2 104 19 G4-CG2 104 92 
16 G3-CG2 104 20 G4-CG3 111 21 
17 G3-CG3 111 18 G4-CG1 98 27 
17 G3-CG3 111 19 G4-CG2 104 22 
17 G3-CG3 111 20 G4-CG3 111 90 
18 G4-CG1 98 19 G4-CG2 104 26 
18 G4-CG1 98 20 G4-CG3 111 28 
19 G4-CG2 104 20 G4-CG3 111 23 
Table A1.10 (above and previous two pages) 
Homology between Ig domains in chicken IgY, human IgE and human 
IgG1-4 
Amino acid sequence identity when individually aligned constant heavy chain Ig 
domains were from u (CUI-4), E (CE1-4) and yi (G1.4-CG1-3). Sequences 
were aligned using ClustalW (Thompson et al., 1994). 
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Taylor, A. I., Gould, H. J., Sutton, B. J., Calvert, R. A. (2007). 
The first avian Ig-like Fc receptor family member combines features of 
mammalian FcR and FCRL. 
Immunogenetics 59 (4), 323-8. 
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Abstract Homologues of almost all mammalian Ig-like 
inunumoregulatory receptor families have been found in the 
chicken, except the Fc receptor (FcR) family. In addition to 
classical FcRs that specifically bind antibodies and mediate 
their effector functions, this family includes "Fc receptor- 
like" (FURL) proteins for which ligands have yet to be 
identified. We have cloned and expressed a full-length 
chicken monocyte transcript that encodes an avian homo- 
logue of the mammalian FcR family. We have termed it 
chFcR/L as it possesses characteristics of both mammalian 
FcR and FCRL, but is phylogenetically distinct from either. 
chFcR/L is a transmembrane protein with four extracellular 
Ig-like domains and a short cytoplasmic tail. It can be 
expressed on the cell surface only in the presence of an 
accessory molecule, chFcRy, through which it acquires 
signalling potential. 
Keywords Chicken -Avian " Fc receptor 
Fc receptor homologue " FcR " FCRL 
In the vertebrate adaptive immune system, the location and 
nature of the response to antigenic challenge depends on 
the production of different antibody isotypes and the 
expression of corresponding Fc receptors (FcR) on a variety 
of cell types (Ravetch and Kinet 1991). Most FcRs are 
members of the immunoglobulin (1g) superfamily. The (x 
chains of the FcR for the IgG subclasses, FcyRl (CD64), 
FcyRll (CD32), FcyRlll (C'DI6) and FcyRIV, and the high 
The FMBL accession number of the nucleotide sequence reported 
here is AM41231 I. 
A. I. Taylor "II. J. Gould " B. J. Sutton " R. A. ('a! cn (. :) 
Randall Division for Cell and Molecular Biophysics. 
New Hunt's Ilouse, King's College London. Guy's Campus. 
London SEI IUL. UK 
C-mail: rosy. calvcrt(a kcl. ac. uk 
affinity receptor for IgE, FcERI, are composed of two or 
three closely related extracellular Ig-like domains that 
contain the Fc-binding site, a transmembrane domain and 
a cytoplasmic tail. Except for FcyRll and its isoforms, the 
FcRLx chains invariably lack signalling motifs in their 
cytoplasmic tails and must associate with adaptor molecules 
(typically FcERIy) to transduce signals. 
Data mining of genomes and expressed sequence tag 
(ES]') libraries has shown that all immunoreceptor families, 
of which FcR is one, show considerable diversity. Numer- 
ous genes have been identified in mice and humans that 
have genomic proximity and homology to the classical FcR 
and are collectively described as 'FcR-like' (I: ('RI. ). 
Despite the presence of domains closely related to those 
responsible tier Fc binding in FcyRl, FcyRll, FcyRIll and 
FccRI, the F('RI. appear to lack the ability to bind Fc 
(Davis et al. 2002). As yet, no ligands have been found fier 
any FURL, but their preferential expression on l3 cells 
(Davis et al. 2001, Ifatzivassiliou et , if. 2001, Miller et al. 
2002) and the presence of one or more immunorecehtor 
tyrosine-based activation (I'l'AM) or inhibitory (I'I'IM) 
signalling motifs, which have been shown to he functional 
(Ehrhardt et al. 2003; Leu et al. 2005), is consistent with an 
immunoregulatory role. A link between polymorphisms in 
an l'('RL and autoimmune disease is also suggestive of 
such a function (Ikari et al. 2006, Kochi et al. 2005, 
Umemura et al. 2006). 
FCRL sequences have been identified in bony fish and 
an amphibian, vertebrate classes that are phylogenetically 
distant from mammals (Davis et al. 2005, Stafford et al. 
2006). To date, no direct homologues of this family of 
immune receptors have been found in birds. The chicken 
(Gallus q(if us) is an invaluable model organism for 
comparative studies, as it allows us to study the evolution- 
ary link between mammals and more basal vertebrates. 
Q Springer 
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<Domain 1 
.S., 1 .. _. '1 .. VIF07EVTLRQGFFV 
91 GCAGAGATGGCCCTGCTGACCATGGACCCCCCCTGGAGTCTGATATTCCAGGGGGAAAGCGTCACCCTGCGGTGCCAGGGACCCCCTGTG 
SKQQPTAW_HNG I< LLEHTETNTYRIQNAP. Y 
191 C ACAAGCAGCAGCCCACAGCCTGGTACCACAATGGCAAACTCCTGGAGCACACAGAAACCAACACGTACAGGATCCAGAATGCCA3GTAT 
Domain 2 
., Q NSF YEQ. FGSTSSNSVTLSSSYDLLIL 
271 AAACAGAATGGCAGATATGAGTGCCAGAGCCCCGGCTCCACGTCCAGCAACTCCGTCACCCTGAGCGTCTCCTATGACCTGCTGATSCTC 
QVPSHAVFEGELLQMCCRGWY. VGLAAVRF 
361 CAGGTCCCATCGVAT GCAGTGTTTGAAGGGGAGCTGCTGCAGATGCAGTGCCGGGGATGGAAGGTGGGCAGTTTGGCT, CGGT000GTTC 
YRDGADITKPYTSAMQLSIPQAKAHHRY 
451 TACAGGGATGGAGCCGACATCACCAAACCCTACACCTCACCCATGCAGCTCTCCATCCCCCAAGCCAAGGCCCACCACAGCGGCAGATAT 
HCAMHS.. SLKRR.. _QGLYISIKELFTS 
541 ^_ACTGCAGTGCAGACATGCACTCCTACTTGTCAT"AAAGAGGAGGGAATCTCAGGGTTTATATATTTCCATCAAAGAGCTCTTCACCTCC 
, Domain 3 
PVLSVASSAEPLEGPLNL3CITGLSP1RF 
631 CCAGTGCTG. AGCGTAGCAAGCTCAGCAGAGCCCCTCGAAGGAAGTCCCCTCAACCTGAGCTGCATCACACAGCTCAGCCCCTACAGACCC 
HTVLWYLFYGNSTVLQGPVTE Y[ VPAVP 
721 CACACTGTCCTCTGGTACCTCTTCTATGGAAACAGCACGGTCCTTCAAGGTCCCGTGACCTCCTCTGAGTACCAGGTGCCAGCAGTGAGG 
> <Dorair. 4 
LMDTSFYSCEVRTE5SNVQKWSPP. VPITIK 
611 GTCATG(; ACACi;,;,; C; TTCTAC: TCCTGTGAGGT(; (: GGA(. ý5; AC; AGCTCc[AATGT(: A. AAATGCAGTCCTC;, GT(; : CATCH VATC AAA 
RVPISGMSLEVWPQEGQVMEGHP. LVLHC 3V 
901 CGAGTCCCCATCTCGGGGATGTCCCTGGAGGTTTGGCCCCAGGAGGGACAGGTGATGGAAGGACATCGCCTGGTGCTGCACTGCTCCGTG 
ATGTG 3I SFSWHREGSAEV L RD5RYEIPS 
991 GCCACGGGCACCGGCTCCATCTCCTTCTCCTGGCACCGAGAGGGCTCTGCAGAAGTCLTGGGGAGGGACAGCCGCTACGAGATCCCATCG 
TQQSDNGQYYCMASNGDSPA3LNVQVTVV 
10? 1 ACCCAACAGAGTGACAACGGGCAGTATTACTGCA^. GGCTTCTAATGGGGACAGCCCAGCCCGGAGCCTGAAGGTGCAGGTCACTGTAGTG 
< Tiansm-mbran. Domain 
6VS.. PFCRRVP. ALLLLAALGTLLLEVMVVH 
1171 GGT6Tt: T(: TTCA(: ('t. TT('TG(: AGCC ;T ; TCAGAG(7A(7T(; CTG(: TGCT(; GCAG('G('T;; ;; ; A('('(: TATTGCTGGAG(; TGATGGTTGTCi'A, ' 
VLTAGSRAFFGTCQQTLMEPFAPGGDV 
1261 GTCCTýAC: TGCAGGGAGCAGAGCCCC. AAAAGGAACAAAGCAGC. kACACTCATGGAGCCATTTGCACCAGGAGGGGATGTTTQAGGAGCG 
1351 CCGTAAACCCACTGCCAGCCCTACAAAGGCACCCCGG. AAGTGAGCAkCATGAGCACCCCCACATCCCACCCTCACTCTCACCTGTCCACG 
41: ^", A :A ! AAA ''A: 1T . T: TA,: T':. ... "AT. , 
5JC1 1. I:. A AAA J, AAAAAAA55 AA 
b 
II III IV V VI VII 
5'UT S, S2 EC, EC-, EC., EC, TM /C 3'UT 
CI 
300bp 
Conti 76522 Contig 3134.3 II Contig 11625.1 
Fig. I Sequence characteristics of chicken chFcR'L. a Nucleotide and 
predicted amino acid sequence of chFcR/L. The full length cDNA was 
cloned by SMART RACE PCR (Clontech, UK) using primers based 
on sequences homologous to mammalian FcR and FURL identified in 
the chicken genomc (http: //www. ensemhl. org/(iailus_gallus/index. 
hdnl) and UHSRC chickEST database (http: /lwww. chick. umist. ac. uk/). 
Protein motifs \ýcrc identified using InterProScan (Zdobnm and 
Apweiler 2001). Predicted signal peptide, Ig domains and tr nsmem- 
brane helix are labelled above the amino acid sequence. The signal 
peptide cleavage site, marked with it . slash. was predicted to be between 
residues 19 (A) and 20 (E) using SignalP3. () (Iittp: //www. cbs. dtu. dk/ 
services/SignalP/). Potential N-glycosylation sites are shaded grey; 
polyadenylation sequence is under/necl and the stop codon (TGA) is 
Lý] Springer 
I Contig 7652.1 
umlerlined and marked ý%ith an toicri. %/). Nucleotide numbers are 
shown at the Ir/i, b Schematic rhFcR, T gene representation. ('unties 
covering almost all of the chEeR I. gene were identified in the chicken 
genomc by the BLAST search using the chFcR/L cl)NA sequence. P('R 
using genomic DNA ",,, is used to corroborate the contigs and to 
complete the sequence. Fxons are numbered and labelled according to 
the regions they encode (filled indicates translated equencc): 5'('T and 
3'('T untranslated regions. S1 and S2 signal peptide. E(' j extracellular 
Ig domains 14. TV transmcmhranc helix. C cytoplasmic fail. 
c Realignment of eh/ i'R%/. in the chicken genome. The correct order 
of contigs that cover chh'(R, L, labelled \%ith their 2(H)4 assembly II) 
codes. The EM13L accession number tier chFcR 1. cDNA is AM41231 I 
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(Hillier et at. 2004). We have cloned and expressed a novel 
chicken protein that represents the first homologue of 
mammalian FcR and FCRL identified in the class Aves. 
Mammalian FcR and FCRL sequences were used with 
the Basic Local Alignment Search Tool (BLAST) to search 
the chicken genome and EST libraries. Two contigs 
(7,652.1 and 3,134.3 in the February 2004 assembly) and 
several ESTs were identified by the criterion of best 
reciprocal hit to an FcR or FCRL and analysed using 
Genscan and InterProScan (Burge and Karlin 1997; 
Zdobnov and Apweiler 2001). Partial sequence duplication 
suggests that these contigs overlap and cover four exons of 
a larger gene. 5' and 3' RACE PCR using primers specific 
for each exon were used to elucidate the sequence of the 
complete coding sequence for a novel protein that we have 
termed chFcR/L after the new nomenclature for FcR and 
FCRL (Maltais et al. 2006). The full-length transcript 
(Fig. la) was then amplified from complementary DNA 
(cDNA) derived from a chicken monocyte cell line, MQ- 
NCSU, known to express receptors for IgY Fc (Qureshi et 
at. 1990). Avian IgY is the orthologue of both mammalian 
IgG and IgE (Faith and Clem 1973; Warr et at. 1995), and 
thus, its FcRs may be functionally equivalent to mamma- 
lian FcyR and FccR. 
Despite further BLAST searching of the updated release 
of the chicken genome (May 2006), no other FcR or FCRL 
homologues were identified. Many immune-related multi- 
gene families that consist of numerous closely related 
sequences (such as the LRC and MHC) have proven 
difficult to fully sequence by the shotgun approach used 
for the chicken genome (Burt 2005). As the genome is, 
thus, incomplete, it is unwise to conclude that this is indeed 
the only sequence. 
In addition to the contigs described above, a further two 
were identified in the chicken genome that encode further 
exons of chFcR/L. The gene structure of chFcR/L, shown in 
Fig. lb, was elucidated by the alignment of contigs with the 
cDNA sequence. The fragments of chFcR/L were unas- 
signed to any chromosome in the February 2004 release of 
the chicken genome, but have since been anchored to 
microchromosome 25 in the March 2006 assembly. In both 
releases, chFcR/L is incorrectly assembled, as it lies in a 
region of Ig domains that are known to be difficult to order, 
but we have now definitively realigned the relevant contigs 
in the chicken genome (Fig. lc). 
The full length chFcR/L cDNA contains a 1,308-bp 
coding sequence for a 20aa signal peptide and a 415aa 
transmembrane glycoprotein consisting of four extracellular 
domains that belong to the immunoglobulin (Ig) superfam- 
ily, a transmembrane helix and a short cytoplasmic tail 
(Fig. la). The extracellular Ig domains have up to 48% 
amino acid identity with Ig domains of the members of the 
mammalian FcR and FCRL, which is consistent with the 
level of conservation of other immune-related orthologues 
that have been observed between bird and mammal (Hillier 
et al. 2004). 
At -3,670 bp, the chFcR/L gene is smaller than any 
mammalian FcR or FCRL gene due to introns that, whilst 
they conform to the GT-AG rule (Breathnach et al. 1978; 
Catterall et al. 1978), are less than 25% of the size of their 
mammalian counterparts, which is typical of most chicken 
genes (Waltari and Edwards 2002). As shown in Fig. lb, 
chFcR/L has seven exons: exons III, IV, V and VI encode 
one extracellular Ig domain each (EC1-4), and follow the 
phase 1 splicing typical of Ig and Ig-like domains (Davis et 
al. 2002; Ravetch and Kinet 1991). The transmembrane 
domain (TM), cytoplasmic tail (C) and 3' untranslated region 
(UT) are all encoded by exon VII. The signal peptide is 
encoded in chFcR/L over two exons (S I and SZ), the second 
of which is 21 bp in length. The split signal peptide is 
characteristic of FcR and FCRL, but not other Ig-containing 
immunoreceptor gene families, such as the mammalian 
LRC (Davis et al. 2002) or the recently discovered CHIR 
of chicken (Dennis et al. 2000; Viertiboeck et at. 2005). 
S, also encodes the 5'UT and the ATG translation initiation 
codon. 
chFcR/L contains four Ig domains (Fig. 2a) unlike any 
known FcR, and EC4 has the highest sequence similarity to 
a type found only in certain FCRL (Fig. 2b). However, in 
contrast to all surface-expressed members of the FCRL 
family that contain one or more ITIM- or ITAM-like 
sequences, chFcR/L lacks any known signalling motif in 
its cytoplasmic tail (Fig. 2a, b). Thus, chFcR/L combines 
features that in mammals are found in either FcR or FCRL, 
but not both, making it unique amongst all family members 
known to date. 
Screening the NCBI non-redundant protein database 
with the amino acid sequence of chFcR/L using BLAST 
returns members of the mammalian FCRL and FcR, as well 
as several Xenopus FcR homologues (Guselnikov et al. 
2004) and the recently discovered Ictalurus punctatus 
(catfish) FcR (Stafford et at. 2006). Phylogenetic analysis, 
comparing these hits with individual domains of chFcR/L, 
reveals that every domain has a related counterpart that 
variously occurs throughout the FcR and FCRL (coloured 
according to homology in Fig. 2a-c). A single homologous 
domain type is primarily responsible for Ig binding in each 
of the FcR (coloured dark blue in Fig. 2b). Domain EC2 of 
chFcR/L shares greatest homology with this domain, and it 
contains the conserved residues that are its hallmark (Davis 
et al. 2002). However, it is difficult to resolve where chFcR/L 
fits into the phylogeny of the FcR and FCRL. Profiase exon 
duplication events have occurred in a lineage-restricted 
fashion, and the evolutionary distance between mammals, 
birds, amphibians and fish has led to the considerable 
divergence of immune-related genes. Domains ECI-EC3, 
Springer 
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+ MoLse And-V5 Fig. 2 chFcR L contains Ig domains that share a common anccsu} 
with mammalian FeR and FCRL. a Schematic representation of 
chFcR L in the cell membrane in putative association with chFcR 
6C, a Fxtraccllular Ig domains 14. T. ti transmcmbrane helix. 
cytoplasmic tail. Although unconfirmed. chFcRy is shoe n a> :i 
homodimcr as in mammalian FcR complexes. Green triangles HAM 
motifs. b Schematic representation of mammalian FcR and , cleet. d 
FURL. The mammalian F('RL that contain the longest stretchc. oi 
alignment to chFcR L are showwn. Ig domains are coloured accordin 
to their relatedness to chFcR/L. Green Irianilce. s ITAM or [TAM-lik 
motifs. reel lriunt le. ý r rim or ITIM-like motifs. purple squares inucin- 
like regions. c Phylogenctic trcc showing comparison of indivi lu tI 
domain sequences of chFcR'L (hohl) with those of representativC 
mammalian FcR and F('RL, catfish IpFcRI and a member of the I R(-. 
C'D89. Sequences were aligned using ('IustalW (Thompson ct al. 
1994), and the neighbour-joining tree. with 1,000 bootstrap replicate. 
and pairv se gap deletions, was drawn using MEGA 3.1 (Kumar cl al. 
2004). The cculc' har represents evolutionary distance in substitution, 
per amino acid. Accession numbers for the sequences used are the 
following: human (hu)FcyRl (C'A112557), huFc), Rll (C'AA35642). 
huFcyRlll (CAA36870), huFccRi (AAI105912). huFC'RL. I 
(NM 052938), huF('RL2 (NM 030764). huFCRL3 (NM 052939), 
huFCRL4 (NM 031292), huF('RL5 (NM 031291), huF('RL6 
(NM 00 1 0043 1 0). huFC'RLA (NM 032735), huF('RLI3 
(NM 001002901 ). huFcaR, CDS9 (P24071 (. mouse (mo)FcyRl 
(P26151). moFcyRII (AAA37608). moFcyRIII (NP 034318). moFc- 
yRIV (NM_144559), moFccRl (NP (134314). moF('RLI 
(NM 153090), tnoFC'RL5 (NM 183222). ntoFCRLS (NM 030707), 
moFCRLA (NM 145141). moF('RLI3 (NM 001029994), catfish (Ip) 
FcRI (DQ286290) and chicken (ch)FcR/L (AM41231I) 
which have relatives in both FcR and F('RL, are outliers to 
one or both of these families (Fig. 2c). Although it is unclear 
whether chFcR/L is more closely related to one family rather 
than the other, it is apparent that mammalian FcR and FCRL, 
and chicken chFcR/F. share a common ancestry. If just a 
single gene is present in the chicken, it suggests either that 
all other FcR/FCRL genes have been lost in the avian 
lineage or that all mammalian FcR and FCRL family 
members are derived from a chFcR/L-like ancestor-that 
is. duplication events have occurred in the mammalian 
lineage, but not the avian lineage. 
chFcR/L cDNA was cloned into a mammalian expres- 
sion vector, pRY (Young et al. 1995), with the addition of 
an N-terminal V5 epitope tag after the predicted signal 
peptide cleavage site (Fig. 1) to allow detection by 
immunostaining. The vector was transiently transfected 
into CHO-K I cells with or without a vector containing the 
coding sequence of the chicken orthologue of FcRy 
(Viertlboeck et al. 2005). The VS tagged chFcR/L expres- 
sion was verified by intracellular staining in all trans- 
fections (data not shown) but was detectable at the cell 
surface only when co-transfected with the chFcRy (Fig. 3). 
The requirement of FcRy association for cell surface 
expression is a characteristic of human FcERIa, FcyRllla 
(Kurosaki and Ravetch 1989: Miller et al. 1989: Ra et al. 
1989) and FcyRI in vivo (Ernst et al. 1993, Masuda and 
Roos 1993; van Vugt et al. 1996), although the latter can be 
transiently expressed in its absence (Allen and Seed 1999). 
; ýý 
++ Ani mouse FITC 
c hFc RiL 
chi cil'L 
FcR. 
Fig. 3 chFcR L protein can he r\pres, cd at the cell , url: iee in the 
presence of chFcRy. ('110-KI cells were grown in I)MI: M I0 
FC'S on chamber slides and transfected with a mammalian 
expression . ector encoding chFcR I. with an N-terminal VS tag 
((iKPIPNPLLGL. DST) and a 5' leader sequence from the variable 
kappa light-chain of the mouse monoclonal antibody B72.3. either 
alone (top) or in conjunction with a similar vector encoding chFeRy 
(bottom), using Transit ('HO transfection reagent (Mires Rio. USA), 
as per the manufacturer's protocol. ('ells were lixcd with 4".. 
paraförmaldchyde in P13S and stained with either mouse anti-VS 
(Sigma-Aldrich. USA) at I l1g ml followed by anti-mouse FIT(' 
(Dako. UK) at 10 Leg/ml or with anti-mouse FIT(' alone (It'll). 
Cells were washed with PUS containing I" USA three times or 
i min each hemccn all steps and incubated with antibodies in the 
same buffer Im I li at 4'('. FIT(' was detected and photographed 
using a Zeiss fluorescence Axioscope fitted ý61h an AxioC'am CCD. 
Scale bar 50 um 
In contrast, the mammalian FCRI. that contain TMs do not 
require an accessory molecule tier their expression or ability 
to trigger intracellular signalling cascades (I? hrhardt et al. 
2003, Len et at. 2005). In vitro expression of' chFcR/l. 
confirms that it is indeed a transmemhrane protein, and its 
apparent association with an orthologue of FcRy suggests 
that it is an activating receptor. Work is in progress to 
investigate IgY binding to chFcR/L. 
To date, orthologues that represent almost all of' the 
mammalian Ig-like immunoreceptor families have been 
described in the chicken, with the notable absence of' the 
FcR and FCRL (Viertlhoeck et at. 2005). chFcR/L is the 
first member of' this tiºmily to he identified in an avian 
species. Its unique features and phylogenetic relationship to 
key players in the mammalian immune system makes it a 
significant addition to our knowledge of' this important 
immunoregulatoiy tiºmily. 
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